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INTRODUCTION 
Enzymatic acetylation of a large variety of compounds is a 
universal phenomenon in nature Currently rore than 32 acyl-
transferases have been described which make use of acetyl-
coenzyme A as acetyldonor (e g IUB, 1979) Only a few of 
these transferases are involved in acetylation of proteins 
Two types of enzymatic protein acetylation can be distin­
guished, namely acetylation of the ε-aminogroup of lysine 
residues (N -acetylation) and of the a-aminogroup of the 
N-termini of proteins (N -acetylation) 
N -acetylation has sofar only been found in histones This 
process is catalyzed by histone acetyltransferase (EC 
2 3 1 48), actually a group of enzymes witn different specif­
icities towards histone acceptors This type of acetylation 
is reversible N -acetylation of histones has been reviewed, 
and the reader is referred to the relevant publications for a 
detailed discusssion (Dixon et al , 1975, Allfrey, 1977, Is-
enberg, 1979, Doenecke and Gallwitz, 1982) Histone 
N -acetylation is a ubiquitous phenomenon in eukaryotes 
There are multiple acetylation sites in all four nucleosomal 
core histones H2A, H2B, H3 and H4 It is assumed that lysine 
residues are acetylated at the same positions in the histones 
of all eukaryotes Since the N -acetylgroups in lysine turn 
over rapidly, there must be a very intricate interplay be­
tween histone acetylating and deacetylating enzymes Both 
have been isolated and purified partially The highly basic 
histones are thought to form salt bridges with the negatively 
charged DNA backbone, thus giving a tight binding of histone 
to DNA in the nucleosome The neutralization of positive 
charges by introducing acetylgroups changes the internal 
structure of the nucleosomes and the ability of nucleosomes to 
interact with each other Thus, histone N -acetylation and 
deacetylation may be part of a system which regulates the 
state of higher order chromatin interactions in relation to 
the respective chromosomal functions Several correlations 
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have been established between the degree of histone acetyla-
tion and the transcriptional activity. Histone N -acetylation 
therefore appears to have an important biological function. 
The first polypeptide with an N -acetylgroup was discovered 
in 1958 by Narita. Thereafter numerous proteins followed. 
№-Acetylation is also catalyzed by acetyltransferases, which 
are, however, not identical to the histone acetyltransferas­
es. This type of acetylation is irreversible. The 
Na-acetylgroup can only be removed from the N-terminus of a 
protein under conditions which are harmful to the polypeptide 
itself. Therefore sequencing of N -acetylated proteins always 
has been a difficult problem. The general strategy is to iso­
late, after enzymatic digestions of the protein, the peptide 
which contains the blocked N-terminus. The smaller this pep­
tide, the easier is the subsequent analysis. Several methods 
have been used to detect the acetylgroup and to determine the 
sequence of the small peptide: 
1. Peptides are subjected to methanolysis, and the liberated 
methyl acetate is determined by gas chromatography (e.g. 
Hoenders et .al,., 1968). The sequence can be determined 
by carboxypeptidase digestion. 
2. Peptides are investigated by H'-NMR (e.g. Cozzone and Mar-
chis-Mouren, 1970). The sequence can be determined by 
carboxypeptidase. 
3. Acetate in proteins can be determined with an enzymatic 
method (Stegink, 1967). Proteins are hydrolyzed, and the 
liberated acetate is metabolized: 
acetate + ATP + CoAi^acetyl-CoA + AMP + PPi (Mg2 + ) 
L-malate + DPN Üoxaloacetate + DPNH + H+ 
acetyl-CoA + oxaloacetate + H„0 —•citrate + CoA 
In this procedure acetate is converted to acetylcoenzyme A 
m the presence of acetyl-CoA synthetase; the acetylcoen-
zyme A formed is coupled with oxaloacetate in the presence 
of citrate synthase. Oxaloacetate in turn is formed from 
L-malate in the presence of malate dehydrogenase and DPN . 
DPNH is measured. This method is normally applied to hy-
drolysates obtained from the complete protein. The 
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sequence of the N-terminal residues then still has to be 
determined. 
A variant has been described (Kuo and Younathan, 1973) 
in which the acetate is metabolized in another way 
4. Peptides are cleaved with anhydrous hydrazine which gives 
acetyl hydrazide and acyl hydrazides , which are identi-
fied by paper chromatography (e.g. Marita, 1958) In a 
variant of this method the reaction mixture is allowed to 
react with l-dimethylamino-naphtalene-5-sulfonyl chlo-
ride (dansyl chloride), and the resulting l-acetyl-2-
dansyl hydrazide is identified by two-dimensional 
thin-layer chromatography (Schmer and Kreil, 1969) The 
sequence of the peptide can be determined by carboxypepti-
dase digestion. 
5 Peptides are treated with [ H.]acetic anhydride, and then 
permethylated with CH,I in order to make them more vola-
tile. The resulting derivative is examined with electron 
impact mass spectrometry (e.g. Morris, 1972; Morris et 
al., 1976). Alternatively, the peptide is subjected imme-
diately to chemical ionization mass spectrometry (e.g 
Morris et_al., 1978). Using this method the sequence of the 
peptide is determined along with the identification of the 
acetylgroup. 
6 It is possible to partially deblock N -acetylated polypep-
tides having serine at position 1 by the induction of an 
N"»0 acyl shift with heptafluorobutync acid (Brandt et 
al., 1980). Provided the ß-carboxylgroup of aspartic acid 
is blocked either via peptide formation with glycine me-
thyl ester or by direct esterification, the treatment 
leads to specific cleavages at seryl and threonyl resi-
dues It has still to be seen how useful this technique 
really is. 
The fifth method is the most powerful one and gives unequiv-
ocal results. At present it is the technique which is used 
most often. How difficult the detection of the acetylgroup 
and the sequence determination of the N-termmal region in the 
case of blocked proteins is, can be illustrated by the fact 
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that in the older literature some mistakes have been made, 
which later had to be corrected , for instance m the cases of 
o-actin of rabbit (Gaetjens, 1966; Alving and Lakin, 1966; 
Adelstein and Kuehl, 1970; Vandekerckhove and Weber, 1978), 
lactate dehydrogenase M-chain of spiny dogfish (Allison et 
al. , 1969; Taylor, 1977) and globin ß-cham of chicken (Satake 
at al., 1963; Matsuda et al., 1964, 1973 ). The last one is not 
acetylated at all. 
For a comprehensive discussion of the structural character-
istics of proteins which are N -acetylated in vivo, and other 
factors important for the acetylation of proteins the reader 
is referred to Chapter I. More information on the properties 
of the responsible N -acetyltransferases can be found in the 
introduction of Chapter IV, and an evaluation of the possible 
functions of the N -acetylgroup is given in the introduction 
of Chapter V. 
A BRIEF OUTLINE OF THIS THESIS 
Chapter I gives a compilation of all N -acetylated proteins 
described m the period 1958-1982 The structural and other 
requirements for enzymatic N -acetylation are discussed. 
Granger et al. (1976) showed that bovine lens contains an 
N -acetyltransferase. This enzyme is probably responsible 
for the acetylation of the subumts of a- and ß-crystallin, 
which make up 80 % of the soluble lens proteins ( Hoenders et 
al., 1968; Mok and Waley, 1968, Van Kamp and Hoenders, 1973) 
Granger described in her thesis (1976) some preliminary at-
tempts to purify and characterize this enzyme. It was thought 
worthwile to pursue this research further. Although an assay 
to determine the enzyme was available, its shortcomings were 
tediousness and excessive time-consumption. Therefore, an-
other more rapid assay has been developed. In Chapter II the 
synthesis of an analogue of o-MSH-(1-10)-decapeptide, with 
norleucme instead of the native methionine at position 4, is 
described. This was necessary m order to have available a 
substrate for N -acetylation which is resistant to oxidation 
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during isolation. Chapter III describes the assay for 
N -acetyltransferase activity which makes use of re-
versed-phase HPLC for isolation of the substrate after enzym-
ic acetylation. Chapter IV describes the partial purifica-
tion of the bovine lens N^-acetyltransferase and its substrate 
specificity. To this end some aminoterminal ACTH-fragments 
have been synthesized. 
By addition of oxaloacetate and citrate synthase to a reti-
culocyte cell-free system it is possible to prepare protein 
chains with prevention of acetylation (Palmiter, 1977). 
Chapter V describes experiments to elucidate the role of 
N -acetylation of the bovine lens protein a-crystallin, which 
make use of this technique. 
In Chapter VI the determination of the blocked M-terminal 
region of 0Bp, the major subunit of bovine lens ¡S-ci ystallin, 
is described. For the identification of the blocking group 
mass spectrometry has been used. 
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CHAPTER I 
THE MECHANISM OF Na-ACETYU\TION OF PROTEINS 
Huub P.C. Onessen, Wi l f r ied W. de Jong, Godefndus I . Tesser and 
Hans Bloemendal 
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SUMMARY 
In the period 1958-1981 the complete or partial sequence of 
361 proteins has been described which are N -acetylated. With 
the aid of these sequences the structural and other require-
ments for N -acetylation have been examined. It appears that 
Na-acetylation is a phenomenon which is almost exclusively re-
stricted to eukaryotes, and for a large part to structural 
proteins. Acetylation is a post-initiational process, re-
quiring the presence of the enzyme N -acetyltransferase and 
the cofactor acetylcoenzyme A. Enzymatic deacetylation does 
not appear to occur. N -acetyltransferases appear to have a 
narrow substrate specificity, which is almost identical for 
enzymes from different tissues and species. The ammo acids 
which are predominantly present at the N-terminus of 
N -acetylated proteins are Ala, Ser and Met. The presence of 
these residues is a very important prerequisite for acetyla-
tion. The N-terminal region following these amino acids is 
also a major determining factor. For proteins starting with 
Met the information necessary for N -acetylation is enclosed 
within the first three residues. The second position is always 
occupied by a strongly hydrophilic ammo acid, and is very 
often acidic. The N -acetylation of proteins starting with 
Ser and Ala is determined by the first 4 and 5 residues, re-
spectively. In both cases the overall hydrophobicity of this 
region must not be excessive. Two- and three-dimensional 
structural characteristics do not seem to play a decisive role 
in N -acetylation. 
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Ν-terminal blocking of proteins is a wide-spread phenomenon 
in eukaryotes, prokaryotes and viruses (Dayhoff, 1972-1978, 
Uy and Wold, 1977; Wold, 1981). As №-acylating groups have 
been recognized formyl, acetyl, pyruvoyl, a-ketobutyryl, glu-
curonyl, a-ammoacyl, pyroglutamyl, murein, glucose (Uy and 
Wold, 1977; Wold, 1981) and carbon dioxide (Kilmartin and Ros­
si-Bernardi, 1969). Some of these blocking groups are 
extremely rare. Brown and Roberts (1976) provided evidence 
that about 80 % of the soluble proteins from Ehrlich ascites 
cells are N -acetylated It is also very likely that approxi­
mately 90 % of the proteins from mouse L-cells is 
N -acetylated (Brown, 1979a). In lower eukaryotic organisms 
(Saccharomyces fragilis. Neurospora crassa) the soluble pro­
teins are acetylated for about 50 % (Brown, 1979b). Therefore 
it is obvious that the N -acetylgroup is a very important 
blocking group. 
The function of N -acetylation is not known, but it has been 
suggested that a general function may be protection of prote­
ins against proteolytic degradation by ammopeptidases 
(Jornvall, 1975) However, experiments to sustain this hy­
pothesis have not provided conclusive evidence (Mauk et al , 
1976; Brown, 1979a; Rubenstein and Deuchler, 1979; Berger et 
al., 1981; Driessen^t al , 1983) 
Ν -acetylation is an enzymatic process, and the responsible 
enzyme has been demonstrated and studied in Escherichia coll 
for nbosomal protein L12 (Brot et al_. , 1973), for n b o -
some-associated proteins from rat liver (Pestaña and Pitot, 
1975a,b; Green et al , 1978), in calf lens (Granger et al., 
1976), rat pituitary (Woodford and Dixon, 1978; Pease and Dix-
on, 1981; Glembotski, 1982b), hen's oviduct (Tsunasawa et 
al., 1981) and in a nbosomal fraction of wheat gerra (Kido et 
ab , 1981) . 
It was initially thought that different N -acetyl aminoa-
cyl-tRNAs might serve as the initiators of protein synthesis 
in various eukaryotic systems (Laycock and Hunt, 1969; Nanta 
et al. , 1969; Liew et аі^ . , 1970), and that therefore 
N -acetylated proteins with different N-termmal amino acids 
should be produced. However, it has become evident (e.g. 
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Jackson and Hunter, 1970, Leis and Keller, 1970; Wigle and 
Dixon, 1970; Chatterjee et al_ , 1972) that methionine is the 
initiating residue of eukaryotic proteins as it is in proka-
ryotes Moreover, on direct search no N-acetylseryl-tRNA 
could be detected in rat liver (Green and Elee, 1978) For 
some N -acetylated proteins it was shown directly that miti-
tiation starts with methionine, e g. for a-crystallin (Strous 
et al., 1972), ovalbumin (Prasad and Peterkofsky, 1976) and 
histones (Kecskes et a_l., 1976). In many proteins the initi­
ator Met is then removed In Escherichia coll the responsible 
methionine aminopeptidase appears to have a preference for 
cleaving the Met-X peptide bond if X is Ala or Ser (Capecchi, 
1966). For this organism a nbosomal-bound aminopeptidase has 
been isolated which preferentially removes N-terminal methio­
nine from peptides (Matheson and Dick, 1970) However, if 
position 2 is occupied by an Asp no hydrolysis takes place. 
For yeast there is evidence that the methionine aminopepti­
dase hydrolyzes the Met-X bond very efficiently m case X is 
Ala or Thr, less efficiently if X is Val, and not at all in 
case X is Leu, lie or Aig (Stewart et al , 1971). For immuno-
globins and hemoglobin it has been shown that Met-X is cleaved 
if X is Ala or Val, but not if X is Glu οι Asp (Burstem et al , 
1976). This clearly demonstrates the important role of the 
amino acid at position 2 However, the overall conformation 
of the N-terminal region may also be an important factor for 
removal of the N-terminal Met It is now thought that for most 
proteins acetylation takes place at the level of the pepti-
dyl-tRNA , and thus is a post-initiational process Strous et 
al. (1973, 1974) and Bloemendal and Strous (1974) showed that 
a-crystallin A_ is acetylated in vitro when the nascent chain 
of about 25 residues protrudes from the ribosome Acetylation 
is complete at a length of 50 residues. In ovalbumin (Palmiter 
et al , 197Θ) the initiator methionine is removed in vitro 
when the nascent chain is 20 amino acids long ; acetylation 
takes place at a length of 44 residues. In vitro the fS-cham 
of cat hemoglobin В is acetylated when the nascent chain is 
about 30 amino acid residues (Kasten-Jolly and Taketa, 1982) 
That acetylation is a post-initiational process has also been 
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suggested for translation of brome mosaic viral RNA in vitro 
(Shih and Kaesberg, 1973), for rat liver polyribosomes in vi-
tro (Pestaña and Pitot, 1974, 1975b; Green et_al., 197Θ). 
Acetylation thus starts when the nascent chain begins to 
emerge from the ribosome at a length of about 25 residues, or 
somewhat later if the initiator methionine has to be removed 
first. Since it normally is assumed that protein chains are 
not yet completely folded when emerging from the ribosome, the 
N-terminal amino acid sequence of a chain can thus be expected 
to be an important factor in N -acetylation. 
Several reports have provided evidence that acetylation of 
proteins can take place m heterologous systems. Berns et al. 
showed that calf lens a-crystallin A- chain mRNA directs the 
synthesis of normally acetylated a-crystallin A^ chains in 
frog oocytes (1972) and in a reticulocyte lysate (1973). 
Brome mosaic virus RNA produces N -acetylated coat protein in 
a cell-free system from wheat germ (Shih and Kaesberg, 1973). 
The wheat germ system is also capable of acetylatmg rat cyto­
plasmic actins (Garrels and Hunter, 1979) and synthetic 
N -desacetyl thymosin o. (Kido ^t a_l. , 1981). The reticulo­
cyte lysate also gives acetylated cytoplasmic actm of 
Drosophila (Berger et al., 1981) and Dictyostelium discoideum 
(Redman and Rubenstein, 1981; Rubenstem et al., 1981). In 
experiments with isolated N -acetyltransferases it has been 
shown that the enzymes from hen's oviauct (Tsunasawa et al. , 
1981) and bovine lens (Granger et a_l_. , 1976) acetylate the 
N-terminus of ammotermmal ACTH-f ragments, the 
(1-13)-sequence of whicn is normally acetylated by pituitary 
N -acetyltransferase to produce a-MSH (Woodward aud Dixon, 
1979; Pease and Dixon, 1981; Glembotski, 1982a,b). Thus at the 
moment it seems probable that eukaryotic cells possess one or 
more N -acetyltransferases capable of acetylatmg various 
proteins with different N-terminal regions. 
Jornvall examined in 1975 the then known 40 N-termmaily 
acetylated proteins for structural characteristics of the 
N-termmal region.. He established that in the acetylated 
N-terminal position serine and alanine are predominant as 
compared with the distribution of M-terminal residues in gen-
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eral. Branched-chain residues would be more frequently 
present in the N-terminal region of acetylated proteins than 
in proteins in general. These properties were observed re-
gardless of origin and function of the proteins. These facts 
indicate that N -acetyltransferases have very specific re-
quirements as far as the structure of the N-terminal region of 
proteins is concerned, although the substrate specificity of 
the enzymes from various tissues and species is very similar. 
Here we describe in detail the structural and other require-
ments for N -acetylation on basis of the now known sequences 
of acetylated and non-acetylated proteins. 
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METHODS 
The primary structures of proteins as compiled by Dayhoff 
(1972-1978) have been used Moreover, for N -acetylated pro­
teins published between 1977 and 19Θ2 the literature has been 
screened Only the first ten amino acids were taken into ac­
count Care was especially taken to check the evidence given 
for the presence of an N -acetylgroup Acetylgroups assumed on 
basis of homology were allowed if the reference protein had 
been determined unambiguously In case of an assumed 
N -acetylgroup in which the first amino acid is not identical 
to that of the reference protein, we did not accept the ace­
tylgroup Sometimes a protein was included which had been 
described as being N-terminally blocked, in this case a homo­
logous N -acetylated sequence had already been reported The 
complete compilation of N -acetylated proteins, listing 361 
entries, is available from the first author 
In order not to overemphasize structures of which many spe­
cies variants are κηο^η, it was necessary to use some means of 
selection For comparison of only the N-terminal amino acids, 
we used stringent selection rules 
1 The N-terminal amino acid must be known 
2. In the case of homologous proteins, only a singe represen­
tative sequence is taken into account However, when there 
is reasonable evidence for products of duplicated or al­
lelic genes one product of each orthologous gene is con­
sidered (Fitch, 1970) This is the case for 
tissue-specific proteins, isozymes and proteins which are 
only found in a restricted group of species The product 
of each unique gene is thus included in our analysis 
3 However, if a species variant has an N-termmal amino acid 
differing from the reference protein it is taken into ac­
count 
4 Precursors which give a product having the same N-termmal 
sequence are not taken into account 
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These rules are not always unambiguous, since it is not known 
in each case if gene products are orthologous or paralogous. 
In these cases the decision has been arbitrary. After se-
lection there is still some bias, because of the presence of 
related gene products 
We estimated the total number and the nature of all se-
quences known up to 1978, by applying criterion 2 and 4 of the 
less stringent rules on the cumulative index of Supplement 3 
of Dayhoff (1978) 
When comparing the (1-10)-decapeptide sequences of 
N -acetylated and non-acetylated proteins, we used some less 
stringent rules in order to have as much structural informa-
tion as possible available 
1. The sequence of at least the first five amino acids must be 
known. Asx, Clx or undetermined positions are not al-
lowed. 
2 If Asx, Glx or undetermined positions occur in the second 
five residues, the sequence up to that residue is consid-
ered. 
3. In case of a protein for which identical sequences are 
known in more species, only one species is taken into ac-
count. However, a variant is accepted as a new entry. Shor-
tened sequences, which are N-terminally identical to 
complete (1-10)-sequences, are not accepted. 
4 In case of a protein in which there is tissue-specificity, 
gene multiplicity, allelic variation or species-dependent 
diversity, every tissue, gene, allei or species product is 
considered as a protein of its own. 
5. Precursor proteins with the same N-terminus as the product 
are not accepted 
6. Acetylated proteins with incomplete blocking (< 60 %) are 
not accepted 
7. Among the non-acetylated proteins all otherwise 
N-terminally blocked proteins are included. 
For the determination of hydrophobicity values we used the 
"hydropathy" index for amino acids of Kyte and Doolittle 
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(1982), which is based on water-vapor transfer free energies 
and the interior-exterior distribution of side-chains from 
amino acids. Values vary from -4.5 for Arg through -0.4 for 
Gly to +4.5 for lie. For every protein the hydrophobicity was 
averaged over the number of positions involved (span length), 
and is thus given per residue. Moreover, the hydrophobicity 
per residue was averaged over all proteins. 
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RESULTS AND DISCUSSION 
The N-terminal residue of proteins 
From experiments by Waller (1963), Horikoshi and Doi (1968) 
and Brown (1970) it is known that methionine, alanine and se­
rine are the major N-terminal amino acids of the soluble un­
blocked proteins of prokaryotes, and that in eukaryotes 
alanine and serine are predominant When all protein sequence 
data from Dayhoff (1972-1978) were assessed for uniqueness 
with the stringent selection rules, 582 proteins were left. 
Table I lists the N-terminal residues of these proteins and 
their relative amounts. When Ala, pyrrolidone carboxylic acid 
(ir-Glu), Met and Ser are taken together they amount to 46.5 % 
of the total. On basis of the average amount of these amino ac­
ids in proteins (Dayhoff, 1978), this should have been around 
20 %. Obviously these amino acids are found much more fre­
quently at the N-terminus of proteins than expected. This is 
demonstrated also very clearly by the ratio between these 
N-terminal amino acids and the average presence of these resi­
dues (Table I). Only Ala, τι-Glu, Met and Ser have a ratio 
higher than 1 Since the protein sequence dataset from Dayhoff 
contains proteins, both soluble and insoluble, from eukaryot-
ic, prokaryotic, viral and bacteriophageal origin, it is 
clear that the N-termmal amino acids determined in soluble 
unblocked proteins, from either eukaryotic or prokaryotic 
source, as described above, do not have to fit exactly with 
the protein data of Dayhoff Immunoglobulins, some contrac­
tile system proteins etc. are not present in prokaryotes and 
lower eukaryotes used for the determinations of Waller 
(1963), Horikoshi and Doi (1968), and Brown (1970). However, 
the predominance of Ala and Ser in the proteins from Dayhoff 
(1972-1978) is quite consistent with these determinations. 
The relative abundance of Met at the N-terminus may be ex­
plained by the fact that this probably is the initiator methi­
onine, which is still present on the chain. When looking at 
the nature of the other three. Ala, Ser and τι-Glu , the latter 
being assumed to originate from Gin (Regier and Kafatos, 
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Ν - t e r m i n a l 
amino a c i d 
A l a 
Arg 
As η 
Asp 
Cys 
Glu 
Gin 
π-Glu 
Gly 
His 
I l e 
Leu 
Lys 
Het 
Phe 
Pro 
Ser 
Th г 
Trp 
Туг 
Val 
Nimber o f 
p r o t e i n s 
101 
25 
10 
27 
15 
30 
3 
59 
33 
8 
IS 
29 
21 
46 
9 
19 
64 
24 
2 
9 
30 
582 
Presence i n 
N - t e r m i nal 
p o s i t i o n 
( 4 ) 
17.4 
4 . 3 
1.7 
4 . 6 
2.6 
5 . 1 
0.5 
10.2 
5.7 
1.4 
3 . 1 
5.0 
3.6 
7.9 
1.5 
3.3 
11.0 
4 . 1 
0.3 
1.5 
5.2 
Average Presence 
presence t e r m i n u s 
(%) presence 
8.6 
4.9 
4 3 
5.5 
2.9 
6.0 
3.9 
. 
8.4 
2 0 
4 . 5 
7.4 
6.6 
1.7 
3.6 
5.2 
7.0 
6 . 1 
1 3 
3 4 
6.6 
2.0 
0.9 
0 4 
0 . 8 
0.9 
1.6 
0 . 7 
0.7 
0.7 
0.7 
0.5 
4.7 
0 . 4 
0 . 6 
1.6 
0.7 
0.2 
0.4 
0 . 2 
on N-
/average 
Percentage o f N - t e m i n a l 
b l o c k i n g and n a t u r e o f 
t h e b l o c k i n g g r o u p 
3.4 Ac + 0.2 Me 
0 2 Ac 
0.3 Ac 
10.2 i i -Glu 
0.5 Ac + 0 . 2 F 
1.2 Ac + 0 . 3 F + 0 . 2 Me 
0 . 2 F t 0 . 2 Me 
4.3 Ac 
21 4 « 
Table I. N-terminal amino acid of proteins compared with the average 
presence in proteins (Dayhoff, 1978). The nature of the blocking group, 
if any, is indicated. 
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1981), it is known that Ala originates from codons starting 
with G (4X), Ser from codons with U (4χ) and Α (2χ), and Gin 
from С (2») . Assuming an equal probability for the use of each 
codon, we find that there is a 50 % probability that the first 
nucleotide of the codon used for these N-terminal residues is 
A or G. However, Manderschied et al (1978) reported that in 
mRNA sequences the initiation triplet AUG is very often fol­
lowed by a codon starting with a purine nucleotide. They found 
that the Escherichia coll 30S initiation complex formation 
with initiator-tRNA occurred far more readily with the tetra-
nucleotides AUGA and AUGG than with AUG itself or AUGU. This 
suggested that the initiator-tRNA, which has a U residue fol­
lowing the anticodon, recognizes the initiation site through 
four nucleotides. In a search for the information necessary 
for an optimal binding of a mRNA to an Escherichia coli ribo-
some, it was found that in the optimal fit an A follows the AUG 
codon (Scherer et a_l , 1980). However, the mRNA sequences 
showed that actually about 70 % of the nucleotides following 
AUG is A or G. It is not known if these rules are also valid for 
eukaryotic mRNAs For many proteins the initiator Met is re­
moved, especially if the second residue is Ala or Ser 
(Capecchi, 1966, Burstein et a_l_. , 1976). In most cases the 
N-termim. of proteins correspond with the second codon of the 
responsible mRNA. If the hypothesis of Manderschied et al 
would have general validity N-termmal Ala and Ser would fit 
reasonably well However, this does not give an explanation 
why the other amino acids coded for by triplets starting with 
an A and G are much less present at the N-terminus of proteins 
than Ala and Ser. 
Which of the N-terminal residues of proteins are blocked' 
It appears that 21.4 % of the known sequences are blocked, ei­
ther by a formyl- (0 7 % ) , a methyl- (0.6 % ) , a pyroglutamyl-
(10.2 %) or an acetylgroup (9 9 %) Of the 21 4 % blocked 
N-terminal amino acids 19 8 % are represented by just four am­
ino acids, Ala, n-Glu, Met and Ser So there is a strong 
preference for N-terminal blocking of exactly the same amino 
acids which are overrepresented at the N-terminus. No expla­
nation for this phenomenon can be given at the moment 
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Factors which may influence N -acetylation 
Several factors may influence N -acetylation of proteins. 
The availability of the enzyme involved is the most important 
one. This has been demonstrated for the products of the pre­
cursor protein pro-opiomelanocortin ACTH, which has 
N-terminally the same sequence as a-MSH, is non-acetylated, 
while α-ΜΞΗ mostly is (Dayhoff, 1972-1978) a-MSH is only ace-
tylated in pars intermedia, while it is non-acetylated in 
other parts of the pituitary and the brain (Evans et al. , 
19Θ2 ) ß-Endorphin, which normally has a free N-terminus, nec-
essary to exhibit its morphomimetic character, becomes 
acetylated only in pais intermedia (Smyth et al., 1979; Smyth 
and Zakarian, 1980, Deakin et al., 1980). The 
N -acetyltransferase responsible for the N-terminal acetyla-
tion of these two polypeptides is present only in secretory 
granules in intermediate pituitary of rat and ox (Glembotski, 
(1982a). N -acetylation has been shown to be linked to a-MSH 
release from pars intermedia of the amphibian pituitary gland 
(Martens et _a_l. , 1981). It may well be that this acetylation 
of products which only come into existence after processing of 
a precursor protein is an exception, since for most proteins 
up to now acetylation has been shown to be a 
post-imtiational process. 
On the other hand a shortage of the cofactor, acetylcoen-
zyme A, may be responsible for incomplete acetylation 
Jornvall et a_l. (1980) showed that two isozymes of yeast alco-
hol dehydrogenase are synthesized with a consistent variation 
in acetylation under physiological conditions. Isozyme I is 
almost completely acetylated, isozyme II, which may be 
non-acetylated up to 40 %, is the predominant form during aer-
eation, when acetylcoenzyme A might be rapidly removed during 
efficient cell respiration. It has also been suggested that 
the availability of the coenzyme is a major factor in partial 
acetylation of human fetal hemoglobin, which has to compete 
with carbonic anhydrases В and С (both are N -acetylated ) for 
the available acetylgroups in reticulocytes, where the m a m 
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source of such groups, the mitochondrion, begins to disappear 
(Spencer and Carter, 1977). However, the case is more compli-
cated because of an enhanced activity of the responsible ace-
tyltransferase in erythrocytes as compared with reticulocytes 
(Garlick et _al^, 1981). Moreover, there is evidence that in 
vitro human fetal hemoglobin can be acetylated 
non-enzymatically (Garbutt and Abraham, 1981a). This acetyla-
tion can be increased by sodium butyrate (Garbutt and 
Abraham, 1981b). There are indications that sodium butyrate 
inhibits the turnover of preformed HbF. . It is suggested that 
this is caused by inhibition of deacetylating enzymes. This 
action of sodium butyrate has indeed been established for hi-
stone N -acetylation (Doenecke andGallwitz, 1982). 
The presence of deacetylases might be a third factor. Since 
there is evidence that N -acetylated proteins turn over at the 
same rate as non-acetylated proteins (Brown, 1979), it is pos-
sible that there exist such enzymes, which would make the pro-
tein accessible for aminopeptidases. However, up to now no 
enzyme removing N -acetylgroups from proteins has been found. 
On the other hand, the existence of enzymes deacylating 
N -acylamino acids has been established fairly well (e.g. 
Endo, 1978, 1980; IUB, 1979; Shvyadas et_al. , 1980a,b; Yamskov 
et al., 1981). Much less is known about enzymes deacylating 
peptides. There are reports on N -acylpeptide hydrolases in 
liver (Schoberg and Tschesche, 1981) and erythrocytes (Gade 
and Brown, 1978). These enzymes catalyze the hydrolysis of 
N -acylamino acids from the N-terminus of small peptides only. 
The human erythrocyte enzyme remarkably only releases acety-
lalanine, while the bovine liver enzyme also hydrolyzes 
acetylmethionine, -glycine, -serine and -phenylalanine. 
Therefore it has been suggested (Gade and Brown, 1978) that 
the removal of acetylgroups from proteins may be effected by 
proteases which release an aminoterminally acetylated pep-
tide, followed by an acylpeptide hydrolase which catalyzes 
the release of the N-acetylamino acid from the peptide and a 
deacetylase which hydrolyzes the acetylamino acid to yield 
acetate and the terminal amino acid. However, it is clear that 
such enzymes are involved in the catabolism of acetylated pro-
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tems At the moment there is absolutely no evidence that 
Na-acetylated proteins are enzynatically deacetylated There­
fore, deacetylation does not seem to play a role in the acety-
lation status of proteins 
In specific cases other factors may yet be involved An in­
triguing example has been desciibed for Escherichia coll 
This bacterium has a ribosonal protein which is found in both 
the Na-acetylated (L7) and non-acetylated form (L12) (Moller 
et al , 1972, Terhorst et a]_ , 1973) Foui copies of L7/L12 
are present on the nbosome ( Subiamaman 1975) Ramagopal 
and Subramanian (1974) provided evidence that during early 
growth L12 is the major foim piesent, while during the sta­
tionary phase L7 is the piedominnnt form This shift 
apparently requires production of new iibosomes, as it does 
not depend on modification of pieassembled iibosomes (Ramago­
pal and Subramanian, 1975) In hschetichia coll at least two 
but a maximum of five subspecies of the large subumts exist 
with regard to the L7/L12 content (Subramanian, 19^5) The 
observed variance ι ^  rhe L7/L12 latio would reflect contin­
uous changes in the selective abundance of these subspecies in 
vivo during the growth cycle Moreo/er, it has been determined 
that the level of the responsible N -acetyltiansferase in Es­
cherichia coll remains constant dui m g the giov>th cycle 
(Subramanian and Nehls, 1975) The possibility of a depletion 
of the available acetyldonors because of a high metabolism 
during growth should be investigated 
In conclusion, when N -acetyltiansferase and acetylcoen-
zyme A are present, the most important factor in 
N -acetylation is the primary stiuctuie of the N-teiminal re­
gion of the polypeptide chain (Jonwall, 1975) 
Which proteins are N -acetylated' 
Up to 1982 361 proteins were described to be N-terminally 
acetylated, many of which are species variations for a single 
protein When only unique genes are taken into account (using 
stringent selection rules) 118 proteins are left Table II 
lists the variety of classes to which they belong About 40 % 
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STRUCTURAL PROTEINS 
actins 
tropomyosin 
intermediary filament 
keratins 
virus coat proteins 
c r y s t a l l i n s 
ribosomal proteins 
hi stones 
myelin proteins 
others 
ENZYMES 
oxidoreductases 
transferases 
hydrolases 
lyases 
isomerases 
TRANSFER PROTEINS 
cytochrome с 
hemoglobins 
Ca- and METAL-BINDING 
parvalbumins 
troponin С 
myosin L-4 chain 
calmodulin 
i n t e s t i n a l Ca-binding 
SlOOb 
metallothioneins 
f e r r i t i n 
HORMONES 
a-MSH 
6-endorphin 
proteins 
PROTEINS 
protein 
6 
2 
2 
8 
9 
3 
4 
10 
2 
2 
10 
5 
4 
3 
1 
4 
12 
4 
3 
1 
1 
2 
1 
3 
1 
1 
2 
48 40 7 
23 19 5 
16 13 6 « 
16 13.6 % 
MISCELLANEOUS PROTEINS 12 10 1 % 
12 
Table II. Number of proteins (unique gene products) which are 
N -acetylated, and the groups to which they belong. 
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are structural proteins From the cumulative index of Supple­
ment 3 of Dayhoff (197Θ) we estimate that about 20 % of all 
unique sequences are accounted for by structural proteins. 
Thus N<I-acetylated polypeptides appear to be more often struc­
tural proteins than expected statistically A predominance 
of structural proteins might be expected, if the function of 
N -acetylation indeed were protection against aminopeptidas-
es. However, since there are many acetylated proteins with 
different size, origin and function, this general property 
does not seem to be a limiting factor for acetylation 
(Jornvall, 1975) 
It is immediately apparent that there are only a few prote­
ins N -acetylated which are not of eukaryotic origin (Table 
III). No example of an acetylated mitochondrial protein, cod­
ed for by the mitochondrial genome (Anderson et а_1. , 1981; 
Bibb et al , 1981), is known, noi acetylated polypeptides from 
bacteriophages There are only 5 pioteins of prokaryotic ori­
gin N -acetylated, 4 of which are nbosome-associated For 
viruses 12 proteins have been described to be acetylated 
When these data are compared with the distribution of these 
groups over all unique gene pioducts contained in Dayhoff 
(1978), it is obvious that predominantly eukaryotic and asso­
ciated proteins of viral origin are N -acetylated. At the 
moment they comprise 96 % of all known acetylated proteins. 
Data for viruses have to be considered with care, since many 
sequences have become available for this group since 1978. 
They might be underrepresented m the list of sequenced prote­
ins of Dayhoff (1978) 
Jornvall et al (1980) remarked that theie aie isozymes of 
bovine heart malate dehydrogenase and aldehyde dehydrogenase, 
in which the mitochondrial form is free, while the cytoplasmic 
form is N -acetylated They suggest that this reinforces an 
apparent link between non-acetylation and an environment with 
efficient aerobic respiration There is another enzyme with 
isozymic forms for which this phenomenon also has been estab­
lished. Mitochondrial aspartate aminotransferase of pig and 
chicken heart is non-acetylated (Kagamiya et al. , 1975; Gehr­
ing et al., 1975, Barra et al , 1977, Kagamiya et al., 1977; 
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Acetylated proteins All sequenced proteins 
Eukaryotes 
Prokaryotes 
Viruses 
Bacteriophages 
entries 
101 
s 
12 
0 
% 
86 
4 
lü 
ü 
77 
18 
1 
4 
Table ΠΙ. Origin of N -acetylated proteins as compared with all 
sequenced proteins. For the comparison only unique gene products 
have been used. 
Barra et al., 1980). The cytoplasmic form, however, is 
N -acetylated in chicken (Shlyapnikov et a_l ·/ 1979; Myasnikov 
et al. , 1980); in pig it is non-acetylated too (Doonan et al. , 
1975). Virtually all Cu/Zn-superoxide dismutases are con­
fined to eukaryotes (Harris et al., 1980), the Mn- and 
Fe-superoxide dismutases are widely distributed in euka­
ryotes, prokaryotes and mitochondria. The latter are all re­
lated to each other^but not to the Cu/Zn family of superoxide 
dismutases. Harris et al. (1980) interpret this similarity 
and the distribution in the light of the endosymbiontic hy­
pothesis, which suggests that mitochondria of eukaryotes have 
evolved from bacteria which existed as intracellular sym-
bionts in primitive eukaryotes (Sagan, 1967; Raven, 1970). 
This theory says that when the atmosphere became more aerobic, 
these symbionts were acquired as a means of confronting selec­
tive pressures that require oxidative pathways (Fridovich, 
1974). Probably the Cu/Zn type of enzyme evolved after the 
prokaryote-eukaryote divergence. In this respect it is re­
markable that almost all Cu/Zn dismutases are Na-acetylated 
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(Dayhoff, 1972-178), while the Mn and Fe dismutases are not 
(Dayhoff, 1972-1978; Harris et_al. , 1980) 
Concluding, N -acetylation is a phenomenon predominantly 
confined to eukaryotes. 
The N-terminal residue of M -acetylated proteins 
When the 361 Na-acetylated proteins, described up to 1982, 
are selected according to the stringent rules, the remaining 
118 unique gene products mainly have Ala, Ser and Met at the 
N-terminus (84.8%) (Table IV) 
Ala and Ser together make up 67 0 % of the total. This is some-
what less than the three-quarter reported by Jornvall (1975). 
However, it is obvious that methionine is found very often as 
N-terminal residue in acetylated proteins While Jornvall 
found only 4 other residues at the N-teiminus of acetylated 
proteins (i.e Asp, Gly, Thr, Val), we now can report the ex-
istence of other N -acetylated N-termini: Asn, Glu and Tyr. 
Although there is a clear preference for Ser, Ala and Met, 
there are still about 15 % proteins with other acetylated 
N-termini. Thus, at the aminoterminus of acetylated proteins 
half of the 20 amino acids can be found It is clear that the 
N-terminal residue of an acetylated protein is an important 
factor, as already established by Jornvall (1975). The three 
amino acids Ala, Met and Ser are all neutral; Ala and Ser are 
very similar in size, while Met is considerably larger. It is 
not known if this different bulkiness can be accommodated by 
the active site of just one N -acetyltransferase Remarkably, 
the larger hydroxyl amino acid Thr and the smaller aliphatic 
residue Gly, as compared with Ser and Ala, respectively, are 
not often present at the N-terminus of acetylated proteins 
The importance of the N-termmal residue is corroborated by 
the fact that the presence of a D-Ser at the N-terminus of an 
ACTH-fragment does not lead to N -acetylation in vitro (Gran-
ger et _al., 1976) This importance can further be demon-
strated with several proteins which are found to be either 
N -acetylated or not, depending on the nature of the aminoter-
minal residue. A convincing example has been found for the 
-35-
N-terminus Unique gene Percentage 
products 
Ac-Ser 
Ac-Ala 
Ac-Met 
Ac-Gly 
Ac-As ρ 
Ас-Glu 
Ac-Tyr 
Ac-Thr 
Ac-Val 
Ac-Asn 
41 
38 
21 
4 
4 
3 
2 
2 
2 
1 
η = 118 
34.8 
32.2 
17.8 
3.4 
3.4 
2.5 
1.7 
1.7 
1.7 
0.8 
Table IV. N-terminal amino acid of N^acetylated 
proteins (unique gene products). 
human mutant hemoglobin Rale igh. In t h i s p r o t e i n t h e β.Val has 
been r e p l a c e d by Ac-Ala (Moo-Penn e t _ a l . , 1977) . The o t h e r ex­
amples which follow are more complicated because more d i f f e r ­
ences than t h e N-terminal r e s i d u e are p r e s e n t . α-Globin nor­
mally has an unblocked Val or Met a t p o s i t i o n 1 (Dayhoff, 
1972-1978). I t i s N^-acety la ted in f i s h e s and amphibians. In 
amphibians t h e N-termmal ammo ac id i s Ala (Chauvet and Ach-
e r , 1968, 1971; Caf f in e t a_l. , 1969) or Ser (Maruyama e t a l . , 
1980), in f i s h e s Ser (Dayhoff, 1972-178; Doonan e t a l . , 1978; 
Bossa e t a_l. , 1978; B r a u n i t z e r e t a l . , 1980). Normally mamma­
l i a n B-globm has Val or Met a t t h e M-terminus wi th a f ree 
aminogroup (Dayhoff, 1972-1978). In the F e l i d a e family di f­
f e r e n t ß -g lob ins e x i s t (Taketa e t al., 1972), some of which 
are blocked a t the N- terminus . In domestic c a t the amino ac id 
a t p o s i t i o n 1 has been shown to be Gly in case of the unblocked 
(1-chain, and Ac-Ser in case of the blocked cha in (Mauk e t a_l , 
1976; Taketa e t a¿ . , 1977). ß-Globms of some r e p t i l e s have 
Ac-Ala a t the N-terminus (Leclercq e t ¿ 1 . , 1981). Tobacco mo-
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saie virus has a coat protein with either Ac-Ala or Ас-Ser on 
the N-terminus. However, one strain variant is known with un­
blocked Pro (Dayhoff, 1972-1978). In cytochrome с mammals 
have Ac-Gly-Asp and plants Ac-Ala-Ser at their N-terminus 
(Dayhoff, 1972-1978). All other eukaryotic cytochiomes с are 
non-acetylated. Insects have N-terminal Gly-Val, lower organ­
isms Pro-Ala, Thr-Gln and Gly-Phe. 
Since there are many non-acetylated proteins which have the 
same N-terminal amino acids as N -acetylated proteins, there 
must be other factors important for N -acetylation 
The N-terminal region of N -acetylated proteins 
From the introduction and preceding sections it has become 
evident that N -acetylation of eukaryotes and prokaryotes is 
not catalyzed by acetyltransferases with the same substrate 
specificity However, N -acetyltransferases from different 
species or tissue origin recognize the substrates of each oth­
er. Assuming that this is the general case, we wanted to 
determine to what extent the primary structure of the 
N-terminal region is a decisive criterion for the suitability 
of a protein to be a substrate for N -acetylation. Vie there­
fore examined the first 10 residues of proteins. 
To this end we made use of our compilation of N -acetylated 
proteins (361 entries), taking into account only those which 
have N-terminal Ala, Ser or Met (261 entries). These three 
were chosen, because they are the most important N-termmal 
residues of acetylated proteins. For the non-acetylated pro­
teins with the same N-terminal ammo acids use was made of 
Dayhoffs protein sequence data set (312 entries). Both prote­
in data sets were then screened with the less stringent 
selection rules This left 136 entries in the case of the ace­
tylated proteins, and 250 of the non-acetylated ones. 
The residual data sets were split up in entries from proka-
ryotic (including bactenophageal) and eukaryotic (including 
viral and mitochondrial) oiigin Since only a limited number 
of proteins is coded for by the mitochondrial genome (Anderson 
et al., 1981, Bibb et al., 1981), of which none іь included in 
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Eukaryotes (viruses, Prokaryotes (bacterio-
mitochondria) phages) 
H-Ala, Η-Met, H-Ser 136 114 
Ac-Ala, Ac-Met, Ac-Ser 133 3 
Table V. Number of proteins, acetylated and non-acetylated, belonging 
either to the eukaryotes of prokaryotes. 
our data sets, it seemed advisable to place all other mito­
chondrial proteins, coded foi by the nucleus of the eukaryote, 
in the eukaryotic section It is evident (Table V) that it is 
not possible to investigate the structural aspects of acety­
lated proteins from prokaryotic ongin, since only 3 are left 
after the selection. On the other hand, a lelevant number of 
sequences is known for eukaryotic proteins 
Both the acetylated and non-acetylated proteins from euka­
ryotic origin were ordered alphabetically and compared. For 
each of the three amino acids Ala, Ser and Met the sequences of 
both categories are given in the one-letter code up to the 
point where a difference between them is apparent (Table VI). 
For the protein sequences now known it is obvious that the de­
cisive information for N -acetylation is enclosed within the 
first 4 amino acids for N-terminal Ala, within 3 for Met and 5 
for Ser. In the case of Ac-Met theie is a conspicuous prefer­
ence for an acidic residue at position 2 Int this respect it 
is remarkable that the methionine aminopeptidase responsible 
for the removal of the initiator Met does not act in case po­
sition 2 is occupied by an acidic residue (Burstein et a_l , 
1976). 
However, the relative information for acetylation does not 
necessarily have to be enclosed in exactly the same number of 
residues of the N-terminal region of each protein. Some addi­
tional information can be gained from those entries of Table 
VI which originate from a single acetylated protein or a set 
of related acetylated proteins (Table VII). Differences are 
present at several positions between the boundaries we estab-
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Ac-
AAQ 
AASI 
ACC 
ACN 
ACR 
ADE 
ADF 
ADK 
ADO 
ADW 
AED 
AEVA 
AFA 
AFG 
AFKG 
!AGU 
AHL 
H-
AAK 
AAN 
AAP 
AASG 
AAV 
Ac-
|AKD 
IALK 
ACD | |AMT 
ADD 
ADG 
ADI 
ADL 
ADR 
ADS 
ADT 
ΑΕΙ 
AES 
AET 
AEVL 
AEVQ 
AFE 
AFKV 
AFP 
AGC 
AGq 
АПК 
AQP 
ASF 
ASN 
A5P 
ASQ 
ATF 
ATK 
ATL 
ATP 
|AVA 
AHR | 
AI | |AYN 
AYS 
H- Ac-
AKEl 
AKG| 
ALT 
ALV 
AL Y 
AMS| 
AN | 
API 
AQll 
AR | 
ASA 
ASD 
ASY 
MDA 
MDD 
MDG 
MDI 
MDK 
MDL 
MDP 
HDV 
MEA 
MEE 
HEI 
|MKR 
ATD 
ATT 
AT Y 
|MN 
AVE 
AVK 
AVL 
AVi) 
AVS 
AVT 
AW 1 
AYDl 
AYR 
H-
MA| 
HDM| 
MEC| 
MH 1 
MI ι 
MKL| 
ML 1 
MQl 
MR 1 
m ι 
Ac-
SAM 
SAO 
SCY 
SDA 
SDEE 
SDQA 
SEAP 
SELE 
SETAP 
SFA 
SFS 
SFT 
SGR 
SGV 
SH 
si 
SKI 
S KP 
SL 
SN 
SRP 
H-
SAG 
SAK 
SDEA 
SDH 
S DN 
SDP 
SDQS 
SEAE 
SEF 
SELT 
SES 
SETAA 
Ac-
SSK 
SSQ 
SSSQK 
STA 
STD 
STST 
SYN 
SYS 
SYS* 
SFD | 
SGH 1 
SKA 
SKQ 
SRE | 
H-
SSSQD 
SST 
STSR 
SV 
SYC 
SYD 
SYE 
SYS* 
Table VI. N-terminal region of acetylated and non-acetylated proteins, 
starting with Ala, Met and Ser. Residues are indicated with the one-
letter code. The sequence is shown up to the point where a difference 
between both classes is apparent. SYS* originates from a-MSH, which 
is non-acetylated in some species; the sequence is identical for all 13 
residues of the peptide. 
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alcohol dehydrogenase: 
SFTLT 
SIPET 
STAGK 
glycogen Phosphorylase: 
SKPKS 
SRPLS 
carbonic anhydrase B: 
ASPD 
ASPE 
myosin L-4 light chain: 
SFSAD 
SFSPD 
parvalbumins*: 
AFAG 
AFGL 
AFKG 
AKDL 
AMTE 
AVAK 
AYSG 
SFAGL 
SITDI 
SSKIT 
keratins*: 
ACCA 
ACCS 
ACND 
cytochrome c: 
ASFA 
ASFD 
ASFG 
ASFN 
ASFQ 
ASFS 
ATFS 
globins*: 
ADFD 
ADWD 
AH LT 
ASFD 
SLSAA 
SLSAK 
SLSAS 
SLSDK 
SLTAK 
SLTKT 
STSTS 
viral proteins*: 
SYNII 
SYNIT 
SYSIT 
α-crystal lin Α,,-chain: 
MDI 
MDL 
MDV 
hi stones*: 
MDA 
MDG 
SEAPA 
SEAPT 
SETAP 
Table VII. N-terminal region of acetylated proteins starting with Ala 
(4 residues). Met (3 residues) or Ser (5 residues). Amino acids are 
indicated with the one-letter code. All variants for a single protein 
or related set of proteins (*) are shown. 
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lished using Table VI, which do not appear to make acetylation 
impossible. 
When we calculate the percentage of occurrence of amino ac-
id residues for positions 2-5 and 6-10 for both the acetylated 
and non-acetylated proteins and compare the results with the 
average percentage of these residues in proteins in general 
(Dayhoff, 1978), there seems to be a preference for Asp and 
Ile m residues 2-5 of acetylated proteins, while Gly, Gin, 
Arg and Val are underrepresented (Table VIII). In the 
non-acetylated proteins Asp and Arg aie overrepresented, whi-
le Ala, Gly and Asn are underrepresented. Other extremely 
variant residues are not seen. We do not find the predominance 
of Ile, Leu and Val as reported by Jornvall (1975), and do not 
perceive a consistent pattern in the differences between ace-
tylated and non-acetylated proteins. Only for Arg the 
predominance in non-acetylated ptoteins is balanced by an un-
derrepresentation in acetylated proteins. In residues 5-10 
of both acetylated and non-acetylated proteins there are also 
apparent differences of an order of magnitude somewhat less 
than for residues 2-5. Thus differences tend to level off on 
going deeper in the chain. However, variations in residues 
2-5 of acetylated and non-acetylated proteins are not con-
sistent for the sequences now known. 
When we compare broad categories of amino acid residues for 
these same regions (Table IX) there seems to be a slight pre-
dominance of hydroxyl amino acids and acidic residues at posi-
tions 2-5 of acetylated sequences compared with proteins in 
general. However, the same phenomenon is apparent in 
non-acetylated proteins. Small aliphatic is underrepresented 
in non-acetylated polypeptides. We do not think that it is 
possible to carry out statistical quantitation, because our 
data sets are still rather small and contain overemphasis on 
related gene products. 
In conclusion, there does not seem to be a clear difference 
in stenc and charge properties of the ammo acid residues of 
positions 2-5 and 6-10 of acetylated and non-acetylated pro-
teins starting with Ala, Ser and Met. However, proteins 
starting with Ac-Met often have an acidic residue at position 
-41-
2-5 
5.9 
2.6 
11.7 
6.8 
2.3 
4.2 
2.0 
3.4 
5.2 
6.7 
2.0 
2.6 
5.3 
3.7 
6.5 
9.4 
8.3 
5.9 
0.5 
5.0 
6-10 
5.6 
3.2 
6.4 
8.2 
5.7 
7.7 
2.6 
1.5 
6.0 
8.2 
1.0 
1.7 
7.9 
5.3 
4.3 
10.1 
6.8 
5.0 
0.3 
2.0 
A' 
2-5 
9.4 
2.6 
9.4 
6.9 
4.9 
5.6 
1.3 
7.1 
8.5 
6.6 
0.6 
3.6 
5.6 
2.2 
2.9 
9.6 
7.7 
2.5 
1.1 
1.9 
c-
6-10 
12.6 
2.6 
7.3 
5.5 
3.6 
7.7 
2.6 
4.2 
9.4 
4.7 
0.8 
4.0 
8.1 
5.7 
1.8 
6.4 
3.2 
5.9 
2.2 
1.7 
proteins in 
general 
8.6 
2.9 
5.5 
6.0 
3.6 
8.4 
2.0 
4.5 
6.6 
7.4 
1.7 
4.3 
5.2 
3.9 
4.9 
7.0 
6.1 
6.6 
1.3 
3.4 
Table VIII. Average percentage of residues at positions 2-5 and 6-10 
of acetylated and non-acetylated proteins, compared with the average 
percentage of residues in proteins in general (Dayhoff, 1978). Amino 
acid residues are indicated with the one-letter code. 
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small aliphatic 
hydroxyl 
acidic 
acidic + acid amide 
basic 
hydrophobic 
aromatic 
A + G 
S + Τ 
D + E 
D + E + 
Η + К + 
I + L + 
F + W + 
н-
2-5 6-10 
10.1 14.0 
17.7 16.9 
18.5 14.6 
Ν + Q 24.8 21.6 
R 13.7 12.9 
M + V 18.0 15.7 
Y 7.8 8.5 
Ac- proteins in 
2-5 6-10 9 e n e r a l 
15.0 
17.3 
16.3 
22.1 
12.7 
16.8 
7.9 
20.3 
9.6 
12.8 
22.5 
13.8 
15.6 
7.5 
16.9 
13.1 
11.6 
19.8 
13.5 
20.2 
8.3 
Table IX. Average percentage of groups of residues at positions 2-5 and 6-10 of acetylated and 
non-acetylated proteins, compared with the average percentage of these groups in proteins in 
general (Dayhoff, 1978). Amino acid residues are indicated with the one-letter code. 
2. Thus, there appears to be a difference between the struc­
tural requirements for acetylation of proteins starting 
either with Ala and Ser or Met. 
The local hydrophobicity of the N-terminal region of 
N -acetylated proteins 
Since no clear stenc and charge properties seem to account 
for the determination of the suitability of the N-terminal re­
gion of proteins for N -acetylation, we decided to investigate 
the local hydrophobicity of the first 5 ammo acids of acety­
lated proteins, since the information for acetylation seems 
to be enclosed in this region (Table VI). For the calcu­
lations we used the same data sets of acetylated and 
non-acetylated proteins as in the preceding section. The hy­
drophobicity of the three N-terminal residues concerned 
differs. Met (+1.9) and Ala (+1.8) are comparable, while Ser 
(-0.Θ) is much more hydrophilic. On calculation we averaged 
the hydrophobicity over positions 1-2, 1-3, 1-4 and 1-5 for 
each protein. We then determined the average for all proteins. 
The results, expressed per residue, are summarized in Fig. 1. 
The most striking results are found for Met. While the 
N-terminal regions of proteins starting with Η-Met show a rel­
atively broad hydrophobicity range, the region of those with 
Ac-Met contains a moderate hydrophilic character for the 
first two positions (= -1.0). Since Met itself has a value of 
+1.9 this means that the second residue always is very hydro­
philic. Further differences on going deeper into the 
N-terminal region are not apparent. Since there are many pro­
teins having also a hydrophilic residue at position 2 without 
being acetylated, other factors must be important too, as was 
already apparent from Table VI. Average values for the first 5 
positions tend to be a little bit more hydrophilic for acety­
lated proteins as compared with non-acetylated proteins. 
However, the values for span length 5 are already very close 
to each other. 
Upon examination of Ala in N-terminal position, we find 
that the hydrophobicity range between the highest and lowest 
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Fig. 1 Hydrophobic!ty of the M-terminal region of proteins start ing 
with Ac-Ala (n=50), Η-Ala (n=87), Ac-Met (n=27), H-Met (n=19), Ac-Ser 
(n=55) and Η-Ser (n=29). Results are shown per residue for span lengths 
of 2 up to 5. Average hydrophobicity for a l l proteins start ing with a 
part icular acetylated or non-acetylated residue is indicated with x. 
The highest and lowest value for one protein is indicated with -. 
value i s near 4 for a c e t y l a t e d p r o t e i n s foi span l e n g t h s up t o 
5, while being somewhat laicjei (4-5) t o r n o n - a c e t y l a t e d p i o -
t e m s The h y d r o p h o b i c i t y pei amino acid i>.oidue foi a c e t y ­
l a t e d p r o t e i n s seems t o be between t h e va lues for phe and Pro 
Extreme h y d i o p h i l i c or hydiophobjc N-t^immfil l e g i o n s of pi o-
t e i n s s t a r t i n g with Ala do not -ipoeai ro be ' u i t a b l e fot ni ^у-
matic M - a c e t y l a t i o n . For Sei t h c i e seems Lo be a s i m i l a i 
behavior as for Ala Values range between the sanie b o u n d a i i e s 
for a c e t y l a t e d p i o t e m s 
In c o n c l u s i o n , the h y d i o p h o b i c i t y oi the N-tormmal reg ion 
seems to p lay a r o l e m M - a c e t y l a t i o n . For Ala and Ser both 
very h y d r o p h i l i c and hydrophobic N-terminal reg ions a re unfa­
vorab le , whi le for Met p o s i t i o n 2 must be very h y d r o p h i l i c 
Thus, again t h e r e has been e s t a b l i s h e d a d i f f e i e n c e between 
Ala/Ser and Met 
The two- and t h r e e - d i m e n s i o n a l s t r u c t u r a l c h a r a c t e r i s t i c s of 
N - a c e t y l a t e d p r o t e i n s 
For s e v e r a l ot t h e now known M a -acety la tod p r o t e i n s i n f o r ­
mation of t h e tv,o- and t h r e e - d i m e n s i o n a l s t r u c t u r e i s a v a i l ­
a b l e . However, s ince M - a c e t y l a t i o n mostly t a r e s p l a c e with 
the nascent chain on t h e rioosome, when t h e chain s t a r t s t o 
p r o t r u d e from the nbosome, a t a l ength of 25 t o 50 r e s i d u e s 
( i f necessary a f t e r removal of the i n i t i a t i o r methionine) i t 
i s not c l e a r t o what e x t e n t , i f any, the s t i u c t u i e of the com­
p l e t e d cha in i s of r e l e v a n c e in the N - a c e t y l a t i o n p i o c e c s 
i t s e l t . In t h e completed cha in t h e '.J-teinunuc i s -lostly on the 
sur face of t h e s t r u c t u r e The N - a c e t y l g i o u p i s found at tne 
beginning of an a - h e l i x in d o g t i s h l a c t a t e dehydrogenaзо M 
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¿.о • 
3.0 · 
2.0 
L O 
0.0 
-1.0 
-2.0 
-3.0 
• 4.0 
Ac-Ala Η-Ala 
1 1-2 1-3 1-4 1-5 1 1-2 1-3 1-4 1-5 
Hydropho-
bicity 
index 
4.0 
3.0 
2.0 
1.0 
0.0 
• L O 
2.0 
• 3.0 
• 4.0 J 
Ac -Met H-Met 
1 1-2 1-3 1-4 1-5 1 1-2 1-3 1-4 1-5 
4.0 
3.0 
2.0 
1.0 
0.0 
• 1.0 
•2.0 
•3.0 
4.0 
Ac-Ser 
χ
 : ;
 •: : ; •••• 
H-Ser 
1 1-2 1-3 1-4 1-5 1 1-2 1-3 1-4 1-5 
Span length (residues) 
- 4 6 -
isozyme (Adams et al , 1970), and of a g-strand in lobster gly-
ceraldehyde-3-Dhosphate dehydrogenase (Buehner _et al , 
1974) In the following examples the N-terminal amino acid is 
separated by one or more residues from two-dimensional struc­
ture characteristics carp parvalbumin (Kretsinger and Noc-
kolds, 1973), human glutathione reductase (Schulz et al , 
1978), horse methemoglobin (Ladner et a_l , 1977), tuna ierr+-
cytochrome с (Swanson et al , 1977), human carbonic 
anhydrases В and С ( Li 1 j as et a_l , 1972, Kannan et al , 1975), 
rabbit glycogen Phosphorylase (Spiang et a_l , 1979), hot se 
phosphoglycerate kinase (Banks et a_l , 1979), hor^e livei al­
cohol dehydrogenase ЕЕ isozyme (Eklund et a_l , 1976), bovine 
Cu/Zn-superoxide dismutase (Richardson et al , 1975) and 
chicken muscle tnosephosphate isomerase (Corran ^е^ al , 
1975) In the case of parvalbumin tne methyl caibon of the 
acetylgroup is tucked back into the intenoi of the protein 
However, a completed thiee-dimensional structure does not 
have to be an impediment for efficient N -acetylation Feline 
η 
β globin chain , syntnesized in t ibit reticulocyte lysate 
with prevention of acetylation (Kasten-Jolly and Taketa, 
1982), and isolated in noimal tetrameric hemoglobin after ad­
dition of carrier protein, can be acetylated by incubation in 
a rabbit reticulocyte lysate cell-free system This same phe­
nomenon has been established for 6- and ε-actin, which are 
found in vitro and m vivo, and aie most likely non-acetylated 
precursors of the cytoplasmic (5- and ï-actin, respectively 
(Carrels and Hunter, 1979, Palmer et al , 1980) In vitro δ-
and ε-actin can be acetylated very easily by incubating these 
proteins in cell-free systems in the presence of acetylcoen-
zyme A 
Some special cases 
As mentioned before, the products of pro-opiomelanocortin 
are acetylated post-translationally The acetylation of a-MSH 
now appears to be a very complicated process a-MSH normally 
contains only an N -acetylgroup In 1979 Rudman et a_l showed 
that in the pituitary of ox, rat, guinea pig and rabbit 
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one-third of the melanotropic activity is represented by a 
structural variant of a-MSH with M,O-diacetylserine as its 
N-terminal residue. When the pituitary gland is incubated m 
vitro, more than 90 % of the melanotropic acticvity released 
in the medium is the diacetylated compound. Physiological se-
cretion of a-MSH may therefore be related to acetylation of 
the hydroxylgroup of serine at position 1. In contrast to 
this suggestion is the finding of Martens _et _a_l (1981), that 
for amphibian pituitary pars intermedia release of a-MSH is 
linked to N -acetylation However, these authors did not 
check the possibility that the compound, which was released, 
might be diacetylated. The separation of the mono- and dia-
cetylated compound appears to be very difficult (Rudman _et 
al. , 1979). The diacetylated compound is also present in por-
cine pituitary (Buckley et al , 1981) in equal amounts as in 
the other species. Biological activity (melanotropic and li-
polytic) is identical to that of a-MSH, so that the extra 
acetylgroup on the hydroxyl oxy-jen of the N-teiminal serine 
does not seem to have any effect in this respect. For bovine 
and rat pituitary the existence of this new melanotropin has 
been confirmed (Evans et al., 1982). Glembotski (1982a) has 
found evidence that in rat pars intermedia ACTH is cleaved in 
CLIP (corticotropin-like intermediate lobe peptide) and 
ACTH-(l-13)-tridecapeptide (Fig 2). The latter is amidated 
C-terminally, followed by N -acetylation. The product, a-MSH, 
then is acetylated at the hydroxylgroup of the N-terminal se-
rine. It is not known, how many enzymes are responsible for 
these two acetylation steps (Glembotski, 1982b). 
A second special case is actin. The N-terminal sequence of 
cytoplasmic actin from Dictyostelium discoideum is 
Ac-Asp-Gly-Glu-Asp-... (Rubenstein and Deuchler, 1979; Van-
dekerckhove and Weber, 1980, Rubenstein et al_. , 1981; Redman 
and Rubenstein, 1981) The N-terminal region is acidic as re-
ported for all other actins, which are all most likely 
acetylated (e.g. Vandekerckhove and Weber, 1978). In this re-
spect actm is a conspicuous exception on the rules for 
N -acetylation as discussed in the preceding sections. In the 
Dictyostelium discoideum gene the initiator methionine imme-
-48-
ACTH 
-CLIP 
ACTH-(l-13)-tndecapeptide anide 
+АсСоЛ 
u-MSH 
+АсСоА 
[SertOAcJ'Ja-MSH 
Fig. 2 Processing of ACTH in rat pitinta>-y ролл ínteArmcUa. 
H-Met- Asp-Gly 
+AcCoA 
Ac-Met-Asp-Gly 
-Ac-Met 
H-Asp-Gly 
+AcCoA 
Ac-Asp-Gly 
Fig. 3 Processing of the N-terminus of act in from O-LdtyoitdUum 
(¿Lóco-uíeum .^n VJXHO. 
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diately precedes the Asp which is the N-terminal residue 
(Firtel et al_. , 1979, McKeown and Firtel, 1981) Generallyin 
eukaryotic systems the initiator methionine is cleaved off if 
the second residue is not acidic (Burstein et a_l , 1976) . For 
actin this cleavage would then not be favorable Rubenstein 
et al. (1981) showed that Dictyostelium actin prepared in a 
rabbit reticulocyte lysate iji vitro contains Ac-Met at the 
N-termmus This product is rather stable Postranslation-
ally Ac-Met is then removed (the acetylgroup is necessary for 
this removal), followed by renewed acetylation (Redman and 
Rubenstein, 1981). These authors suggest that this scheme 
(Fig. 3) is also applicable for brain actin (Sabono and Pal-
mer, 1981). Interestingly Met-Asp-Gly is a sequence which is 
present among N -acetylated proteins with Met at the 
N-termmus (Table VI) Since all the experiments of Ruben-
stein and coworkers have been done in vitro, it is not known if 
this complicated posttranslational processing scheme also 
does take place _in vivo. It would be the second example of 
posttranslational acetylation besides the one described for 
the products of pro-opiomelanocortin 
CONCLUDING REMARKS 
In summary, we have to admit that the mechanism of 
N -acetylation is still far from being fully understood How-
ever, a few aspects clearly emerge from the data available. 
• N -acetylation is a process virtually confined to euka-
ryotes. 
• N -acetyltransferases appear to have a narrow substrate 
specificity, which is almost identical for enzymes from 
different tissues and species 
• The nature of the N-terminal residue and its neighbours 
is crucial. 
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APPENDIX 
A COMPILATION OF Na-ACETYU\TED PROTEINS (1958-1981) 
SOURCES 
For the compilation of the ^-acety la ted proteins from the period 
1958-1977 use has been made of the extensive protein sequence data of 
Dayhoff (1) . For the years 1978 un t i l 1982 the l i t e ra tu re has been 
followed by screening 21 journals: 
1. Airu.no A.CAÁ, Ргрісае. and ViotHAn АЬІІШСЛІ, renamed 
BiockemiitAy АЬііласЛл, Рал-t 3, Am-tno Acuii, Pe.p.ttde¿ and коіым 
2. клсІпл. ел o{¡ KtochuniAtAy and B^ophyi^dò 
3. Aoò-fuUUun JouAnaZ о^ Ztotog-tCJil Soctnce-i 
4. Rujchmj-caZ and Bj-ophyn.caZ Кмеалсй Commun^cattoni 
5. Thz BiOckemccaZ Joivwat {HotieulM. Ai pacts) 
6. Btocfiemü-tt« 
7. Btocfiem-LiiAi/ (a VumiÙLÙLon od аік1ьиіи.уа) 
8. В<.осіиіги.са еХ Ясоркуі-сса Acta, Ρ (PAo-te-tn SfuxcXuJie.) 
9. CamcLuin Journal oi beo скупил Üiy 
10. Compa/ULttvz &u¡chmu>t>iy and Vhyi-cotogy, Б (СотраллХч. е ïkocfiemci-
ixyì 
11. Еалоргап ЗоилплЛ o(¡ соскешлілу 
12. FEES LztteAi, 
13. Hoppe-SzylVi'i ZzAXic.hu.it {ил Thynologichi Chômez 
14. Tkz IntWMUtLonal Jowinal of, ULO chema, ілу 
15. InteAnatuinaJt Jotwutf. Ü(¡ Peptide and Ptiotexn Иеле.алск 
16. Thz Joifinat oi Stolog-Lcal ChmcitAy 
17. Tde ІоиЛгихЛ oi bu¡chmu,tM.y 
18. ЗоилпаЛ. oí Моігсиіал Biology 
19. Ш и л е 
20. Pioczedíngi o¿ thz Hatíonat Acadzmy oí ScA.zncz& oí thz U.S.A 
21. Sctemie 
- 6 1 -
COMPILATION 
The proteins have been ordered according to t h e i r function or o r i g i n . 
No attempts were made to place homologous proteins together as in Day-
hoff (1) . For a l l proteins the sequence of the f i r s t 10 ammo acids 
( i f known) is given in the three-letter code. I f no reference is made 
to the l i t e r a t u r e , a protein entry has been taken from Dayhoff. The 
following symbols have been used-
Ac- indicates an N^acetylated N-terminus of which the acetyl group 
has been determined experimentally or has been assumed on the 
basis of homology 
Ac. indicates an Na-acetylated N-terminus of which the sequence of 
the amino acids following the acetylgroup is not known 
ΐ blanks (flanked by - or .) indicate amino acids which have not 
been determined experimentally 
indicates a peptide bond which has been determined experimentally 
indicates that the sequence has been determined by homology with 
known primary structures 
, indicates that the sequence is not known at a l l , or with great 
uncertainty 
/ indicates that the sequence is followed by amino acids of which 
the sequence is not known; they are not shown 
indicates the end of fragments, the order of which has not been 
determined experimentally 
The use of these symbols is not always unambiguous, especially in the 
case of entries from Dayhoff ( 1 ) , of which only some experimental de­
t a i l s are described without the sequence. Sequences with an Na-acetyl-
group from the l i t e r a t u r e were accepted in case of an unequivocal ex­
perimental determination. Na-acetylgroups assumed on basis of homology 
were allowed i f the reference protein had been determined unambiguous­
ly. In case of an assumed N^acetylgroup, in which the f i r s t amino acid 
is not identical to that of the reference prote in, we did not accept 
the acetylgroup. We sometimes included a protein which has been des­
cribed as N-terminally blocked, in th is case a homologous primary struc­
ture had already been reported. 
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STATISTICS 
In this compilation 361 proteins are l i s t e d . When species variants are 
excluded and only unique qene products are taken into account, 118 
proteins are l e f t , these include, however, variants with a d i f f e r e n t 
N-terminal amino acid. 
N-termi nus Entries % Unique gene % 
Ac-Ala 
Ac-Ser 
Ac-Met 
Ac-Gly 
Ac-Asp 
Ac-Glu 
Ac-Tyr 
Ac-Thr 
Ac-Val 
Ac-Asn 
Unknown 
95 
93 
73 
44 
15 
11 
7 
3 
2 
1 
17 
η = 361 
26.3 
25.8 
20 2 
12.2 
4.2 
3.0 
1.9 
0.8 
0.6 
0.3 
4.7 
products 
38 
41 
21 
4 
4 
3 
2 
2 
2 
1 
0 
η = 118 
32.2 
34.8 
17.8 
3.4 
3.4 
2.5 
1.7 
1.7 
1.7 
0.8 
0.0 
Of the entries 261 (72 %) have an N-terminal Ala, Ser or Met. In case 
of the unique gene products the proteins having these N-terminal amino 
acids number 100 (85 Sä). 
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OmOREDUCTASES 
Alcohol dehydrogenase _E_C 1 1 1 1 
Bl-chain, man 
82-chain, man 
Ε-chain, horse 
S-chain, horse 
Alleloenzyme 5, ViavpluZa тьіаіюда-ьСіл 
Alleloenzyme иг, Оісьоріила metanogoAtei 
Alleloenzyme N-ll, Oiuòvpluia mctuHoqaòtfi 
Isozyme-I, yeast [ЪассНалотцсел сііс таг) 
[sozyme-[l, yeast (Sacciia-umi/ceò сеіе с я а с ) 
Lactate dehydrogenase EC 1 1 1 27 
Η-chain, pig 
H-chain, chicken 
M-cham, pig 
H-cham, r a t 
M-chain, spiny dogfish (Squatut, acanttuju) 
Glyceraldehyde-phosphate dehydrogenase EC 1 2 1 12 
Lobster 
Glutamate dehydrogenase (NADP+) EC 1 4 1 4 
Ыеилолриіа слад è a 
GìuUthiune reductase (NAD'PIH) EC 1.6.4 2 
Han 
Cytochrome с oxidase EC 1 9 3.1 
Subunit VI (= Subunit V I I ) , ox 
MonophenoT monooxygenase (Tyrosinase) EC 1 14 13 1 
Ыгилооролл сллаа 
Superoxide dismutase EC 1 15 1 1 
Cu-Zn enzyme, man 
Cu-Zn enzyme, ox 
Cu*Zn enzyme, horse 
TRANSFERASES 
Glycogen Phosphorylase EC 2 4 1 I 
Muscle, rabbit 
Muscle, dogfish 
Aspartate aminotransferase EC 2 6 1 1 
Cytoplasmic, chicken 
Phosphoglycerate kinase EC 2 7 2 3 
Man 
Horse 
Yeast 
Arginine kinase EC 2 7 3 3 
Lobster 
(2 3) Ac-Ser-Thr-Ala-Gly-Lys Cys-Lys 
(2-3) Ac-Ser-Thr-Ala-Gly-Lys Val-Ile-Lys Cys-Lys 
Ac-5er-Thr-Ala-Gly-Lys-Val-Ile-LyS-Cys-Lys 
Ac-Ser-Thr-Ala-Gly Lys-Val-Ile-Lys-Cys-Lys 
(4) Ac-Ser-Phe-Thr-Leu-Thr-Asn-Lys-Asn-Val-lle 
(4) Ac-Ser-Phe-Thr-Leu-Thr-Asn-Lys-AIa-Val-Ile 
(4-5) Ac-Ser-Phe-Thr-Leu-Thr-Asn-Lys-Asn-Val-lle 
(1,6-7) Ac-Ser-Ile-Pro-Glu-Thr-Gln-Lys-Gly-Val He a' 
(7) Ac-Ser-Ile-Pro-Glu-Thr-Gln-Lys-Ala-Ile-Ile b 
Ac-Ala-Thr-Leu-Lys-Glu-Lys-Leu-Ile-Ala-Pro 
(B) Ac-Ala-Thr 
Ac-Ala-Thr-Leu-Lys-Asp-Gln-Leu-lle-His-Asn 
(9) Ac-Ala-Ala 
Ac-Ala-Thr-Leu-Lys Asp-Lys-Leu-Ile-Gly-His 
Ac-Ser-Lys-Ile-Gly-Ile-Asp-Gly-Phe-Gly-Arg 
Ac-Ser-Asn-Leu-Pro-Ser-Glu-Pro-Glu-Phe-Glu 
(10) Ac-Ala-Cys-Arg-Gln-Glu-Pro-Gln-Pro-Gln-Gly 
(11-13) Ac-Ala-GIu-Asp-Ile-Gln-Ala-Lys-Ile-Lys-Asn 
(14-15) Ac-Ser-Thr-Asp-Ile-Lys-Phe-Ala-Ile-Thr-Gly 
(16-18) Ac-Ala-Thr-Lys-Ala-Val-Cys-Val-Leu-Lys-Gly 
Ac-Ala-Thr-Lys-Ala-Val-Cys-Val-Leu-Lys-Gly 
(19) Ac-Ala-Leu-Lys-Ala-Val-Cys-Val-Leu-Lys-Gly 
(20-21) Ac-Ser-Arg-Pro-Leu-Ser-Asp-Gln-Glu-Lys-Arg 
(22) Ac-Ser-Lys-Pro-Lys-Ser-Asp-Met Glu-Arg-Arg 
(23-24) Ac-Ala-Ala-Ser-Ile-Phe-Ala-Ala-Val-Pro-Arg 
(25-26) Ас-Ser-Leu-Ser-Asn-Lys-Leu-Thr-Leu-Asp-Lys 
(27-2 ) Ac-Ser-Leu-Ser-Asn-Lys-Leu-Thr-Leu-Asp-Lys 
(29-30) Ac-Ser-Gly 
(31) Ac-Ala-Asx-Ala-Ala-Thr c ) 
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Adenylate kinase EC 2 7 4 3 
Isoenzyme AKJ, man Ac-Met-Glu-Glu-Lys-Leu-Lys-Lys-Thr-Lys- I le 
Pig A c - i l t t - G l u Glu-Lys-Leu-Lyj >s-Ser-Lys- I l e 
Fructose-biphosphatase EC 3 1.3.11 
Sheep (32) Ac-Thr-Asp-Glu-Ala-Pro-Plie-Asp T n r - A s n - I l e 
Pig (3J) Ac-Thr-Asp-Gln-Ala-Ala-Phc-Asp-Thr-Asn-I le 
Rabbit (34-36) Ac-Ala-Asp-Lys-Ala-Pro-Phe-Asp-Thr-Asp-I le 
Hyalonuronoglucosamimdase (Hyalonundase) FC 3 2.1.35 
Ox (37) Ac A la.Glu.Leu.Phe.Tyr 
Calcium adenosine triphosphatase EC 3.6 1.3 
Rabbit (38-39) Ac-Met-Glu-Ala-Ala-His-Ser-Lys-Ser-Thr-Glu 
Acylphosphatase EC 3 6.1 7 
Horse (40) Ac-Ser-Thr-Ala-Arg-Pro-Leu-Lys-Ser-Val-Asp 
Carbonate dehydratase (Carbonic anhydrase) EC 4 2 1 1 
I ) t y p e , man Ac-Ala-Ser-Pro-Asp-Trp-Gly-Tyr-Asp-Asp-Lys 
I) type, chimpanzee Ac-Ala-Ser-Pro-Glu-Trp-Gly-Tyr-Asp-Asp-Lys 
I) type, orangutan Ac-Ala-Ser-Pro-Glu-Trp-Gly-Tyr-Asp-Asp-Lys 
I) type, rhesus monkey (1,41) Ac-Ala-Ser-Pro-Asp-Trp-Gly-Tyr-Asp-Asp-Lys 
I) type, baboon Ac-Ala-Ser-Pro-Asp-Trp-Gly-Tyr-Asp-Asp-Lys 
I) type, irus macaque Ac-Ala-Ser-Pro-Asp-Trp-Gly-Tyr-Asp-Asp-Lys 
I) type, green monkey Ac-Ala-Ser-Pro-Glu-Trp-Gly-Tyr-Asp-Asp-Lys 
C(II) type, man Ac-Ser-His-His-Trp-Gly-Tyr-Gly-Lys-His-Asn 
C(I1) type, sheep Ac-Ser-lhs-His-Trp-Gly-Tyr-Gly-Glu-His-Asn 
C(II) type, оя Ac-Ser-His-His-Trp-Gly-Tyr-Gly-Lys-His-Asx 
C{II) type, rabbit (1.^2) Ac-Ser-His-His-Trp-Gly-Tyr-Gly-Lys-Ilis-Asn 
Enolase EC 4 2.1.11 
(43) 
Glucosephosphate isomerase EC 5 3 1 9 
Rabbit (44) Ac-Ala-
CONTRACTILE SYSTEM AND CYTOSKELCTON PROTEINS 
Actins 
Warm-blooded v e r t e b r a t e s 
S t r i a t e d muscle, s k e l e t a l ( o - a c t i n ) , ox (45-47) Ac-Asp-Glu-Asp-Glu-Thr-Thr Ala-Leu-Val-C/s 
S t r i a t e d muscle, s k e l e t a l ( l a c t i n ) , r a b b i t (1,46,48-51) Ac-Asp-Glu-Asp-Glu-Thr-Thr-Ala-Leu-Val-Cys 
S t r i a t e d muscle, s k e l e t a l ( . - a c t i n ) , chicken (45,47,52) Ac-Asp-Glu-Asp-Glu-Thr-Thr-Ala-Leu-Val-Cy 
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Striated muscle, cardiac, ox 
Smooth muscle (type 1), ox 
Smooth muscle (type 2), ox 
Smooth muscle (type 2), chicken 
Cytoplasmic {θ-actin}, ox 
Cytoplasmic (B-actin), rat 
Cytoplasmic (ß-actin), mouse 
Cytoplasmic (ß-actin), chicken 
Cytoplasmic (γ-actin), ox 
Cytoplasmic (γ-actin), rat 
Cytoplasmic (γ-actin), mouse 
Amphibia 
Cytoplasmic (type 1), newt (Ttctatub crataXuA) 
Cytoplasmic (type 3), newt (Тгиилиі cl-utitui) 
Cytoplasmic (type 4), frog (Rana р^рчспа) 
Cytoplasmic (type А), Хелорид £де чл 
Cytoplasmic (type 5), frog [Rana рмрсеи*) 
Cytoplasmic (type S), Хеиориі ¿aew-ci 
Cytoplasmic (type ) , newt (ТчлХилш, аил(аХил) 
Cytoplasmic (type θ), Xenopu¿ tawn 
Non-vertebrates 
Muscle, larval stage (type I ) , D'o&opkUa milanogtuteA 
Cytoplasmic (type И ) , п.аьорШл тгЫподалил 
Cytoplasmic, Рку&алит poZyczpfatfim 
Cytop lasmic, OtcXi/o&lztuM іісАсоіаешп 
(45-47) 
(4S-46) 
(45) 
(45.47,52) 
(45,47,51,53) 
(47,54-55) 
(47,51) 
(45) 
(47,51,53) 
(47,54-55) 
(47.51) 
(56) 
(56) 
(56) 
(56) 
(56) 
(56) 
(56) 
(56) 
(57) 
(68) 
(45.59) 
(60-63) 
Tropowyosln 
α-Chain, skeletal muscle, rabbit 
fl-Chain, skeletal muscle, rabbit 
Cardiac nuscle, rabbit 
Troponin С 
Fast s k e l e t a l muscle, man 
Fast s k e l e t a l muscle, rabbit 
Fast skeletal muscle, frog (Rana /Licutenta) 
Cardiac muscle, ox 
Cardiac muscle, slow skeletal muscle, rabbit 
Troponin I 
Skeletal muscle, rabbit 
Troponin Τ 
Skeletal muscle, rabbit 
Hyosι η 
L-4 light chain, skeletal muscle, rabbit 
L-4 light chain, skeletal muscle, chicken 
Parvalbumin 
pi 4 45 (α/β-lineage), thornback ray (Ra/a ciauata) 
pi S 50 (a-lineage), rabbit 
Dì 5 0 0 , I I I ( α - l i n e a g e ) , p ike (Елсх іисшА) 
Ac-Asp-
Ac-Glu-
Ac-Glu-
Ac-Glu-
Ac-Asp-
Ac-Asp-
Ac-Asp-
Ac-Asp-
Ac-Glu-
Ac-Glu-
Ac-Glu-
Ac-Asp-
Ac-Asp-
Ac-Glu-
Ac-Glu-
Ac-Asp-
Ac-Asp-
Ac-Glu-
Ac-Glu-
Asp-Glu-
Glu-Glu-
Glu-Glu-
Glu-Glu-
Asp-Asp-
Asp-Asp-
•Asp-Asp-
Asp-Asp-
Glu-Glu-
Glu-Glu-
Glu-Glu-
•Asp-Asp-
Glu-Asp-
•Asp-Asp-
Asp-Asp-
•Glu-Glu-
•Glu-Glu-
Glu-Glu-
•Glu-Glu-
Glu-Thr-
Asp-Ser-
Thr-Thr 
Thr-Thr 
l ie-Ala 
I l e - A l a 
I l e - A l a 
I le-Ala-
I le-Ala· 
I le-Ala 
I le-Ala· 
•Thr-Ala-
•Thr-Ala-
•Ala-Leu-
-Ala-Leu-
•Ala-Leu-
•Ala-Leu-
-Ala-Leu-
•Ala-Leu-
•Ala-Leu-
•Ala-Leu-
•Ala-Leu-
Leu-Val-
Leu-Val-
Val-Cys-
Val-Cys-
Val-Val-
Val-Val-
Val-Val-
Val-Val-
Val-I le-
V a l - I l e -
•Val-Ile-
-Ala-Leu-Val-
-Ala-Leu-Val-
-Ala-Leu-Val-
-Ala-Leu-Val-
-Ala-Leu-Val-
-Ala-Leu-Val-
-Ala-Leu-Val-
-Ala-Leu-Val-
Cys 
Cys 
Asp 
Asp 
Asp 
A s x 1 " 
Asp 
Asp 
Asp 
A s x e > 
Asp 
-Asp 
-Asp 
-Asp 
-Asp 
-Asp 
-Asp 
-Asp 
-Asp 
Ac- f ) 
Ac- 9) 
Ac-Glu-Gly-Glu-Asp-Val-Gln-Ala-Leu-Val-Ile h ) 
Ac-Asp-Gly-Glu-Asp-Val-Gln-Ala-Leu-Val-Ile ' ) 
Ac-Met-Asp-Ala-Ile-Lys-lys-Lys-Met-Gln-Met 
(64-65) Ac-Net-Asp-Ala-Ile-Lys-Lys-Lys-Met-Gln-Het 
(64,66) Ac-Met-Asp-Ala-Ile-Lys-Lys-Lys-Met-Gln-Met 
Ac-Asp-Thr-Gln-Gln-Ala-Glu-Ala-Arg-Ser-Tyr 
Ac-Asp-Thr-Gln-Glη-Ala-Glu-Ala-Arg-Ser-Tyr 
( 1 , 6 7 ) Ac-Ala-Gln-Pro-Thr-Asp-Gln-Gln-Met-Asp-Ala 
Ac-Met-Asp-Asp-Ile-Tyr-Lys-Ala-Ala-Val-Glu 
(68) Ac-Met-Asp-Asp-Ile-Tyr-Lys-Ala-Ala-Val-Glu 
Ac-Gly-Asp-Glu-Glu-Lys-Arg-Asn-Arg-Ala-lle 
Ac-Ser-Asp-Glu-Glu-Val-Glu-His-Val-Glu-Glu 
Ac-Ser-Phe-Ser-Ala-Asp-Gln-Ile-Ala-Glu-Phe 
(69) Ac-Ser-Phe-Ser-Pro-Asp-Gln-lle-Asp-Asp-Phe 
Ac-Ser-Ser-Lys-lle-Thr-Ser-Ile-Leu-Asn-Pro 
Ac-Ala-Met-Thr-Glu-Leu-Leu-Asn-Ala-Glu-Asp 
Ac-Ala-Lys-Asp-Leu-Leu-Lys-Ala-Asp-Asp-Ile 
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ρ' 4 Ь (ъ-1 ineage), f r o g ( R a u ι i m i t u b i ) 
pi 4 52, I I I ( P - l i n e a g e ) , coelacanth {LaUmexta JuiLtannai)^) 
pi 4 ^ ( - l i n e a g e ) , cod (Giidm ^аіігішь) 
pi 4 36 ( - l i n e a g e ) , hake 
p i A 10, l i ( ч - l i n e a g e ) , p i k e (EÒÌX iac-tiLi) 
p i 4 5 ( B - h n e a g e ) , w h i t i n g 
I I ( F - I i n e a g e ) , carp (Ccrpt-ttiuì салгмс ) '71) 
pi 4 25 F I I I ( ß - l i n e a g e ) , carp (Скрипи,:, саір« ) 
p i 4 47 ( P - l i n e a g e ) , carp ( С у р г л к и catfJ-ti') (72) 
V ( e - l i n e a g e ) , chub [UUCUCILÌ cLphatiLòι (73) 
P r o f i l i n 
Spleen, οχ 
Intermediary f i l a m e n t p r o t e i n s 
K e r a t i n IF subunits ( 5 - 7 ) , e p i d e r m i s , ox 
IF subuni ts ( 3 , one decamin), kidney c e l l s , hamster 
Ac-Ser- I le-Thr-A-.p- I le-Vai-ber-t i lL-Lyb-Asl · 
Ac-Ala- Va l -A la-Lys-LeL- i -eu-A la-A la-A la-Aüp 
Ac -A la -Phe -Lys - j l y - I l e -Leu -S r r -Asn -A la -A -
Ac A l a - P h e - A l a - d y - l l e - L e u - A l a - A s p - M i a As¡ 
Ac-Ser-Phe-Ala-Gly-Leu-Lys-Asp-Ala-Abp-Val 
Ac-A la -Phe-AIa -G ly - I le -Leu-A la -Asp-A la -Asp 
Ac-A la-Tyr -Ser -C i ly - I le -Leu-Asn-Asp-A la-Ast 
Ac-Ala-Phe-Ala-Cly-Val -Leu-Asn-Asp-Ala-Usu 
Ac-Ala-Phe-Ala- t i l y -Val -Leu-Asn-Asp-Ala-A^p 
Ac-A la-Phe-Gly-Leu-Lys-Glu-A la-Asp- I le -Thr 
(74) Ac -A la -G ly -T rp -Asn-A la -Ty r - I l e -Asp-Asn-^cu 
(75-76) Ac-Ser 
(76) Ac-Ala 
CALCfUH-ßfNOING PROTCrNS J) 
Calmodulin 
B r a m , u t e r u s , ox (1.77-78) 
Phosphorylase kinase EC 2 7.1 38 fi subun i t , r a b b i t (79) 
T e s t i s , r a t (60) 
Scal lop (PaUHOpecfen) (Θ1) 
Sea anemone (МсХгикшл і с п ч ^ е ) (82) 
Tetrahymena (TeX/uihymena руыбонмд) (83) 
I n t e s t i n a l c a l c i u m - b i n d i n g p r o t e i n 
Major component, p i g 
Minor component, p i g 
Ac-Ala-Asp-Gln-Lcu-Thr-Glu-Glu-Gln- I lc-A'a 
Ac-Ala-Asp-Gin L e u - T h r - G l u - G l u - G l n - I ì e - A b 
Ac -A la -Asp-G lu -Leu-Thr -G lu -G lu -G ln - l l e -A la 
Ac -A la -Asp-G ln -Leu-Thr -G lu -G lu -G ln - l i e -A la 
Ac -A la -Asx~Glx .Leu-Thr -G lx -G lx -G lx - I l e -A la 
Ac-AIa-Asp-Gln-Leu-Thr-Glu-Glu-Glπ-I le-Ala 
(1,84) Ac-Ser-Ala-Gln-Lys-Ser-Pro-Ala-Glu-Leu-Lys 
(1,84) Ас-Ala-Gln-Lys-Ser-Рго 
FIBROUS PROTEINS 
Keratin 
Wool h i g h - s u l f u r f r a c t i o n B2 r e l a t e d 
L i n c o l n w o o l , SCMK-BZA, sheep 
L i n c o l n w o o l , SCMK-B2B, sheep 
L i n c o l n w o o l , SCMK-B2C, sheep 
Merino w o o l , SCMK-B2, sheep 
Wool h i g h - s u l f u r f r a c t i o n H I B r e l a t e d 
Merino w o o l , <:Γ··"> I l I B Z , sheep 
Merino w o o l , SCMKB-II1B3, sheep 
Merino w o o ) . SCMKB-1I1B4, sheep 
Mohair, Ι Γ Ι 0 2 , south a f r i c a n angora goat 
Fedther 
Rachis, emu [Огмтсиил nova^-fuÎtandtaz) 
Callus» r a c h i s , goose ( A n i c i <i(mviticuò} 
Calamus, s i l v e r g u l l 
Ac-Ala-Cys-y/s-Ser-Thr-Ser-Phe-Cys-Gly-Phe 
Ac-Ala-Cys-Cys-Ser-Tnr-Ser-Pne-Cys-Gly-PhL 
Ac-Ald-Cys-Cys-Ser-Thr-Ser-Phe-Lys-GV-Ph» 
Ac-A^a-Cys-Lyb-Ser-Thr-Ser-Phe/ 
Ac-Ala-Cys-Cys-Z'la-Pro-A'-o-Cys-Cy -Se· -1 «ι' 
Ac-Ala-Cys-Cys-Ala-Arg-Leu-Cys íyz-^er а 
Ac-Ala-Cys-Cyi-Ala-Arg-Leu-Cys-Cys-^cr-.a 
Ac-AI<i-Cys-CyS-i1ta-Pro-/ ,rg-[,ys-C Js j e t ι 
(1,85) Ac-Ser-Cys-Tyr-Asn-Pro-CiS-l eu- l ' ro-Arr j , 
(86) Ac-Spr-Cy.-Tyr 
Ac-Ald-Cys-Asn-Asp-LPu-Cys-Gly-P'-o-C/i-'i 
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ELECTRON-TRANSFER PROTEINS 
Cytochrome с r e l a t e d proteins 
Cytochrome с 
Kan 
Chimpanzee 
Rhesus monkey 
Сіи-СІі/цсгЬ-іл patin 
Long-wnged oat (Moui р-Силяд sci't^b*.* w ) 
Dog 
Elephant sral (vu^ourfia ¿сояспс) 
Sheep 
Ox 
Pig 
Guanaco ('.олк guarite ) 
Camel (CamLiiLi tiv-nencítii) 
Major component, H.cpp<i|4íarui и і ^ і ч Ч и ' 
Minor component, fupptjpi (алиі u^ratb^ui 
Horse 
ûonkey 
Zebra (Е^шм йиаддс· 
C a l i f o r n i a çrav whale 
Rabo 11 
Mouse 
T e s t i s - s p e c i f l f , mouse 
G'ay kangaroo 
Pekín duck 
Ρ i geon 
Ostrich 
King penguin 
Chicken 
Turkey 
Emu 
Snapping t u r t l e 
Rattlesnake 
Bul l frog 
Puget Sound dogfish 
Tuna f i s h 
Bonito 
Iso-1-cytochrome c, carp 
Iso-2-cytochronie c, ca-p 
Freshwater prawn ("лсл^Ьіасішіг maíc.rp^^M 
Pacific lamprey [Întaiphenub VudZHlatiib) 
Ginkqc b<Îoba 
Elder (Sambucas mgJta) 
θοχ-elder (Ac?' ncgurdt) 
Castor 
Sunflower 
Major component, sesame 
Minor component, sesame 
Cotton 
Hemp (Ca»mab<i ьаХл а) 
Rice (tH.yz.i l a t t e a ) 
«heat 
Ar-
Ac-
Ac-
( 8 / ) 
( 3 ' ) 
(88-89) 
Asp-Val-
Asp-Val-
AsTVal-
Asp-Val-
Asp-Vai-
Asp-Val-
Asp-Val-
•Asp-Vai-
•Aip-Va'-
Asp-ïü'-
•Ase-Val-
•Asp-Va1-
•Asp-i/al-
•Asp-He-
•Asp-Val-
•А^р- лі 
Asp-Val-
•Asp-Va' 
•Asp-Va1· 
'Asp-Val-
•Asp-Ala 
•Asp-»al-
•Asp-Val-
•Asp-Val-
•Asp-He-
•Asp-1le-
•Asp-Ile-
•Asp-lie-
•Asp-lie-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val-
•Asp-Val· 
•Thr-Phe· 
•Ser-Phe-
•Ser-Phe 
•Ser-Phe-
•Ser-Phe 
•Ser-Phe-
•Ser-Phe-
•Ser-Phe· 
•Ser-Phe-
•Ser-Phe-
•Ser-Phe· 
Glu-Lyv 
Glu Lys-
Glu-Lys-
Glu-Lys-
•Glu-L)S· 
•Glu-i yS' 
•Glu-L/s· 
•Glu-Lys 
•Glu-lys· 
•Clu-Ljs 
•Glu-^yS' 
•G1N-L,S' 
•Glu-Ly; 
•Cil-Lys 
•G-u-1 ys 
-Glu-cys 
-Glii-L>S 
Glu-Lvs 
•Glu-Lys 
•Clj-Lys 
•G'u-Aia 
•Glu-Ly>; 
-Clu-Lys 
-Glu-Lys 
•Glu-Lys 
•Glu-Lys· 
•Glu-Lys· 
•Glu-Lys 
•Glu-Lys· 
•Glu-Lys 
'jlu'-ys 
•Glu lys-
•G1U-L»S· 
•Ala-Lys 
•Ala-Lys 
•Glu-Lys 
•Asp-Lys 
•Glu-Lys-
•Glu-Lys· 
•Ser-Glu' 
•Ala-Glu 
-Ala-Glu· 
•Asx-Glx-
.Ala-Glu· 
•Asx-Glx 
•Ser-Glx-
•Gln-Glu· 
•Asx-Glx 
-Ser-Glu 
•Ser-Glu· 
Gly-Lys-
Gly-Lys-
Gly-Lys-
Gly-Lys-
•Gly-Lvs-
•Gly-Lys-
Gly-Lys-
•Gly-Lys-
•Gly-Lys-
Gly-Lys-
Gly-Lys-
Cl>-Lys-
•G'y-Lyi-
•Gly-Lys-
•Gly-Lys-
•Gly-Lys-
Glv-.ys-
•Gly Lys-
•Gly-Lys-
-Gly-Lys-
•Glv-Lys-
Gly-Lys-
Gly-Lys. 
Gl>-L.ys 
Gly-Lys-
Gly-Lys-
•Gly-Lys-
Gly-Lys-
Gly-Lys-
Gly-Lys-
Gly-Lys-
Gly-Lys-
Gly-Lys-
.Gly-Lys-
Gly-Lys-
.Gly-Lys 
Giy-Lys-
Gly-Lys· 
•Giy-Lys· 
•Ala-Pro 
Ala-Pro 
•Ala-Pro 
Ala-Pro-
•Ala-Pro-
•Ala-Pro-
•Ala-Pro-
Ala-Pro 
•Ala-Pro 
•Ala-Pro 
•Ala-Pro 
Lys-
Lys-
Lys-
L/s-
Lys-
Lys-
ly>-
i y s -
Lys-
Lys-
l y s -
Lvs-
Lys-
l y ^ -
•Lys-
Lys-
Lys-
•Lys-
Lys-
LyS-
•Lys. 
Lys-
Lys-
Lys-
Lys-
Lys-
•Lys-
Lys-
Lys-
Lvs-
Lys-
LyS-
Ly<-
Lys. 
Lys-
Lys. 
Lys-
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
ε-Phe 
p-Pne 
u-Phe 
e-"ht 
c-Pre 
e-Phe 
e-=he k ) 
e-Phe 
e-Pne 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-P^e 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
e-Phe 
al-Phe 
nr-Phe 
nr-Phe 
-Lys.Val-Phe 
al-Phe 
le-Pne 
Lys-Val-Phe 
Pro-Gly-Asp 
Pro-Giy-Asn 
Pru-Gly-Asn 
Pro-Gly-Asx 
Ala-Gly-Asp 
Pro-Gly-Asx 
Pro-Gly-Asx 
Pro-Gly-Asn 
Pro-Gly-Asx 
Pro-Gly-Asn 
Pro-Gly-Asn 
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Buckwheat 
Parsnip {Pastinaca iattva) 
Mufig-bean 
Pumpkin 
Potato 
Tomato 
Leek ( A i t t u m pct-mm) 
Rape 
C a u l i f l o w e r 
Spinach (Spourea оіглас&а) 
Abut-íton thtophnab U 
Love-in-a-mist [NigeLta damucena) 
Nasturtium {Тпорагоішп majiu>) 
Niger (Gux-zo-tta аЬуіііилса) 
ÏntcAümoJipha іХслІлп&ІмА 
Euglena дідші^б 
Cytochrome C550· 
Раллсоссил de.ru.t>u.$-tcanò (=HLCAOCÜUCU¿ аггиХпл^сапь) 
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ala-
Ac-Ser-
Ac-Gly-
Thr-Phe-Ser 
Ser-Phe-Ala· 
Ser-Phe-Asx-
Ser-Phe-Asx-
Ser-Phe-Gly· 
Ser-Phe-Asn· 
Thr-Phe.Ser 
Ser-Phe-Asp-
Ser-Phe-Asp 
Thr-Phe-Ser· 
Ser-Phe.Gln-
Ser.Phe.Asx· 
Ser-Phe-Ala· 
Ser-Phe-Ala· 
Thr-Phe-Ala 
Asp-Ala-Glu' 
•Glu-Ala-
•Glu-Ala-
•GIx-AIa-
•Glu-Ala-
•Glu-Ala-
•Glu-Ala-
•Glx-Ala-
•Glu-Ala-
•Glu-Ala-
•Glu-Ala-
Glu-Ala-
•Glx-Ala-
•Glu-Ala-
•Glu-Ala-
•Asx-Ala-
•Arg-Gly-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Pro-
Pro-Ala-
Pro-Ala-
Pro-Ala-
Pro-Pro-
Lys-Lys· 
•Gly-Asn 
Gly-Asp 
Gly-Asx 
Gly-Asx 
Gly-Asn 
Gly-Asn 
Gly-Asx 
Gly-Asn 
Gly-Asn 
Gly-Asn 
Gly-Asn 
Gly-Asx 
•Gly-Asp 
Gly-Asp 
•Gly-Asx 
•Leu-Phe 
Ac-Asn-Glu-Gly-Asp-Ala-Ala-Lys-Gly-Glu-Lys 
HEME CARRIER PROTEINS 
Glotnns 
Hemoglobin a-chain* 
Frog (Кдиа ььсиХе.п£а) (90-91) 
CoD?«inent of Hb I I I , bullfrog tadpole (Лапа catzàbeiana) (92) 
(93) 
(94-95) 
(94) 
(96) 
Toad {Ва^о taf,υ) 
Port Jackson shark (НеХглоdorUuj. poitiLojaclioonA.) 
Carp 
Cttiiponent of Hb I , t rout (Saune -t'LLde.uà) 
Component of Hb IV, trout (Salmo ¿Алгігил) 
Goldfish (Салдлічііб аилдЛид ) 
Desert sucker (Саі біопш СЫАЬЫ) 
Hemoglobin ß-cham 
Component of Hb Raleigh ( B ^ v a l i n e - a c e t y l a l a m n e ) , man (97) 
Component of Hb В, cat (Futa, саХи ) (98-100) 
Component of Hb В t y p e , f i s h i n g c a t (101) 
Component o f Hb В t y p e , j u n g l e cat (101) 
Component of Hb В t y p e , caracal (101) 
Component of Hb В type, cheetah (101) 
Component of Hb В t y p e , serva l (101) 
Component of Hb В t y p e , t i g e r (101) 
Component of Hb В t y p e , puma (101) 
Component of Hb В t y p e , l i o n (101) 
Nile crocodile (Ciccodijiaj, nUoUcibb) (102) 
Alligator (ШлдаГсч ηα>ύ<Λи.ррч.епААД) (102) 
Hemoglobin γ-chain 
Component of Hb F ^ f e t a l Hb, man (103) 
Component of fetal Hb, rhesus monkey (Macaca rmlatta) (104) 
Hemoglobin r - c h a i n 
Component of errtiryonic Hb, man 
Myoglobin. 
Shark (He,teAodoHtut> pe l íu i jack* ι m) (107) 
Shark (GalcoKkifiuA aiLitnatiA) (106) 
Ac-Ala-Leu 
Ac-Ser-Leu-Ser-Ala-Ser-Glu-Lys-Ala-Ala-Val 
Ac-Ala-Leu 
Ac-Ser-Thr-Ser-Thr-Ser-Thr-Ser-Asp-Tyr-Ser 
Ac-Ser-Leu-Ser-Asp-Lys-Asp-Lys-Ala-Ala-Val 
Ac-Ser-Leu-Thr-Ala-Lys-Asp-Lys-Ser-Val-Val 
Ac-Ser-Leu-Ser-Ala-Lys 
Ac-Ser-Leu-Ser-Asp-Lys-Asp-Lys-Ala-Val-Val 
Ac-Ser-Leu-Ser-Asp-Lys-Asp-Lys-Ala-Asp-Val 
-Ala-His.Leu-Thr-Pro-Glu-Glu-Lys Ser~Ala 
-Ser-Phe-Leu,Ser,Ala,Glu,Glu,Lys 
Ala-Ser-Phe-Asp-Pro-His-Glu-Lys-Gln-Leu 
Ala-Ser-Phe-Asp-Ala-His-Glu-Arg-Lys-Phe 
Ac-Gly-His-Phe-Thr-Glu-Glu-Asp-Lys-Ala-Thr 
Ac-Gly-His-Phe-Thr-Glu-Glu-Asp-Lys-Ala-Thr Γ 
(105-106) A c - S e r - L e u - T h r - L y s - T h r - G l u - A r g - T h r - l l e - I l e 
Ac-Thr-Glu-Trp-Glu-His-Val-Asn-Lys-Val-Trp 
Ac-Ala-Asp-Trp-Asp-Lys-Val-Asn-Ser-Val-Trp 
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Shark ( M u i f i f u i OUCÍWLÍ tcu- i ) 
Ye l l ow f i n tuna (Tfiumiu-s aLbacaim) 
I nve r teb ra te g lob ins 
G lob in , gastropod mol lus i . (Аріуыа Umaam) 
Myoglobin, gastropod mol lusc (Арічыл kunadcn) 
Hemoglobin α - c h a i n , mol lusc (Андгіала Viapczta} 
LegheflKHjlobin 
Legbemog)ob)n b, soybean 
(109) Ac-Val-Asp-Trp-Glu-Lys-Val-Asn-Ser-Val-Trp 
(110-111) Ac-Ala-Asp-Phe-Asp-Ala-Val-Leu-Lys-Cys-Trp 
Ac-Ser-Leu-Ser Ala-Ala-Glu-Ala-Asp-Leu-Ala 
(112) Ac-Ser-Leu-Ser-Ala-Ala-Glu-Ala-Asp-Leu-Val 
(113) Ac-Val-Ala-Asp-Ala-Val-Ala-Lys-Val-Cys-Gly 
(114) Ac-AJa 
VIRAL PROTEINS 
Coat p r o t e i n s 
Tobacco mosaic v i r u s coat p r o t e i n 
S t r a i n ER 
S t r a i n 06 
S t r a i n dahiemtruxt 
S t r a i n HR (Holmes r i b - g r a s s ) 
S t r a i n ORS {ОаопходСс ішп r i n g s p o t ) 
S t r a i n vutganz 
S t r a i n 0M 
S t r a i n 0 
S t r a i n Kokubu 
S t r a i n cmpea 
Turn ip y e l l o w mosaic v i r u s coat p r o t e i n 
Coat p r o t e i n 
A l f a l f a mosaic v i r u s coat p r o t e i n 
S t r a i n S 
S t r a i n 425 
S t r a i n VRU 
Adenovirus type 2 c o a t ( - a s s o c i a t e d ) p r o t e i n s 
Некоп p r o t e i n 
Component IX (hexon a s s o c i a t e d ) 
F iber p r o t e i n 
Other v i r u s coat p r o t e i n 
Cucuntoer v i r u s 4 
Virus Xf 
Envelope protein PE2, Sindbis virus 
Other viral proteins 
(115) 
Gag p r e c u r s o r p o l y p r o t e i n ( P r 7 6 g a 9 ) , Rous sarcoma v i r u s (121) 
S m a l l - t a n t i g e n . Simian v i r u s 40 (122-123) 
Large-T a n t i g e n , Simian v i r u s 40 (122-123) 
Ac-Ser-Tyr-Asn-I le-Thr-Tt i r-Pro-Ser-Gln-Phe 
Ac-Ser-Tyr-Ser-He-Thr-Thr-Pro-Ser-His-Phe 
Ac-Ser-Tyr-Ser- I le-Thr-Ser-Pro-Ser-Gln-Phe 
Ac-Ser-Tyr-Asn-I le-Thr-Asn-Ser-Asn-Gln-Tyr 
A c . S e r . T y r . S e r . l l e j T h r . T h r . P r o . S e r ^ G l x . L e u 
Ac-Ser-Tyr-Ser- I le-Thr-Thr-Pro-Ser-Gln-Phe 
Ac-Ser-Tyr-Ser- I le-Thr-Thr-Pro-Ser-Gln-Phe 
A c - 5 e r - T y r - S e r - I l e - T h r - T h r - P r o - S e r - G l n - P h e 
Ac-Ser-Tyr-Ser- I le-Thr-Thr-Pro-Ser-Gln-Phe 
A c - A l a - T y r - S e r - I l e - P r o - T h r - P r o - S e r - G l n - L e u 
Ac-Met-Glu-I le-Asp-Lys-Glu-Leu-Ala-Pro-Gln 
Ac-Ser-Ser-Ser-Gln-Lys-Lys-Aia-Gly-Gly-Lys 
Ac-Ser-Ser-Ser-Gln-Lys-Lys-Ala-Gly-Gly-Lys 
Ac-Ser-Ser-Ser-Gln-Lys-Lys-Ala-Gly-Gly-Lys 
(116-117) Ac-Ala-Thr-Pro-Ser-Met-Het-Pro-Gln-Trp-Ser 
(117) Ac-Ser-Ala-Asn-Ser-Phe-Asp-Gly-Ser-I le-Val 
(117) Ac-Met-Lys-Arg-Ala-Arg-Pro-Ser-Glu-Asp-Thr 
( M B ) Ac-Ala-Tyr-Asn-Pro- I le-Thr-Ser 
(119) Ac-Ser-Gly-Val-Gly-Asp-Gly-Val-Asp-Val-Val 
(120) Ac- - A l a - A l a - -Leu- - -Ala-Met-Cys 
A c - M e t - G l u - A l a - V a l - I l e - L y s - V a l - l l e -
Ac-Het-Asp-Lys-Val-Leu-Asn-Arg-Glu-Glu-Ser 
Ac-Met-Asp-Lys-Val-Leu-Asn-Arg-Glu-Glu-Ser 
EYE-LENS PROTEINS 
o - C r y s t a l l i n 
aA2-chain 
Man {Homo ¿appetti) 
Rhesus monkey (Macaca nutatta) 
Potto (PzAodictcciLo patti) 
(1,125) Ac -Me t -Asp -Va l -Th r - l l e -G ln H is -Pro Trp-Phe 
(1,125) Ac -Me t -Asp -Va l -Th r - I l e -G ln .H i s -P ro Trp-Phe 
(124) Ac-Met-Asp~Val T h r - I l e - G l n - H i s - P r o - T r p - P h e 
-70-
Gal ago (Galaqo сыыисаиааЫь) 
Brown lemur (ίετνίΛ. faivut) 
Treeshrew (Тцрола befапделл ) 
European hedgehog ( Cenaci ui lu^upaeuj) 
Jamaican fruit-eating bat (Attibeai j(Wtì<cen4t.i) 
Oog (Catu^ ьалиЛлаллл ) 
Gray seal (Hattchoetu-j gii/pui) 
California sea lion (2<Uopluti (.аІА^олгі^апио) 
American mink [Mmt&ta vuton) 
Cat (Feí^-j COXUA) 
Sloth bear (Меіиліаі uutnoò) 
Malayan pangolin (Mat^i javrtfuca) 
Ox (Воь ілшіаі) 
Pig (Saò 4CA(?ia) 
Giraffe (Gvia^a сатеІсралаіііА) 
Dromedary (Comeíoó dtomedíruui) 
Hippopotamus (H^ppcpiiamoi атр/иЬч.иі) 
Horse (Equui cabaltuj,) 
White rhinoceros (Срлд^оі^г^ишп ытш) 
Malayan tapi r {Тар шл -cwd-tciM) 
Mmke whale [BaùiitwptzAa acuioioàfiAia) 
Cormon porpoise (Рйосаеиа í-necaena) 
African elephant (LcxodorUa a c c a n a ) 
Cape hyrax (Ріссау-ui саремш) 
Aardvark (ОлусХглораь a¿en) 
Brazilian rana tee (TnchechuA 4.nunqticä) 
Rabbit (ОіусХоІддил cuiwcafiü) 
American pika {Ochotona pfunctpa) 
Rat (Rattiu non.vig4.cMj>) 
Golden hamster (Медосллс&Сид аилп.(а&) 
Mongolian gerbil (Меи-опел ungiwcufaiui) 
Guinea pig (Cavíü ponctlùio) 
Springhaas (Pedeíei сааіл) 
Two-toed sloth (Chùtoeput hod^manní) 
Three-toed sloth (Btadypiu vanxegoXtu) 
Ant bear (Талаигіиа me^cana) 
Red kangaroo (Маслори* ли^ил) 
North American opossum (P^duípíu* mvuupwtu) 
Chicken (Οα££ω galtiu) 
Frog (Rana е-ісиІеиЛі) 
Shark (Squa£xj acaní/uai) 
iA Ins-chain 
Rat (RatfiLi iicivcg-tcoi) 
aB2-chain 
Han (HfiTii òapj.e.nb) 
Ox (Sei ta i ra i ) 
Shark (Squaiuò асшьСкіал) 
S-Crystallin 
liBp-chain 
Ox (Boi, taiLtuu) 
(124) 
[12t) 
(124-125) 
(124-125) 
(124) 
(1.125) 
(124) 
(124) 
(124) 
(1,124-125) 
(124) 
(124) 
(1.125) 
(1.125) 
(124) 
(124) 
(124) 
(1.125) 
(125-126) 
(124) 
(125-126) 
(124) 
(125-126) 
(125-126) 
(124,127) 
(124,127) 
(1.125) 
(124) 
(1.125) 
(124) 
(124) 
(124) 
(124) 
(124) 
(124) 
(124) 
(1.125) 
(1.125) 
(124-125) 
(124-125) 
(120) 
Ac-Met-Asp-Val Thr-
Ac-Het-Asp.Väl Thr. 
Лс t-Asp-Val-Thr 
Ar-Met-Asp Val-Tlir. 
Ac-Met-Asp-lle Thr 
Ac-Met-Asp-Ile-AiΊ-
Ac-Met-Asp I l e - A l a -
Ac-Met-Asp I l e Ala 
Ac-Met-Asp I l e Ala-
Ac-Met-Asp-Ile-Ala-
Ac-Met-Asp I l e Ala 
Ac-Met-Asp-lle-Ala-
Ac-Met-Asp-lle-Ala-
Ac-Met-Asp-Ile-Aia-
Ac-Met-Asp-Ile Ala-
Ac-Met-Asp-Ile-Ala-
Ac-Met-Asp I l e - A l a -
Ac-Met-Asp-lle-Ala-
Ac-Met-Asp-Ile-Ala-
Ac-Met-Asp H e - A l a -
Ac-Met-Asp-Ile-Ala 
Ac-Met-Asp-Ile-Ala-
Ac-Het-Asp.Val-Thr. 
Ac-Ket-Asp.Val Thr 
Ac-Met-Asp-Val-Thr-
Ac-Met-Asp-lial-T/rr-
Ac-Met-Asp-Val-Thr-
Ac-Met-Asp-Val-Thr-
Ac-Met-Asp-Val-Thr-
Ac-Met-Asp-Val-Thr-
Ac-Met-Asp-Val Thr-
Ac-Met-Asp-Val Thi-
Ac-Het-Asp-Val-Thr-
Ac-ltet-Asp.Val-Thr. 
Ac-Met-Asp.Val Thr. 
Ac-Met-Asp Val-Thr-
Ac-Met-Asp-Ile-Thr-
Ac-Met-Asp-Ile-Thr-
Ac-Met-Asp-Ile-Thr-
Ac-Met-Asp-Ile-Thr-
Ac-Met-Asp-Leu-Ala-
le Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp.Phe 
le-Gln-His-Pro~Trp Phe 
le Gin His-Pro-Trp.Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-Gln-Pro-Trp.Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Glη-His-Pro-Trp-Phe 
le Gin His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le Gln-Hls-Pro-Trp.Phe 
le-Gln-His-Pro-Trp.Phe 
le-Gln-His-Pro-Тгр Phe 
le-Gln-His-Pro-Trp-Phe 
le-GJn-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-HIs-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp~Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro~Trp Phe 
1e-Gln-H1s-Pro-Trp-Phe 
le-Gln-His-Pro-Trp.Phe 
le Gln-Gln-Pro-Trp.Phe 
1e-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-GIn-His-Pro-Trp-Phe 
le-Gln-His-Pro-Trp-Phe 
le-Gln-Tyr-Pro-Trp-Phe 
(129) Ac-Met Asp-Val Thr-Ile-Gln-His-Pro Trp-Phe 
Ac-Met-Asp-Ile-Ai a-Ile-His-His-Pro-Trp-Il e 
Ac-Met-Asp-Ile-Ai a-Ile-His-His-Pro-Trp-Ile 
(124) Ac-Met-Asp-Ile-Ala-Ile-Gln-His-Pro-Trp-Leu 
(130-Ш) Ac-Ala-Ser-Asn-His-Glu-Thr-Gln-Ala-Gly-Lys 
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nieOSOMAL PROTCINS 
30S Hìbosomal protein SS 
3QS Ribosomal protein S18 
ЕісНгЛА.сЫ.а cod 
50S Ribosonal protein L7 
Eiche.fn.cfu.a cotí 
Elongation factor Tu 
Eocfie>u.efuíi coU 
(132) Ac-Ala-His-Ile-Glu-Lys-Gln-Ala-Gly-Glu-Leu 
Ac-Ala-Arg-Tyr-Phe-Arg-Arg-Arg-Lys-Phe-Cys 
Ac-Ser-Ile-Thr-Lys-Asp-Gln-Ile-Ile-G)u-A1a n) 
(133-136) Ac-Ser-Lys-Glu-Lys-Phe-Glu-Arg-Thr-Lys-Pro 
CHROMOSOMAL PROTEINS 
Hi stone HI 
Thymus Lys-rich histone f r . 1 (CTL-1), ox 
Thymus Lys-rich histone fr. 2 (RTL-2). rabbit 
Thymus Lys-rich histone f r . 3 (RTL-3), rabbit 
Thymus Lys-nch histone f r . ή (RTL-4), rabbit 
Erythrocyte (CEL-5), chicken 
Testis , trout 
Maize (Zea mat/A) 
Maize ( Ζ ω таі/д) 
Histone HZA 
Spleen, HZAfl), two v a r i a n t s , man 
Spleen, H2A(2), two v a r i a n t s , man 
Thymus, two v a r i a n t s , ox 
Chloroleuttemia c e l l s , three v a r i a n t s , r a t 
Friend leukemia c e l l s , H2A(2), mouse 
Rainbow t r o u t (Salno gacldtie^u.) 
Sea urchin (РалгсЯитде алдиіодіи) 
Sea urchin ( і,ат\гс.к*.пчі nwttotcs) 
H2A(2), wheat germ (Т/иХч.силі atAtLvum) 
Н2А(Э), wheat germ {Tmtt-ztm aeittuujn) 
Histone H4 
Ox 
Pig 
Rat 
Rainbow t r o u t {SaXm сшлапгліл) 
Sea urchin (Ріитгіес*кица fiwXta\t>) 
Pea 
( 1 , 1 3 7 - 1 3 8 ) 
(139) 
( 1 , 1 3 7 ) 
( 1 . 1 3 7 ) 
( 1 3 9 ) 
( 1 4 0 ) 
( 1 4 1 ) 
( 1 4 1 ) 
(142) 
( 1 4 2 ) 
( 1 , 1 4 3 ) 
( 1 4 4 ) 
(145) 
(146) 
(147) 
( 1 4 7 ) 
Ac-Ser-Glu-Thr-Ala-Pro-Ala-Ala-Pro-Ala-Ala 
Ac-Ser-Glu-Thr-Ala-Pro-Val-Ala-Pro-Ala-Ala 
Ac-Ser-Glu-Ala-Pro-Ala-Glu-Thr-Ala-Ala-Pro 
Ac-Ser-Glu-Ala-Pro-Ala-Glu-Thr-Ala-Ala-Pro 
Ac-Ser-Glu-Ala-Pro-Thr-Val-Ala-Ala-Pro-Ala 
Ac-Ala-Glu-Val-Ala-Pro-Ala-Pro-Ala-Ala-Ala 0 ' 
Ac-S/A-Thr-Asp-Val-S/A-Glu-Thr-Pro-S/A-Pro P) 
Ac-S/A-Thr-Glu-Val-S/A-Glu-Thr-Pro-S/A-Pro p ' 
Ac-Ser-GlyArg.Gly Lys Gln-Gly-Gly-Lys Ala 
Ac-Ser-Gly-Arg.Gly-Lys Gln-Gly-Gly-Lys.Ala 
Ac-Ser-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Ala 
Ac-Ser-Gly-Arg-Gly-Lys-Gln-Gly-Gly-Lys-Ala 
Ac-Ser-Gly-Arg Gly-Lys.Glu-Gly-Gly-Lys.Ala 4) 
Ac-Ser-Gly-Arg.Gly-Lys-Thr-Gly-Gly-Lys-Ala 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Ala-Lys-Ala-Lys 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Ala-Lys-Gly-Lys 
Ac-Met-Asp-Gly-Ser-Lys-Leu-Lys-Lys-Val-Ala 
Ac-Met-Asp-Ala-Ser-Lys-Ala-Lys-Lys-Val-Ala 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu 
Ac-Ser-Gly-Arg-Gly-Lys-Gly-Gly-Lys-Gly-Leu 
HORMONES ANO ACTIVE PEPTIDES 
Pro-opiomelanocortin related polypeptides 
a-MSH 
Monkey 
Sheep 
Ас-Ser-Tyr-Ser-Het-Glu-His-Phe-Arg-Trp-Gly 
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly 
-72-
о« 
Pig 
Arabian camel (Camvtuo алотнааллил) 
Horse 
Leu^enkephalin 
Rat 
Θ-Endorphin 
B-Endorphin-(l-2?), ox 
ß-Endorphin, pig 
B-Endorphin-(l-27), pig 
ß-Endorphin, horse 
ß-Endorphin» rat 
ß-Endorphin-(bZ7), rat 
0-Endorphin-(l-26), rat 
B-Endorphin-I, salmon (OncoikynchuA ktfa) 
ß-Endorphin-II, salmon {Oncoihynchub keXa) 
(149) 
(150) 
(150-151) 
(152) 
(153-155) 
( 1 5 3 , 1 5 5 ) 
(155-156) 
(157) 
(158 ) 
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly 
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly 
Ac-Ser-Tyr-5er-Met-Glu-His-Phe-Arg-Trp-Gly r ' 
Ac-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly 
(14β) Ac- О 
Ac-Iyr-Gly-Gly-Phe-Met-Thr-Ser-Glu-Lys-Ser ' ) 
Ac-Tyi~Gly Gly-Phe-Met~Thr-Ser-Glu-Lys-Ser v ' 
Ac-Туг Gly-GlyPhe-Met-Thr Ser-Glu-Lys-Ser *' 
Ac-Tyr-Gly Gly-Phe-Met-Ser-Ser-Glu-Lys-Ser v ' 
... ») 
Ac-Tyr-Gly Gly-Phe-Met-Thr Ser-Glu-Lys-Ser v ' 
Ac-Tyr-Gly-Gly-Phe-Met-Lys-Pro-Tyr-Thr-Lys 
Ac-Tyr-Gly-Gly-Phe-Met-Lys-Ser-Trp-Asn-Glu 
NERVOUS SYSTEM PROTEINS 
Иуеііп basic protein 
Man 
Chimpanzee 
Од 
S(mall) variant, rat 
Myelin P2 protein 
Ас-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gl n-Arg-Hi s 
Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His 
Ac-Ala-Ala-Glη-Lys-Arg-Pro-Ser-Cln-Arg-Ser 
Ac-Ala-Ser-Gln-Lys-Arg-Pro-Ser-Gln-Arg-His 
Peripheral nerve myelin, o* 
Sciatic nerve myelin, rabbit 
S-100b protein 
Brain, θ-subunit, OK 
(159-160) 
(161-162) 
Ac-Ser-Asn-Lys-Phe-Leu-Gly-Thr-Trp-Lys-Leu 
Ac-Ser-Asn-Lys-Phe-Leu-Gly-Thr-Trp-Lys-Leu 
(163-164) Ac-Ser-Glu-Leu-Glu-Lys-Ala-Val-Val-Al a-Leu 
METAL-BINDING PROTEINS 
Metallothionein 
Liver, MT-2, containing Zn, man 
Liver, ^ - l A , containing Zn, liorse 
Kidney, MT-1A, containing Cd + Zn, horse 
Kidney, MT-IB, containing Cd + Zn, horse 
Liver, KT-I, containing Cd + Zn, mouse 
Liver, MT-II, containing Cd + Zn, mouse 
Ferr i t in 
Spleen, apoferr i t in, horse 
Liver, apoferr i t in, rat 
(165) Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-Ala-Ala-Gly 
(166) Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-Pro-Thr-Gly 
(166) Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-Pro-Thr-Gly 
Äc-Met-Asp-Pro-Asn-Cys-Ser-Cys-Val-Ala-Gly 
(167) Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-Ser-Thr-Gly 
(16Θ) Ac-Met-Asp-Pro-Asn-Cys-Ser-Cys-Ala-Ser-Asp 
(1,169) Ac-Ser-Ser-Gln-11e-Arg-Gln-Asn-Tyr-Ser-Thr 
(170) Ac-Ser-Ser-Gln 
MISCELLANEOUS PROTEINS 
ADP/ATP earner 
Mitochondrion, heart, ox (171) Ac-Ser-Asp-Gln-Ala-Leu-Ser-Phe-Leu-Lys-Asp 
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Band 3 polypeptide from erythrocyte membranes 
Man 
OvaTbumin 
Chicken ( 
Phosphatidylcholine exchange protein 
Liver, ox 
Rhodopsι η 
Ox 
Structural protein from mitochondria 
Heart, ox 
Thymosin al 
Thymus, ox 
Z-protem 
Liver, rat 
(172-173) Ac-Met-Glu-Glu/ 
,174-177) Ac-Gly-Ser-Ile-Gly-Ala-Ala-Ser-Met-Glu-Phe 
(178-179) Ac-Met-Asp-Pro-Gly-Ala-Gly-Ala-Phe-Ser-Glu 
(180-182) Ac-Met-Asn-Gly-Thr-Glu-Gly-Pro-Asn-Phe-Tyr 
(1B3) Ac-Ser 
(1,184) Ac-Ser-Asp-Ala-Ala-Val-Asp-Thr-Ser-Ser-Glu 
(185) Ac-Met-Asn-Phe-Ser-Gly-Lys-Tyr-Gln-Val-Gln W ' 
- 7 4 -
REMARKS 
a. Isozyme-I is acetylated for 90 to 95 %. 
b. Isozyme-11 is acetylated for 60 to 80 %. 
с Asx-2 is probably Asn. 
d. δ-Actin is a non-acetylated form of S-actin, which is present in 
small amounts in cultured cells. It probably is the precursor. 
e. e-Actin is a non-acetylated form of γ-actin, which is present in 
small amounts in cultured cells. It probably is the precursor. 
f. A component, behaving as the cytoplasmic type II on IEF, is present 
in small amounts in cultured cells. It probably is a non-acetylated 
precursor. 
g. Type III is a non-acetylated form of type II, which is present in 
small amounts in cultured cells. It probably is the precursor. 
h. A non-acetylated form is present in small amounts in cultured cells. 
It probably is the precursor. 
In y¿tw translation in a reticulocyte lysate system gives proces-
sing of the N-terminus with two Na-acetylation steps: 
Met-Asp-Gly-... — » Ac-Met-Asp-Gly-... — » Asp-Gly-... — » Ac-Asp-Gly-... 
i. A non-acetylated form is present in small amounts in cultured cells. 
It probably is the precursor. 
j. This section contains calcium-binding proteins, which do not form 
part of CONTRACTILE SYSTEM AND CYTOSKELETON PROTEINS. 
k. The minor component is present for 10.6 %. 
1. The minor component is present for 30 %. 
m. The fetal γ-chain is only partly acetylated. 
n. This protein is also present in a non-acetylated form, which is 
called LIZ. 
o. This protein is acetylated for 90 to 95 %. 
p. Positions 1, 5 and 9 have not been determined with certainty; either 
serine (S) or alanine (A) is present. This protein is acetylated 
for 94 %. 
q. H2A(1) probably has the same N-terminal sequence. 
r. This polypeptide is acetylated for about 50 %. 
s. Leus-enkephalin is acetylated for 20 to 25 %. This acetylated form 
is found only in ролл ¿ntvmídia. of the pituitary. 
t. This polypeptide is partly acetylated. 
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v. This polypeptide is partly acetylated. The acetylated form is found 
only in pituitary. 
w. This protein is acetylated for about 84 %. 
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CHAPTER II 
Synthesis of an analogue of a-MSH-(l-10)-decapeptide as a substrate for 
enzymatic N" -acetylation 
H.P.C DRIESSEN1·1,H. BLOEMENDAL',W.W.DE JONG1 and G I TESSER' 
1
 Department of Organic Chemistry and 2 Department of Biochemistry, 
Catholic University of Ni/megen, Nijmegen, The Nethertands 
Received 10 December 1981, accepted for publication 25 March 1982 
The synthesis of a stable substrate for enzymatic Na -acetylation is described To 
this end an analogue of a-MSH41-10)-decapeptide with norleucme instead of 
methionine at position 4 is prepared t-Butylation of an intermediate Z-Tyr-OMe 
leads only to about 75% conversion in a few hours' reaction time, and cannot be 
earned to completion The [Nle4]-decapeptide is as good a substrate for enzy­
matic /Va-acetylation as the original decapeptide containing methionine 
Keywords t-butylation, enzymatic A^-acetylation, a-MSH-(l-10)-decapeptide analogue, 
norleucme, subsliate 
TV-terminal acetylation of proteins is a wide­
spread phenomenon in eukaryotes, and to a 
lesser extent in prokaryotes and viruses (1) 
Virtually nothing is known concerning the 
underlying mechanism and possible functional 
implications JVa-acetylating activity has been 
studied and demonstrated in Escherichia coli 
for ribosomal protein LI 2 (2), for nbosome-
associated proteins from rat liver ( 3 - 5 ) , in calf 
lens (6), rat pituitary (7) and hen's oviduct 
(8), and in a ribosomal fraction of wheat germ 
(9) 
In many of these experimentsW-acetylation 
has been studied with the use of synthetic 
model peptides, since there are virtually no 
naturally occurring substrates available In the 
study of the N" -acetyl transferase from bovine 
lens (6), initially synthetic des-A'0" -acetyl-Q-
melanotropin (10) was used, a substrate which 
is found to be AMerminaUy acelylated m vivo 
( 1 ) After it had been proven that the acetylaling 
enzyme specifically acetylates theo-NHj group 
of the AMcrminal serine (neglecting the е-МНг 
group present at position 11), the shorter 
(1-10)-decapeptide turned out to be suitable 
as a substrate, too, although it had only one 
fourth the activity of the tndecapeptide amide 
( И ) 
Since the assay used in the initial experiments 
(6) does not easily discriminate between Na-
acetylation of the substrate and of endogenous 
components of the enzyme preparation, it was 
necessary to develop a simple, non time-
consuming method Reversed phase HPLC was 
found to give a fast separation of the product 
of the acetylation (H Dnessen, manuscript 
ι·! preparation) An additional difficulty was 
the sensitivity of the subsl.ate for oxidatior 
at the melhionyl residue, leading to a sulfoxide 
The oxidated decapeptide behaves differently 
in chromatography as a result of Us increased 
polarity, and probably is a less suitable sub­
strate for enzymatic W11-acetylation ( I I ) It 
therefore appeared desirable to have available 
a model substrate which does not have this 
sensitivity for oxidation This can be achieved 
by replacing methionine at position 4 of the 
decapeptide by norleucme, which is known to 
0367-8377/82/090289-09 $02 00/0 © 1982 Munksgaard, Copenhagen 
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be a close analogue of methionine (12-15). We bonate (22), which attacks solely the amino 
here describe the synthesis of this analogue of group Then the tert -butylether group was 
the (l-lO)-decapeptide of a-MSH H-Ser-Tyr- introduced at the hydroxy! functions with iso-
Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-OH(I) butylène (23). As had been noted by Kinoshita 
(20), in the case of Z-Tyr-OMe the reaction was 
Synthesis ofdes-N"1 -acetyl-[4-norleucinel a- not complete. Since a quantitative reaction was 
melanotropin-fl-lOj-decapeptide desirable, it was looked at in more detail. It 
In the well proven strategy for the synthesis of appears impossible to drive the reaction to corn-
compounds of this type, the C-terminal (5-10)- pletion, as it turned out to come to a standstill 
hexapeptide γ-ferf.-butylester is acylated with a after a few hours, when the mixture was homo-
tetrapeptide derivative comprising the N- geneous (Fig. 3). L-Norleucine was prepared 
terminal (l-4)-sequence (Fig 1)(16, 17). In by the enzymatic digestion of Z-Gly-DL-Nle-OH 
order to perform this condensation without using carboxypeptidase A, as described by Raj 
racemization the acylation is conducted using et al. (24) for tryptophan analogues. 
the azide for carboxyl activation The penultimate stage in the preparation of 
In the present investigation the desired tetrapeplide derivative 19 presented a problem: 
(1—4)-fragment was constructed using maximal the introduction of the jV-protecting tert • 
protection (Fig. 2) The benzyloxycarbonyl butyloxycarbonyl function with di-ferr.-butyl-
group was chosen for У -protection, since it dicarbonate (25) caused also some acylation of 
ensures by its stability a rapid and complete a hydroxyl group, presumably that of the 
removal of terf.-butylether functions by treat- tyrosyl residue However, hydrazinolysis of the 
ment with trifluoroacetic acid, unlike an N- crude 18 gave the desired tetrapeptide deriva-
terminal tert -butyloxycarbonyl group (18, 19). tive 19, which could be purified only with sub-
The feri .-butylether functions were used for stantial loss because of its poor solubility. Total 
protection of the hydroxyl groups during the yield based on compound 7 (in the reaction 
construction of tetrapeptide intermediate IS with 10) amounted to 32% for 19. 
Eventually, after acid treatment and catalytic The assemblage of the decapeptide derivative 
hydrogenolysis a tert -butyloxycarbonyl group 21 (Fig. 1) was affected almost quantitatively 
was introduced at the A -^terminus of the tetra- after purification by countercurrent distri-
peptide methylester 17, which was subsequently bution. The desired substrate I was obtamed as 
converted via the hydrazide into an azide All a single compound in 70% yield on treatment 
couplings between fragments were performed with trifluoroacetic acid, and resisted oxidation 
using the azide for carboxyl activation. by peroxides as expected. Part of it was acetyl-
The required tyrosine derivative 9 was earlier ated for identification purposes using the 
described by Kinoshita(20), the serine derivative selectively acetylating acetoxyphthahmide (26). 
7 by Schroder (21). However, in this synthesis For the new assay, mentioned in the inlro-
both tyrosine and serine were acylated as their duction, an internal standard identical to the 
methylesters using benzyl succinimidyl car- acetylated substrate was necessary to correct 
BOC-Ser-Tyr-Ser-Kle-NH-KHj ^9 • Н-61о(0ви')-Н\5-Р(іе-АГ5-Тгр-С1у-0Н ?0 
-1 
BOC-Sei^Tyr-Ser-Hle-GlutMu'l-Hls-Phe-Ar^-Trp-Gly-OH 21 
TFA-H20 
H-Ser-Tyr-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-OH ^ 
CH3C0-0-NPht / ^ Ч CH3["C]0-0Np 
OUCO-decapeptide Д CH3[ ,4]0-decapeptide Д І 
FIGURE 1 
Synthesis of H-Ser-Tyi-Ser-
Nle-Glu-Hu-Phe-Aig-Tip-
Gly-OH I by condensation 
of a tetra- and a hexa­
peptide denvauve. 
-88-
a-MSH-{ 1 - 10)-decapeptide analogue 
Z-Tyr(Bii )-0Ме 9 
2-5*г(8и 1 ) -»Н-«Н 2 7 • К-І»г(Ви г ) -0Яе Н> І-5ег(Ви 1 )-НН-1(Н г 7 . Н-Шс-ОМе Э 
НО* NO* 
2-5ег(ви')-Іуг(Ви')-0«е И 
7-5ег(Ви')-Туг(Ви1,-| 
7-5ег(Ви')-М|р-0Не J3 
Н-5ег(ви')-М1е-0Ие li 
2 - 5 < ! г ( В и 1 ) - Т у г ( В и ' ) - 5 е г ( В и ' ) - » І е ОНе IS 
Z-Ser-Tyi^SM-N1e-0H« 16 
I V м 
K-Ser-Tyr-Ser-Mle-OHe il 
I BOC-0-BOC 
BOC-Sír - Iyr -Ser-Nl í -О И е 18 
1 і«
г
-ни2 н2о 
BOC-Ser-Tyr-Str-Nle-KH-HHj 19 
FIGURE 2 
Synthesis of BOC-Ser-Tyr-
Ser-Nle-NH-NH, 
for losses during the work-up. For this purpose Procedures, using the HI'LC assay (H. Dnessen, 
part of I was acetylated with p-nitrophenyl- manuscript in preparation) an acetate incorpor-
[1-14C]-acetate, prepared from p-nitrophenol atiun of 101 pmol/min-ml S-15 was found 
and [1- , 4C] acetic anhydnde according to the 
procedure of Tesser & Schwyzer (27) Yield of 
СНз[ 1 4 С] O-decapeptide ПІ was 52%; an im­
purity, the nature of which is not known, 
was present. « 
Biological activity of peptide 1 
Incubation of I in the presence of calf lens ^ ^ _ 
extract (S-15)(6) as the source of jVa-acetyl-
transferase, and acetylcoenzyme A indicated » «, » » » , « , , . 
that I is as good a substrate for measuring the -..,„... _,.. 
acetylatmg activity as the original des-W" - FIGURE 3 
acety!-a-MSH-(!-10)-decapeptide, but prefer- i-ButyUtion of Z-Tyr-OMe approaches its maximum 
able because of its resistance to oxidation m a few hours, but leaves about 25% of umeacted 
Under conditions as described in Experimental starting material 
-89-
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EXPERIMENTAL PROCEDURES 
Nuclear magnetic resonance spectra ('N-n.m r ) 
were either measured on a Vanan Associates 
Model T-60 (60 MHz) or on a Bruker WH-90 
(90 MHz) In the first case deutenochloroform 
was used as a solvent, in the second deuterio 
methanol unless otherwise stated Chemical 
shifts are reported as δ-values (ρ ρ m ) relative 
to tetramethylsilane as an internal standard 
Melting points were measured on a Buchi 
Schmelzpunktbestimmungsapparat nach Dr 
Toltoli, and are uncorrected Optical rotation 
was determined with a Perkin-Elmer Polarimeter 
241 (D line). Elemental analyses were per­
formed by Mr. J. Diersman in the micro-
analytical department Mr. M van der Gaag 
performed the amino acid analyses using a 
modified Jeol JLC-6AH amino acid analyzer 
(1 column, 4 buffers) Peptides were hydro-
lyzed in 5 7 M HCl in sealed, evacuated tubes 
at 110° for 24 h Ile and Leu were used as an 
external standard. Ser was determined by 
extrapolation from a time-dependent hydro­
lysis of 24, 48 and 72h Trp was determined 
according to Bencze & Schmid (28) Peptide 
content was determined by measuring the 
ratio Tyr/Тгр in the presence of a known 
amount of Trp (Bencze-Schmid) and by deter­
mining the number of nmoles present m a 
sample (amino acid analysis). Liquid scintil­
lation counting (LSC) was performed using a 
Packard Tncarb Model 3375 and 3380 with 
Picofiuor 15 as a scintillation agent at an 
efficiency of 72% 
Carboxypeptidase A was obtained from 
Boehrmger, Mannheim [1-'4C] acetic anhydride 
(500μΟ, 120mCi/nimol) was supplied by 
Amersham as a toluene solution (5%, w/w) 
[aceryl-3H] -acetyl coenzyme A was supplied 
by New England Nuclear 
For thin-layer chromatography ( t i c ) , pre-
coated sihcagel plates with a fluorescence 
indicator of Merck were used To develop the 
chromatograms the following solvent systems 
were used 
A = chloroform-methanol-acetic acid 
(95 20 3v/v) 
В = l-butanol-acetic acid-water (4 1 1 v/v) 
С = l-butanol-acetic acid-pyndine-water 
(4 1 1 2 v/v) 
Detection of components on thin layer 
plates was performed using 
u ν quenching of fluorescence after exposure 
at 254 nm 
nin, ninhydnn reagent for detection of free 
amino groups 
TDM, 4,4' tetramelhyldiamine-diphenyl-
methane test for chlonne reactive 
compounds (amine, hydrazide, 
phenolic OH) 
B, Barton reagent for detection of reducible 
compounds 
Ehrlich detection of tryptophane 
Sakaguchi detection of arginine 
Pauly detection of histidine 
+, positive identification 
Acetylation reaction 
The reaction mixture contained in Sorensen 
phosphate buffer, pH 7 4, 0.31 mM Ι, 2 5μΟ 
(5 45 ДМ)[ДСЕ'І>'/-ЭН)-acetyl coenzyme A and 
200μΙ S-15 (6) in a final volume of 650μ1 
The assay mixtures were incubated at 37° for 
1, 2 and 3 mm The reaction was started by the 
addition of acetyl coenzyme A, and stopped 
by chilling in ice To the reaction mixture 
СНэ[ ,4С] Odecapeptide III was added as an 
internal standard, and both the enzymalically 
and chemically acetylated compounds were 
isolated by reversed phase HPLC (H Dnessen, 
manuscript in preparation) 
L-NleOMe3 
Z-Gly-DL-Nle-OH 1 Racerrac norleucme (5 Og, 
38mmol) and 14 1 g Z-Gly ONp (43 mmol) 
were suspended in 50 ml acetomtrile-water 
(4 1, v/v) Triethylamine (5 32 ml, 38mmol) 
was added with stirring The yellow suspension 
was stirred at room temperature for 17 h 
Filtration of the turbid solution gave 1 Og un-
reacted norleucme The filtrate was concentrated 
in vacuo, the residue was dissolved in water 
after acidification with K.HSO4 solution, pH 5 
p-Nitrophenol was extracted with ether On 
acidification of the water layer to pH 2 the 
product precipitated, and was isolated by 
filtration The precipitate was recrystallized 
from acetic acid-isopropyl ether to give 4 6 g 
white needles From the mother liquor another 
2 4g were obtained Οκ,Η^Ν,Ο., (322 36), 
yield 58%,mp 1315-132 7" T i c one spot 
R, 0 52(A), uv -l-,TDM + 
CHN analysis (theoretical value in parentheses) 
С 59 4 (59 62), Η 6 8 (6 88), Ν 8 6 (8 69) 
-90-
H Me OH 2 Z G l y D L N l c O H I (3 6g 
1 1 mmol) was digested with 40()μ] ol a Lar 
boxypeptidase A solution in water (ratio 
1 360 w/w) ("ollowmg the procedure of Raj 
et al (24) After 45 h the solution was con 
centratcdin vacuo upon which Ζ Gly D Nie OH 
precipitated The filtrale was adsorbed on a 
column of Biordd AGI X2 (acetate cycle, 
25 χ 1 4 cm) On elution with ? M acetic acid 
ninhydnn positive material was set Гіее the 
pertinent fractions were collected and evapor­
ated to dryness ш vacuo The residue was 
crystallized trom ethanol water (I 1 v/v) to 
give three Iractions of while crystals in all 
0 6 3 g CeH.jNOj (13118) yield 87/
r
 T i c 
one spot R, 0 4 2 (B) nin+ TDM+ [ a ] 2 0 
+ 23 6 [c 4 6 M HCl] 
CHN analysis С 54 9 (54 44) Il 10 I (9 99) 
N 1 0 8 ( 1 0 6 8 ) 
Nie OMc S Norleucine 2 was estenfied using 
thionylchlonde m methanol ( 7 H I 6 N 0 2 C I 
(181 66) yield 817r m ρ 137 0 Π 8 0° Mazur 
et al (29) Ι 3 6 - Π 9 ° T i c R f 0 4 8 ( D ) n i n + 
TDM+, conUmmation of 2 present |or j 2 0 + 15 
[ c l I M H ( l | + 14(29) 
CHN analysis С 46 5 (46 28), H 9 0 (8 88) 
N 7 7 ( 7 71) 
Z-Ser(Bu') NH-NH2 7 
Z-ONSu 4 N hydroxysuccinimide was acylated 
with benzyloxycarbonylchloride according to 
Frankel (22) СцНцМОа (249 22) yield 78% 
m ρ 79 5 81 0°, 78-80° (22) T i c one spot 
R f 0 47(A), u ν +,TDM + 
CHN analysis С 58 1 (57 83), Η 4 6 (4 45), 
N 5 7(5 62) 
Ή η m г (60 MHz), ί 7 30, singlet (5Η, 
С 6 Н 5 ), δ 5 30 singlet (2Н,-СН 20 ) δ 2 75 
singlet (4Н CHj-CH2 ) 
Z-SerOMeS Ser-OMe-HCl (1 56 g 10 mmol) 
and ZONSu 4 (2 49g, 10mmol) were dis 
solved in 15 ml acelonitnle water (4 1, v/v) 
After cooling to 0° 1 4 ml triethylamine 
(lOmmol) were added The solution was stirred 
at room temperature for 3 h then concentrated 
іи vacuo, diluted with water acidified with 
KHS0 4 solution and extracted with ethyl 
acetate The ethylacetate layer was treated with 
a MSH ( I - 10)-decapeptide analogue 
NallCOj solunon and washed neutral with 
water Alter drying (Na 2 S04) the ethylacetate 
was evapoiated in vacuo to yield 2 51 g of a 
yellow oil C , 2 H 1 5 N 0 5 (253 25) yield 999f 
T i c one spot R, 0 66 (A) u ν + TUM+ 
2 Ser(liii') OMe 6 t Butylation of the hydroxyl 
group was accomplished lollowing ihc general 
procedure ol Beyerman (2?) / Sei OMe 5 
(20 03 g 79 mmol) wis dissolved in 85 ml 
dioxanc 2 0 ml H 2 S 0 4 cone was added and 
the solution cooled to — 20° in a pressure 
prool flask About 240ml condensed isohutene 
wcic added The flask was closed and the 
turbid mixture was stirred at room temperature 
loi 4 days The clear solution was then pooled 
to—20° and the flask was opened The solution 
was neutrah/cd with triethylamine .nul the iso 
bulene was evaporated Walci and ether were 
added The cthei layer was icidified with 
KHSO,, solution until pH 4 treated with 
N a I I ( 0 3 solution and washed neutral with 
water Alter drying ( № 2 Ь 0 4 ) the cthci was 
removed in lacuo to give 2Ì 61 g ol a yellow 
oil ( 1 6 H M N 0 5 (309 36) yield 979- T i c one 
spot Rf 0 67 (A) , uv + TDM + 
Z-Ser(Bu,)NHNH2 7 Hydrazinolysisofesterô 
was performed following the procedure of 
Schroder (21) The product contained an im 
purity, which could not be removed by re 
crystallization from isopropylalcohol pet ethei 
С,,Н 2 зЫз0 4 (309 37) yield 80% Schroder 
( 2 1 ) 8 1 % m p 1 0 9 5 - 1 1 0 0 ° 1 1 2 5 - 1 1 3 5° 
(21) Τ 1 с Rf 0 65 (A),u ν + B+ an impurity 
was present R, 0 76 (A) u ν + B+ [a]" + 
11 9 [c 1 DMF] + 1 3 6 ( 2 1 ) 
CHN analysis С 58 4 (58 24), Η 7 6 (7 49) 
Ν 1 3 6 ( 1 3 58) 
Z-Tyr(Bu')OMe9 
Ζ Туг OMc 8 This compound was prepared as 
described for Z-Ser-OMe 5 The resulting oil 
was crystallized from ethylacetate pet ether to 
give two fractions of white crystals (
 ι 8 Η „ Ν θ 5 
(329 35) yield 89% m ρ 9 1 0 93 0° 
Kinoshita (20) 92-93° T i c one spot R f 
0 72(A) u ν + TDM + 
CHN analysis С 65 6 (65 64) Η 5 8 (5 82) 
N 4 2 ( 4 25) 
' H n m r (60 MHz), δ 7 27, singlet ( 5 H C 6 H 5 ) 
- 9 1 -
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δ 66 7 1, multiplet(4H,-C6H4-). δ 5 3 - 5 7 
mullipleU 1 Η, ΝΗ-), δ 5 05, singlet(2H, CH,0·), 
δ 4 3-4 8. multiplet(lH,C0H), δ 3 62, singlet (ЗН,-ОСНз),6 2 9-3 2,multiplet(2H.C3H2) 
Z-Tyr(Bu' І-ОМе 9. t-Bulylation was performed 
as described 1Ъгг-5ег(Ви')-0Ме 6 The resulting 
oil contained unchangeably about 25% of 
starting material 8, irrespective of the re­
action time (Fig 3) The oil was taken up in 
chloroform methanol (99 5 0 5, v/v), and ap­
plied in two portions onto a column of Merck 
Kieselgel 60 (70-230 mesh ASTM, 21 χ 7cm), 
equilibrated with the same solvent On elution 
the fractions containing 9 were collected, and 
evaporated to dryness ¡n vacuo to yield a 
yellow oil which crystallized on standing The 
product was recrystallized i rom pel ether 
isopropylelher (8 2, ν/ν) Γ 2 2 Η 2 7 Ν0 5 (385 46) 
yield 22%, m ρ 52 5-53 5° Kinoshita (20) 
51 -53 5° T i c . one spot R, 0 82 (A), u ν +, 
TDM+ | α ] " - 3 0 9 [с 1, DMF] , - 2 9 3 (20) 
CHN analysis С 68 6 (68 55), Η 70 (7 06) 
Ν 3 7(3 63) 
'H-nmr (60MHz) δ 7 27,smglel(5H,C6Hs-), 
δ 6 6-7 1, multiplet(4H,-C6H4-), δ 5 3-5 7, 
multiplet(lH,-NH ),δ 5 05, singlet(2H,-CH20-), 
δ 4 1-4 8, multiple« 1Н,С
а
Н), δ 3 62, singlet 
(3H,-OCH,), δ 2 9-3 2 multiplet(2H,CpHj). 
δ 1 30,singlet(9H,-CMe3) 
Percent conversion ofZ-Tyr OMe 8 us 
determined by ' И η m r {tig 3} 
Reaction time (h) 
3f 
18 
96 
120 
Conversion (%) 
73 
76 
66,79 
69 
Z-Ser(Bu'l-Tyr(Bu')-NH-NH2 ¡2 
Z-SerfBu' )-Туг(Ви' j-OMe 11. Ζ 5ег(Ви')-МН-
МНз 7 (6.19 g, 20 mmol) was dissolved in 
200 ml DMF, and cooled to - 1 5 ° Then 
14 5 ml of a 3 8 M solution of HCl in ethyl-
acetate (55 mmol) were added dropwise with 
stirring The temperature was maintained at 
— 15° Now 2 74ml t-butylnitri(e (24mmol) 
were added, and the solution was stirred for 
I 5 mm tit — 1 5° It was neutralized with 9 46 ml 
ethyldnsopropylamme The solution was added 
immediately to H Tyr(Bul)-OMc 10, which had 
been prepared by hydrogcnolysis of 8 1 I g 
гТуг(Ви')-ОМе 9(21 mmol) The temperature 
ol the reaction mixture ol jzide and ammo 
component was allowed to rise to 0°, and the 
solution was kept at this temperature for 4 
days It was concentrated m vacuo, diluted with 
water and extracted twice with ethylacetate 
The combined extracts were washed with 
KHSO, and KHCO3 solutions and washed 
neutral with saturated NaCI solution After 
drying (N32804) the ethylacetate was removed 
ш vacuo to give 10 2 g ol an oil, which was 
crystallized from pet ether to give 8 47 g while 
crystals From the mother liquor another 
0 42g were obtained ( 2 ,Н а д М 2 0 7 (528 65) 
yield 84% in ρ 67 0 68 5° Tic one spot 
Rf 0 82(A),uv + TDM + 
CHN analysis С 65 7 (65 КЧ). Η 7 7 (7 63), 
Ν 5 3 (5 30) 
ZSeríBu'l-Tyr/Bu'j-NH-NÍ^ 12. Z-Ser(Bu1)-
Туг(Ви1)-ОМе 11 (8 88 g, 16 8 mmol) was dis­
solved in 17 ml methanol 3 27 ml hydrazine 
hydrate (67 2 mmol) were added The solution 
was stirred for 22 h at room temperature, 
during which time the product precipitated 
partially Water (60 ml) was added, and a heavy 
precipitate formed Filtration and drying over 
KOH m vacuo gave 8 80 g white crystals, which 
contained an impurity CMH4(,N406 (528 65), 
yield 98%, m ρ 98 0-100 5° T i c , Rf 0 71 
(A), UV+, B+, an impurity was present Rf 
081 ( A ) , u v + , B + [ a ] 2 : , - 5 5 [c l.DMF] 
CHN analysis С 63 3 (63 62), Η 79 (7 63), 
Ν 106(1060) 
Z-SerfBu'l-Nle-OMelS 
Condensation of Z-SerlBu'y^Hj 7 and H-Nle-
OMe 3 was performed as described for Z-Ser 
(Ви1)-Туг(Ви')-ОМе 11 The product was re-
crystallized from pet ether C22H34N206 
(422 52), yield 86%, m ρ 49 5-51 5° T i c , 
one spot R{ 0 83 (A), uv +, TDM+ [ a ] 2 3 
about 0 [c 1, DMF], ditto [c 1, HOAc], ditto 
[c I.EtOH] 
CHN analysis С 62 6 (62 54), Η 8 2 (8 11 ), 
N 6 7(6 63). 
- 9 2 -
a-MSH-( 1 - IO)-decjpeplide analogue 
Z-SerfBu''J-TyrfBu')-8ег(Ви'¡-Nle-OMe IS 
The acylation of H-SeriBu^-Nle-OMe 14, 
obtained by hydrogenolysis of 13, with the 
azide derived from Z-SeKBu'^TyriBi/j-NH 
NHj 12, was carried out as described for 11 
The product was crystallized from ethylacelale 
pet ether Γ,,,ΗΜΝ.,Ο,Ο (784 99), yield 84% 
mp IWS-ISSS" T i c , one spot R, 087 
(A),uv+,TDM+ [ о ] и - 3 6 [с I.DMF] 
CHN analysis С 64 4 (ò4.26), Η 8 4 (8 22), 
N7 2(7 14) 
1
 H-η m г (90MHz, only protecting groups and 
aromatic core of Tyr) δ 7 35, singlet (5H, 
C6Hs-), δ 7 00, AA'BB' (4H, -C6H,-),6 5 10, 
singlet (2H, -CH,0-), δ 3 71, singlet (3H, 
-OCH3), δ 1 29, singlel (9H, -СМез of Туг), δ 
1 18, singlet (9H, -СМез of Ser), δ I 13, 
singlet (9H, СМез of Ser) 
BOOSer-TyrSer-NleNH-NHt 19 
Z-Ser-Tyr-Ser-Nle-OMe 16. Z-SeríBu'l-Tyr 
(Bu'j-SerCBu'J-Nle-OMe 15 (2 14g, 2 8mmol) 
was dissolved in 110 ml tnfluoroacetic acid-
water (90 10, v/v) After 15 mm the solution 
was concentrated m vacuo, ether was added, 
and a heavy, white precipitate formed This was 
filtered, dried and recrystalhzed from methanol-
wate r Yield 1 16g white crystals, from the 
mother liquor another 0 9g were obtained 
СэоН«<Д,010 (616 66). yield 71%, m ρ 208° 
TJc.,onespotR l0S4(A),u.v+,TDM+,B+ 
H-Ser-TyrSer-Nle-OMe 17. The bcnzyloxy-
carbonyl group at the У -terminus of Z-Ser-
Tyr-Ser-Nle-OMc 16 was removed by hydro­
genolysis C22H34N.,Oe (482 S3),yield virtually 
quantitative Τ 1 с , one spot R, 0 48 (B), u ν +, 
B+,nin-l-,TDM+ 
'H-n m r (90 MHz, only protecting group and 
aromatic core of Tyr); δ 6 88, AA'BB' (4H, 
-С6К,-).6 3 71, singlet (ЗН,-ОСНз) 
BOCSer-Tyr-Ser-Nle-OMe 18. A ten -butyloxy-
carbonyl group was introduced at the V^-
termmus according to the procedure ot Moroder 
et at (25) To a solution of 0 227 g H Ser Tyr-
Ser-Nle-OMe 17 (0 47 mmol) 0 114g di-tert 
bulyldicarbonate (0 52 mmol) in 1 5 ml DMF, 
cooled to 0°, 66μΙ triethylamme (0 47 mmol) 
were added with stirring After stirring had 
been continued ІогЗОпип at room temperatine, 
the solution was concentrated in vacuo, and 
water and ethylacetate were added The water 
layer was acidified with KHSO4 solution and 
extracted a second time with ethylacetate 
After drying (Na^SOi) the solvent was re­
moved in vacuo to yield 0 274 g ol a white 
solid Τ 1 с revealed the presence ol an im­
purity, since the crude compound underwent 
hydrazinolysis 111 the next stage giving only one 
product, we speculate that the impurity consists 
of a compound bearing an additional BOC 
group at the oxygen of the tyrosyl residue 
t'27H«N4O10 (582 65) T i c , R, 0 Si (A), 
u ν +, B + , impurity Rf 0 68 (A), u ν +, B + 
BOC-Ser-Tyr-Ser-Nle-NH-NHï 19 Hydrazino-
lysis was accomplished as described for 12 The 
product could be recrystalhzed from water with 
large losses only C26H42N60, (582 65), yield 
68% T.1 с , one spot Rf 0 53 (B), u ν + 
TDM+, B+ [α| " - 0 8 [с 1, DMF) 
1
 H-η m r (90 MHz, CDjOD-DjO, 1 1 v/v cou 
taming CD3COOD. only protecting groups and 
aromatic core of Tyr) δ 6 95, AA'BB' (4H, 
-C6H4),6 1 41, singlet (9H,-CMF3) 
H-Ser-Tyr-Ser-Nle-Glu-His-Phe-Arg-Trp-Gly-OH I 
Boc-Ser-Tyr-Ser-Nle-Glu(OBu')-Hts-Phe-Arg-Trp-
Gly-OH 21 The tetrapeptide derivative 19 was 
condensed with 1 26 mmol H-Glu(OBul)-His 
Phe-ArgTrp-Gly-OH 20 as described for II 
After coupling the solution was concentrated 
m vacuo, and the peptide was preripitated with 
acelonilnlc Filtration and drying over KOH 
in vacuo gave 1 98g peptide, still containing 
a small amount of hexapeptide 20 The crude 
preparation was subjected to counter current 
distribution in the system n-BuOH-EtOH 
buffer (7 2 8, v/v)(buffer composition 19 25g 
amniomumacctate and 28 5 ml acetic acid, 
made up to 1000ml with water) Aftei 150 
transfers (K = 7 3, r
m
„ = 128 for product 
K = 1 9 for hexapeptide, (3 = 3 8) chroma 
tographically pure product was pooled, and the 
solvent removed in vacuo to give 2 0g of a 
reddish product C 6 9H«N, 60 1 8 (1437 61),yield 
virtually quantitative, peptide content 94% 
T i c , one spot R, 0 54 (C), uv+, TDM+, 
B+, Ehrlich+, Pauly+, Sakaguchi+ (a) 2 3 
- 11 4 [L l.DMF] 
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Amino acid analysis (iheoretical value in 
parentheses) Ser 1.97 (2), Glu 1.03 (1), Gly 
1.00 (1), Nie 1.01 (1), Туг 1.04 (1), Phe 0.99 
(1),Тгр 1 15(1), His 0 9 8 ( 1 ) , A r g 0 9 7 ( l ) . 
Deprotecnon of 21 The protected decapeptide 
21 (1 I2g, 0 8 mmol) was dissolved in 50 ml 
tnfluoroacetic-water (9 1, v/v), and the air in 
the reaction vessel was displaced by pure nitro­
gen After 30 mm the solvent was evaporated 
ш vacuo, and the peptide was precipitated with 
ether. The precipitate was dissolved in 0.1 M 
acetic acid and applied on a column of Merck-ll 
weak basic anion exchanger (acetate cycle, 
15 χ 1.8 cm). On elution with the same solvent 
the ultraviolet absorbing fractions were pooled 
and lyophilized to give 0 81 g reddish product. 
ΟοΗβοΝ,ίΟ« (1281 39), yield 70%; peptide 
content 83%. T.I.C., one spot R, 0.36 (C), 
U.V.+, nin + , TDM+, B+, Ehrlich+ [ a ] 2 3 -
32.8 [c 1, 1% acetic acid] 
Amino acid analysis: Ser 1 94 (2), Glu 1.03 (1), 
Gly 1.01 (1), Nie 1.00 (1), Туг 1.00(1), Phe 
1.01 (1), Trp 1.06 (1), His 0 9 8 ( 1 ) , Arg 0.97 
(D-
Acetylation of I 
CHjCO-decapeptide II. Decapeptide I (20mg, 
12.5μπιο1β) was suspended in 2ml DMF, and 
the pH was adjusted to 9 - 1 0 with ethyldiiso-
propylamine. JV-acetoxyphthalimide (26) 
(5.4 mg, 26.3μπιο1) was added with stirring. 
The suspension was stirred for 18 h. After 
filtration, the peptide was precipitated with 
several volumes of ether, and dissolved in 2 ml 
6% acetic acid. This solution was filtered over 
a column of Sephadex G25 fine (32 χ 1.8cm), 
equilibrated with the same solvent. The peptide 
containing fractions (detection at 280 nm) were 
pooled and lyophilized to give 9.5 mg white 
product. C „ H
e
2 N 1 6 0 „ (1323.14), yield 50%. 
Т.1.С., one spot Rf 0.39 (C), u.v +, nin-, 
T D M + , B + . 
С Я з [ | 4 С ] O-decapeptide III. p-Nitrophenyl-
[1-14C]-acetate was prepared as described by 
Tesser et al. (27) from 14.7μπιοί [1-1 4C] 
acetic anhydride (500 /iCi) The product was 
dissolved in 500μ1 dry DMF, brought to pH 
8 - 9 with ethyldnsopropylamine, and added to 
4.0mg decapeptide I (2.6imiol) with vigorous 
stirring The suspension was stirred for 4 days, 
during which time it became clear The peptide 
was precipitated with 1 ml ether, collected by 
centrifugation and washed with another 1 ml 
ether The precipitate was dissolved in 1 ml 50% 
acetic acid, and filtered over a column of 
Sephadex G25 fine (25 χ I 5 cm), equilibrated 
in the same solvent. The peptide containing 
fractions (detection with t I.e. and LSC) were 
pooled (9 3 ml) and diluted to 100 ml with 
water Yield was 80.5μΟ, with a concentration 
of 805nCi/ml 5% acetic acid. With reversed 
phase HPLC under assay conditions (H Dnessen, 
manuscript m preparation) it appeared that 
15% of the radioactivity did not coelute with 
the СНэ CO-decapeptide II but instead eluted 
as a separate peak following II; the nature of 
this contamination is not known C 6 2 H e 2 N 1 6 0 , 7 
(1325 14); yield 52%. Τ l.c , as specified for 
II. Punty 85%. 
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CHAPTER I I I 
A Rapid and Specific Assay for /V-Acetyltransferase Activity 
H. P. С DRIESSEN.'t W W. DE JONG,* G. I. TESSER,t AND H. BLOEMENDAL* 
Departments of ·Biochemistry and ^Organic Chemistry University of Nijmegen. 6525 EZ Nijmegen 
Geert Grooteplein Noord 21. The Netherlands 
Received April 13, 1982 
A rapid and specific assay for JV-acetyltransferase activity is described This assay makes 
use of acidic precipitation for removal of products resulting Trom acetylation of endogenous 
substrates from the enzyme preparation and of reverse-phase HPLC for isolation of the У -
terminally acetylatcd synthetic substrate The virtue of the assay lies in its fast, not too 
laborious, and reasonably accurate determination of activity during isolation and purification 
of the enzyme 
The TV-terminal acetylation of proteins is 
a widespread phenomenon in eucaryotes, 
and to a lesser extent in procaryotes and 
viruses ( 1 ). Virtually nothing is known con­
cerning the underlying mechanism and pos­
sible functional implications. 7V"-Acetylat-
ing activity has been demonstrated for ri-
bosomal protein LI2 in Escherichia coli (2) 
and ribosome-associated proteins from rat 
liver (3-5), and it has been studied in calf 
lens (6), rat pituitary (7,8), hen oviduct (9), 
and in a ribosomal fraction from wheat 
germ (10). 
In the study of the TV'-acetyltransferase 
from bovine lens (6), synthetic des-N^-ace-
tyl-or-melanolropin (11), a compound that 
is normally found to be acetylated exclu­
sively at the TV-terminus in vivo ( 1 ), was used 
initially The shorter (l-IO)-decapeptide 
also turned out to be suitable as a substrate, 
although it has only one-fourth of the activ­
ity of the tridecapeptide amide (12). This 
peptide is susceptible to oxidation at the 
methionyl residue, leading to a sulfoxide 
which behaves differently in chromatogra­
phy as a result of its increased polarity and 
which probably is a less suitable substrate 
for enzymatic TV'"-acetylation (12). It there­
fore appeared desirable to have available a 
model substrate that does not have this sus-
0003-2697/82/14O352-O6$02.OO/0 
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ceptibility to oxidation. This was achieved 
by synthesizing the analog ( I ) of the ( 1 -10)-
decapeptide of des-N "'-Ac-a-MSH (13), in 
which the methionine at position 4 has been 
replaced by norleucine, a close analog of 
methionine: H-Ser-Tyr-Ser-Nle-Glu-His-
Phe-Arg-Trp-Gly-OH (I). 
The assay used earlier by Granger et al 
(6) does not easily discriminate between TV"-
acetylation of the substrate and of endoge­
nous components of the enzyme preparation. 
It thus was necessary to develop another 
method that was both simple and rapid. A 
first attempt, making use of paper chroma­
tography, ( 12) did not suffice because of its 
laboriousness and time consumption. How­
ever, reverse-phase HPLC was found to pro­
vide a fast isolation of the product of the 
acetylation from the assay mixture and 
turned out to be a suitable technique for an 
assay, as described in this paper. 
MATERIALS AND METHODS 
Apparatus. The Chromatograph assembly 
consisted of an Orlila Mikro-Dossier-Mem-
branpumpe DMP-AE-10.4, two Valco CV-
6-UHPa-N60 7000 psi injectors, coupled as 
described by Lankelma et al. (14) with a 
concentration column (50 X 1.8 mm i.d ) in 
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the loop of the second injection valve, and 
a separation column ( 150 X 4 6 mm ι d ) A 
LKB 2138 Uvicord S (206 nm) with a flow 
cell for HPLC was used for detection For 
testing of the experimental setup, only one 
injector with a separation column (250 X 4 6 
mm ι d ) was used Sometimes detection was 
performed with a Vanan Aerograph 254/ 
280 nm uv detector (254 nm) Liquid scin­
tillation counting was performed with a 
Packard Tn-Carb Model 3380 ( 5 H/ , 4 C dou­
ble-label setting) 
Chemicals Absolute methanol and ace­
tone were "Baker analyzed" quality, o-phos-
phonc acid (mm 85%) and formic acid (98-
100%) were reagent grade from Merck. 
Lichrosorb RP-18, 10-μιη particle size, was 
obtained from Merck, Pico-Fluor 15 from 
Packard [aceryZ-'HlAcetyl coenzyme A 
(specific activity between 0 8 and 2 4 mO/ 
mmol) was supplied by New England Nu­
clear Water was deiomzed and purified fur­
ther by Millipore filtration 
Columns Columns were packed by the 
slurry method The reverse-phase material 
was suspended at a concentration of 10 to 
15% (w/v) in methanol glycerol (75 25 v/v) 
and pressurized with methanol at 400 bar 
Assay To 400 μΐ of a solution of 200 nmol 
decapeptide I (13) in Serensen phosphate 
buffer, pH 7 4, cooled in ice, 200 μΐ of an 
7Va-acetyltransferase preparation and 6-25 
μΐ of a solution of [acerW-'H ¡acetyl coen-
zyme A in water, pH ~ 5 (0 6-2 5 μΟ) are 
added The volume is made up to 650 μΐ with 
buffer (final concentrations decapeptide I, 
0 31 mM, coenzyme, 0 3-5 5 μΜ, depending 
upon the specific activity), and the solution 
is thoroughly mixed The reaction is started 
by incubating three of these assay mixtures 
at 370C for 1, 2, and 3 mm, and is stopped 
by chilling in ice Then ΙΟΟμΙοΓ СНз['4С]0-
decapeptide III (16 nCi) (13) is added as an 
internal standard Proteins are precipitated 
with about 5 vol of 1 м formic acid in ace­
tone with vigorous shaking The precipitate 
is removed by centnfugation at 5000 rpm 
for 5 min, and the clear supernatant is con­
centrated to about 0 5 ml by flushing with 
pure nitrogen at room temperature The re­
sidual solution is cleared at 10,000 rpm m 
a SS-34 rotor in a Sorvall RC-2B (15 mm, 
room temperature) to remove all particulate 
matter in order not to jeopardize the HPLC 
column 
The sample is injected via a loop of 0 5 
ml onto the concentration column with 
methanol water (20 80 v/v) eluanl at a flow 
rate of I ml/imn After 1 mm the sample 
is set free by backflushing the concentration 
column with methanol water (50 50 v/v), 
containing 0 4% o-phosphonc acid, at an 
elution rate of 2 5 ml/mm, and injected onto 
the separation column After about 5 mm, 
samples of 1 6 ml are collected for 7 or 8 
mm Each sample is mixed with 14 ml of 
Pico-Fluor 15 as a scintillation agent and 
counted at a J H/ H C double-label setting 
RESULTS AND DISCUSSION 
To measure the enzymatic activity of an 
TV-acetyltransferase preparation it is nec­
essary to determine the initial velocity under 
steady-state conditions The present assay 
is a discontinuous one, because use is being 
made of three separate incubations, per­
formed at 370C, for 1, 2, and 3 mm The 
three incubations contain the enzyme prep­
aration, of which the activity has to be de­
termined, the substrate (I), and the labeled 
acetyl donor, [acery/-3H]acetyl coenzyme A 
This we take as the minimum required to 
determine the initial velocity from the in­
corporation of [3H]acetate as a function of 
time What is needed as an improvement 
over the assay used thus far (6) is a fast and 
simple removal of the products of acetylation 
of endogenous components of the enzyme 
preparation Next, a fast, not too laborious 
separation of the product of enzymatic acet­
ylation [acefy/-3H]CH3CO-decapeptide (II) 
from residual 'H-activity, originating from 
the labeled cefaclor, is required 
The first improvement, removal of inter­
fering products of the preparation, can be 
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accomplished by deproteinizing an incuba­
tion sample with 5 vol of 1 M formic acid in 
acetone. Under these conditions the residual 
substrate (1) and the product of acetylation 
(II) do not precipitate However, to correct 
for possible losses in this precipitation step 
and further processing, an internal standard 
consisting of CHj[" ,C]0-decapeptide (III) 
(13), which is chemically indistinguishable 
from the product of enzymatic acetylation 
(II), is added before precipitation. The pre­
cipitate, which contains a large amount of 
3H-labeled activity, is removed by centnfu-
gation. 
The second improvement, specific isola­
tion of II, can be accomplished by reverse-
phase HPLC. To make the assay as rapid 
as possible, isocratic elution is required. 
When this assay was devised (in 1978), sev­
eral methods for separation of small peptides 
by reverse-phase HPLC had been described. 
Most interest was centered on the fully po­
rous, silica-based packings of 10 μπι, or 
smaller, covalently coated with a Cie-alkyl 
chain (cf. 15-20). Eluants consisted mostly 
of aqueous systems containing either meth­
anol or acetomtnle It seemed promising for 
a fast isocratic elution to use water and 
methanol, containing o-phosphonc acid, as 
an eluant (19,21 23) The addition of this 
hydrophilic ion-pairing reagent gives marked 
decreases in retention times together with 
improved reproducibility In addition, phos­
phoric acid can be successfully used at 206 
nm and permits the use of significantly lower 
concentrations of organic solvents in the 
mobile phase, thus reducing the possibility 
of denaturation or precipitation. 
We checked the behavior of synthetically 
acetylated (I) (CH3CO-decapeptide IV), 
which is chemically identical with the prod­
uct (II) of enzymatic acetylation under assay 
conditions, on the HPLC column with eluants 
consisting of water and methanol, containing 
o-phosphonc acid. Keeping the phosphoric 
acid concentration constant at 0.3% and 
changing the methanol concentration gives 
a marked effect upon the elution of peptide 
IV (Fig 1A) Practical methanol concentra­
tions lie between 45 and 60%. With 50% 
aqueous methanol, a similar effect is exerted 
by changing the concentration of the phos-
30 W SO 60 70 80 0 00 0 10 0.20 0 50 0 40 
I ffeOH Ι Η-,ΡΟ^ 
FIG 1 Relation between eluant composition and elution time of CH^CO-dccapeptide IV Column, 
Lichrosorb RP-18, 10 μιη (250 X 4 6 mm ι d ), elution rate, 3 6 ml/min, detection, uv 206 nm (A) 
Effect of increasing concentrations of methanol in the methanol water eluant, containing 0 3% o-phos-
phoric acid (B) Effect of increasing concentrations of o-phosphonc acid in the 50% methanol eluant 
Vertical bars denote the peak width, dots the lop of a peak 
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phone acid (Fig IB) A concentration of 
0 1% or more is required for an elution time 
of less than 10 mm Consequently, eluants 
containing methanol in water at a concen­
tration of 45 to 60% with 0 4% o-phosphoric 
acid on a pC i e column are useful for a fast 
and reproducible assay, and the elution can 
be followed at 206 nm 
For HPLC separation the setup described 
by Lankelma et al (14) is used The residual 
sample is injected via a loop of 0 S ml in the 
first injection valve and adsorbed on a con­
centration column in the loop of a second 
valve For the loading of this short column, 
filled with Lichrosorb RP-18, 20% methanol 
is used as an eluant Under these conditions 
the peptides I (residual substrate), II (prod­
uct), and III (internal standard) bind strongly 
to the reverse-phase material, so that the 
sample is concentrated considerably By 
backflushing the concentration column with 
50% methanol + 0 4% H3PO4, the peptides 
are set free and injected on a separation col­
umn containing RP-18 Depending on the 
quality of the column, the methanol concen­
tration has to be varied sometimes Residual 
'H-labeled material elutes with a fc'=:0 
(Fig 2) After 4 or 5 mm decapeptide I is 
eluted and can be traced by its absorption 
at 206 nm The eluant is then collected in 
samples for 8 to 9 mm Peptides II and III 
elute at the same position Because of the 
isocratic elution, a new sample can be loaded 
immediately 
As there is still some leakage of 3H counts 
from the large Ή peak (Fig 2), originating 
from the labeled cofactor, which contami­
nates peptides II and III, a background mea­
surement is required To this end a parallel 
assay is done, in which either buffer instead 
cpm 3H I—I and 
чаю -l " C [ _ ] 
absorbance at 
206 nm [ 1 
г 0 150 
о г « б в io i2 м 
elution time [mini 
FIG 2 Separation profile of assay mixture by reverse-phase HPLC Column, Lichrosorb RP-18, 10 
μιη ( 150 X 4 6 mm ι d ), eluant 56% methanol, containing 0 4% o-phosphonc acid elution rate 2 5 ml/ 
mm, detection, uv 206 nm (- ), 3H cpm (—), and 1 4C cpm ( ) Loading of the concentration 
column, 0-1 min backflushing of the concentration column and loading of the separation column, 1-4 
min, elution of Ή labeled material with а к ^- 0 (originating from the coenzyme), 2 5 mm M C peak 
at 3 mm is a counting artefact, elution of residual substrate (I), 5-9'^ min, coelution of [acetyl 
'HjCHjCO-decapeptide (II) and C H J C ' C I O decapeptide (III) б'Л-Юй min and elution of contam 
•nation present in III, Ю'Л-121а mm The 206-nm pattern is given only partially for the sake of clarity 
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DRIESSEN ET AL 
of enzyme or heat-inactivated enzyme is 
added; two or three blank incubations suf­
fice. The mean of the leaking 3H activity 
present under the internal standard on elu-
tion is subtracted from each assay point We 
assume that part of the background also con­
sists of counting errors and uncatalyzed Л'"-
acetylalion of the substrate (I) by acetyl 
coenzyme A, being an active thioester. How­
ever, these two factors normally give a neg­
ligible contribution. 
If necessary, the amount of 'H counts 
found for each assay point can be corrected 
for with the 14C counts of the internal stan­
dard; however, the variation in this standard 
is mostly minimal after HPLC. The amount 
of [3H]acetate incorporation/200 μ\ enzyme 
preparation is plotted against the incubation 
time. From the slope of the linear curve the 
initial velocity can be calculated and ex­
pressed in the amount of picomoles [3H]ac-
etate incorporated min"' ml"' enzyme prep­
aration. 
In this way we devised a rapid and specific 
assay for /V-acetyltransferase activity; the 
product of enzymatic acelylation (II) is eas­
ily separated from the products of acelyla­
tion of endogenous substrates and from re­
sidual 3H activity, originating from the 
coenzyme. The enzymatic activity of a 
preparation can be determined within 1 day. 
Detection limit is about S pmol (in the units 
expressed in the preceding alinea). To achieve 
an accuracy of about S to 15%, however, 
enzyme activities exceeding 20 pmol are re­
quired. The highest activities ever measured 
are of the order of 300 pmol. As a result of 
the low concentration of the enzyme in tis­
sues and because of its instability, activities 
between SO and 100 pmol are usually found. 
Under the assay conditions the enzyme is 
virtually saturated with the substrate (I); a 
higher concentration is impossible because 
of solubility problems. The coenzyme is pres­
ent in concentrations, that are normally not 
oversaturating. However, a larger concen­
tration is not feasible, because the high costs 
of the 3H-labeled coenzyme are prohibitive. 
The assay is not suitable for exact kinetic 
measurements, but meant for a rapid and 
not too laborious determination of the pres­
ence of TV-acelylaling activity during iso­
lation and purification. 
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APPENDIX 
HPLC-COLUMNS AND SETUP 
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PACKING OF A REVERSED PHASE HPLC-COLUMN WITH THE SLURRY METHOD 
Reversed phase nedium (1.8 g of Lichrosorb RP-18, 10 μη) is suspended 
in 12.5 ml of methanol-glycerol (75 : 25 v/v). The solid is dispersed 
by ultrasonic agitation for 10 rain, and iimediately transferred to a 
filling column (18 cm хЭ.Згп ID), which has been coupled to the sepa­
ration column (15 cm χ 4.6 mm ID) to be filled. The latter column con­
tains the dispersing solvent. A pump is connected to the filling column, 
and brought to a pressure of 400 bar with methanol. This pressure is 
released in one puis on the filling tube, causing the reversed phase 
medium to fill the separation column. The back pressure falls to about 
50 bar (depending on the pump rate). Immediately a second pulse of 400 
bar is applied, and back pressure now only drops to about 200 bar. The 
pump flow rate is increased to 5-8 ml/min (back pressure 300-400 bar). 
About 100 ml of methanol is pun^pd through at this rate , while the 
back pressure drops to about 50 bar. The filling column is removed 
and the separation column closed. It is advisable to flush the newly 
packed column with another 100 ml of methanol before testing. 
releasing valve 
pump 
pressure gauge 
filling 
column 
separation 
column 
-104-
HPLC-COLUMN PARAMETERS 
t : retention time of a sample 
t : retention time of an unretarded sample 
t - t 
N/RI : theoretical number of plates per m = χ 
column length in m 
R . : resolution for samples a and b 
2 ст
а
 +
 "b 
A f : asynmetry factor a/b 
For further theoretical considerations the reader is referred to: 
Deelder, R.S., van den Berg, J.H.M. and van de Venne, J.L.M. (1980) 
Hoge druk vloeistofchromatografie, 7th ed., Technical University 
Eindhoven, Eindhoven, The Netherlands 
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TEST-PROTOCOL FOR REVERSED PHASE HPLC-COLUMNS 
Determination of column-paraneters with test samples: 
eluant 
e l u t i on rate 
sample 
detection 
determination 
calculat ion 
methanol-water (8 : 2 v/v) 
2.6 ml/miη 
50 μΐ of mesitylene (1% v/v) and chrysene {<1% w/v) 
in eluant 
UV25, 
tr,; t , h, σ, a and b for both compounds 
A, and N/m for chrysene; R for chrysene and mesi­
tylene 
Evaluation of column qual i ty: 
N/m of chrysene qual i ty 
>10,000 
8,000 « 10,000 
6,000 « 8,000 
5,500 « 6,000 
< 5,500 
excellent 
good 
satisfactory 
dubious 
unusable 
Asymmetry factor and resolution are only taken into account for dubious 
or sat isfactory columns; decisision on usefulness then is arb i t rary . 
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25-29 
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SUPPLIER 
Orlita 
Ori i ta 
Orlita 
Orlita 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrom Liack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chror.ipack 
Chrompack 
Chrompack 
ORDER 
NR. 
4004 
22547 
4004 
4431 
22056 
22602 
22620 
22621 
22645 
22640 
22407 
22407 
22397 
22397 
4901 
4911 
22101 
AMOUNT PART 
2 Orlita pump, teflon tube suction side 
1 Orlita Mikro-Dosier-Membranpurape ¡JMP-AE 10.4 
2 Orlita pump, lower head 
2 Orlita pump, upper head 
2 S.s. tube, pretreated, 1/16" OD χ 0.50 mm ID, 3 m 
2 HPLC pressure gauge 0-600 bar, 1/16" connections 
2 S.s. tube, pretreated, 1/16" OD χ 0.50 mm ID, 0.5 m 
2 Swagelok s.s. union 1/16" 
2 High pressure filter with 1/16" tubing, porosity 2 ym 
2 Valco 7000 psi 6 port switching valve UHP-N60 1/16" 
11 Valco zero volume nut 1/16", stainless steel 
11 Valco ferrule 1/16", stainless steel 
1 Adapter for Valco syringe (fill port fitting) 
2 Valco flushing syringe 1 ml 
1 Low dead volume s.s. tubing, 1/16" OD χ о.50 mm ID 
2 Low dead volume s.S. tubing, 1/16" 0D χ 0.50 im ID 
1 Low dead volume s.s. tubing, 1/16" OD χ 0.25 mm ID, 25 
1 Low dead volume s.s. tubing, 1/16" 0D χ 0.2J .nm ID, 45 
1 S.s. tubing, 1/4" OD χ 1.8 mm ID, 5 cm 
2 Parker Hannifin s.s. nut 1/16" 
2 Parker Hannifin s.s. ferru le l / i V 
2 Snubber 1/4" χ 1/16" (not deliverable anymore) 
REMARKS 
Pump assembly 
-Puis« damper 
-Pressure gauge 
-Pulse damper 
-Filter 
Injection valve 
-Injection syringe 
-Sample loop 1 ml 
-Waste outlet 
cm 
cm 
Concentration 
column 
23 
-24 
25 
•26 
27 
28 
'29 
30 
31 
32 
33 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
Chrompack 
LKB 
Kipp & 
Zonen 
22022 
22397 
22351 
4901 
4911 
22101 
22022 
22397 
4430 
2 
1 
1 
2 
2 
2 
2 
1 
1 
1 
1 
о 
COMPONENTS OF THE HPLC-SETUP 
Separation 
column 
Removable frit for 1/4" snubber, s.S., porosity 2 pm J 
Low dead volume s.S. tubing, 1/16" OD χ 0.25 mm ID, 4 cm 
LiChroma s.S. tubing, 1/4" 0D χ 4.6 mm ID, 15 cm 
Parker Hannifin s.S. nut 1/16" 
Parker Hannifin s.s. ferrule 1/16" 
Snubber 1/4" χ 1/16" (not deliverable anymore) 
Removable frit for 1/4" snubber, s.S., porosity 2 ym 
Low dead volume s.S. tubing, 1/16" OD χ 0.25 mm ID, 5 cm 
Stainless steel low dead volume union 1/16" 
LKB 2138 Uvicord S with flow cell for HPLC -UV206 detector 
3D9 two channel recorder -Recorder 
pumphead 2 pumphead 1 
ІІ 
.*.» 
sample 
loop 
recorder, 
hoed 
concentration 
column 
valve 2 
Λ 
separation 
column 
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VALVE 1 
f i l l -po r t waste outlet 
VALVE 2 
woste outlet 
sample 
loop 
Step 1 
eluant 1 
LOAD POSITION 
concentration 
column 
eluant 2 
LOAD POSITION 
Step 2 
INJECT POSITION LOAD POSITION 
S t e p 3 
INJECT POSITION INJECT POSITION 
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CHAPTER IV 
ISOLATION AND CHARACTERIZATION OF BOVINE LENS Na-ACETYL-
TRANSFERASE 
Huub P.C. Driessen, Wilma T.M. Vree Egberts, Michele Granger, Wilfried 
W. de Jong, Godefridus I. Tesser and Hans Bloemendal 
SUMMARY 
The iso lat ion and characterization of bovine lens N -acetyltransferase 
is described. The enzyme has an apparent re lat ive molecular mass of 
170,000 and an isoelectr ic point of about 5. A stable preparation can 
be obtained in good y i e l d by ul tracentr i fugat ion of a 15,000 g lens 
supernatant in an isokinet ic glycerol gradient ( p u r i f i c a t i o n about 
5-fold). Attempts to further pur i fy the enzyme on basis of i t s isoelec­
t r i c point became unfeasible, because of the extreme i n s t a b i l i t y 
following such separation steps. Nevertheless, isoelectr ic focusing 
in a flatbed of Sephadex-IEF yielded the enzyme in about 760-fold 
pur i ty; however, the procedure was d i f f i c u l t to reproduce. The apparent 
Michaelis constant for acetyl coenzyme A, the acetyl donor, is 
4.6 + 0.3 μΜ in the presence of 0.31 mM substrate. Some substrate 
requirements were studied with the use of synthetic aminoterminal ACTH-
fragments. The enzyme evidently needs an N-terminal amino acid with the 
L-configuration. The minimal length needed for enzymatic Na-acetylation 
seems to be at least 8 amino acids. In contrast to ear l ier observations 
the rate of acetylation increases roughly l inear ly with length up to 
at least 39 residues. 
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N-temnnal acetylation of proteins is a widespread phenomenon in eu-
karyotes, and to a lesser extent in prokaryotes and viruses (1). V i r t u a l ­
ly nothing is known concerning the underlying mechanism and possible 
functional implications. Na-acetylating a c t i v i t y has been studied and 
demonstrated in Eic/ie/u-ch-ta co£t for ribosomal protein L12 (2) , for 
ribosome-associated proteins from rat l i v e r (3-5), in calf lens ( 6 ) , 
rat p i t u i t a r y (7, 8) and hen's oviduct ( 9 ) , and in ribosomal f ract ion 
of wheat germ (10). 
The enzyme from hen's oviduct has been pur i f ied p a r t i a l l y (40 x ) . I t 
has a pH optimum of 7.2 and a re lat ive molecular mass of about 250,000 
(9). Extensive p u r i f i c a t i o n was d i f f i c u l t because of the i n s t a b i l i t y of 
the enzyme. Using ACTH-fragments as substrates and acetyl coenzyme A as 
the acetyldonor, th is enzyme in v-ut/w preferent ia l ly acetylates the 
ot-NHp-group, l i k e the enzyme from rat p i t u i t a r y (7, 8). The l a t t e r is 
localized predominantly in subcellular fract ions sedimenting above 
10,000 g. I t has a broad pH optimun with a maximum near 7.6. The en­
zyme from wheat germ is associated with the nbosome fract ion and cata­
lyzes the transfer of acetylgroups from acetyl coenzyme A to the N-ter-
minus of synthetic Nci l-desacetyl thymosin αϊ (10). The pH optimum l ies 
below 7.5. The enzyme is activated considerably by KCl-concentrations 
as high as 3.0 M. Granger et al. studied the Na-acetyltransferase from 
bovine lens (6) and showed that i t acetylates aminoterminal ACTH-frag-
ments solely at the N-terminus using acetyl coenzyme A. Acetylation of 
des-Nai-Ac-a-MSH was proportional to the amount of a 15,000 g lens 
supernatant (S-15). The reaction is a thermolabile process with a 
pH-optimum near 7 4. 
Since N -acetylation is such an important phenomenon in the eye lens, 
approximately 80 % of the water-soluble lens proteins being N-terminally 
acetylated (11-15), we thought i t worthuile to further characterize and 
pur i fy the Na-acetyltransferase from bovine lens. 
MATERIALS AND METHODS 
ACTH-fragments 
Nine peptides of different length with the N-termi nal sequence of the 
adrenocorticotroph hormone (ACTH) were either obtained as a gift or syn­
thesized by the classical approach (Table I). The ACTH-(l-8)-octapeptide 
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' - . I g ' ( c - 1 . 7 8'. HOAc) 
¡ « ¡ J ' (c 1, 0 1 H HCl) 
R f , ascending chroma-
tbgraphy on s i l i c a 
nBuOH-HOAc-pyridlne-Η,Ο 
(1 1 1 г ï / v ) 
Ά descending chroma­
tography on paper 
nBuOH-HOAc-pyndlne-H 0 
(1-2) 
*24 1 
nd 
0 36 
0 45 
(1-3) 
nd 
*23 1 
0 31 
0 « 
(1-4) 
-7 β 
nd 
0 39 
(0 24) 
0 54 
(0 35) 
(1-5) 
-22 5 
nd 
0 34 
(0 20) 
0.48 
(0 30) 
(1-8) 
-30 0 
nd 
0 34 
(0 23) 
0 43 
0 35) 
(1-10) 
-32 5 
nd 
0 39 
(0 34) 
0 51 
(0 43) 
¡D-Ser' -
(1-10) 
-35 8 
nd 
0 39 
Ю 34) 
0.51 
Í0 43) 
(1-13) NH 
•¡2 3 
nd 
0 40 
(0 35) 
0 49 
(0 46) 
(1-24) 
-86 7 
nd 
var iab le 
0 36 
(0 19) 
¡1-39) 
porcine 
-
(pure on 
t h i n l aye r 
chromato-
graphyj 
(pure on 
papercfno-
matogt-aphyj 
( 4 1 1 2 v /v ) 
Eluent fo r HPLC-sepa-
ra t i on column 
MeCH-H-O v/v + 0 4 
H.PCU 
Eljent for HPLC-con-
centration column 
MeOH-Η,Ο v/v 
S p e c i f i c a c t i v i t y U/mg 
( v i t С d e p l e t i o n t e s t ) 
Source of peptide g i f t of t r y p t i c g i f t of g i f t of synthe- g i f t of g i f t of 
Dr H R i t - hydro ly- Dr W R i t - Dr U R i t - s ized by Dr W Я t - Dr J van 
t e l sate of t e l t e l Ρ Sncets t e l Nispen 
Ci ba-Geigy (1-10) Ci ba-Geigy Ciba-Geigy С ι ba-Geigy Organon 
Table I. Physical parameters of the ACTH-fragments and their source. Peptides (1-2), (1-3) and 
(1-5) have been synthesized by the authors with a classical solution approach. Optical rotation 
[a] was measured with a Perkin-Elmer Polarimeter 241 (D-line). R f values between brackets indicate 
the peptide containing a methionine sulfoxide. 
(1-2) (1-3) (1 1) (l-r) (1-8) (1-10) ГО-Sei-1]- (1 13)-NH2 (1-241 (1 39) 
(1-10, 
Ala 
Arg 
Asp 
Gin 
Glu 
Gly 
His 
Leu 
Lys 
MeL 
Phe 
Pro 
Se-
Trp 
Tyr 
Val 
D 97(i 
1 00(1 
) 2 02(2) 
) 0 98(1) 
1 03(1) 
0 99(1) 
93(2) 
1 02(1) 
0 97(1) 
0 98(1) 
0 97(1) 
0 99(1) 
1 91(2) 
1 04(1) 
0 98(1) 
0 98(1) 
1 02(1) 
0 96(1) 
0 95(1) 
0 97(1) 
2 00(2) 
0 99(1) 
1 09(1) 
0 96(1) 
0 99(1) 
1 02(1) 
0 97(1) 
1 02(1) 
0 96(1) 
1 96(2) 
0 90(1) 
1 10(1) 
0 99(1) 
0 93(1) 
1 03(1) 
0 85(1) 
1 05(1) 
1 02(1) 
0 92(1) 
0 73(1) 
1 90(2) 
0 91(1) 
1 0°(.) 
1 09(1) 
3 16(3) 
1 10(1) 
2 14(2) 
1 12(1) 
3 04(4) 
1 06(1) 
0 99(1) 
2 72(3) 
2 07(2) 
1 03(1) 
2 02(2) 
2
 01(3) 
0 98(1) 0 97(1) 
Table II. Amino acid analyses of ACTH-fragments. Peptides were hydrolyzed in 5.7 M HCl 
in sealed, evacuated tubes at 1100C for 24 hr with norleucine as internal standard. 
Amino acid analysis was performed with a Rank Hilger Chromaspek analyzer or with a 
Jeol JLC-6AH amino acid analyzer. Values between brackets indicate the theoretical 
number of residues. 
was obtained by t r y p t i c hydrolysis of ACTH-(l-10)-decapeptide. In ad­
d i t i o n we acquired the [D-Ser^-ACTH-fl-lOJ-decapeptide. Some purity 
parameters and amino acid analyses can be found in Tables I and I I . 
Details on the synthesis of ACTH-(l-8)-octa- and ACTH-(l-10)-decapeptide 
are given in the Appendix. Peptides with methionine invariably contained 
a few percent of methionine sulfoxide. 
Enzyme determinations 
Na^a«tyU£ansfe£ase_assay^ Details of the assay and the synthesis of 
the substrate, des-N^'-Ac-fNle^J-MSH-fl-lOJ-decapeptide, have been pu­
blished elsewhere (16, 17). Deviations with regard to the HPLC-elution 
conditions for the ACTH-fragments arc shown in Table I . 
Since neither ACTH-(l-24)-tetracosapeptide nor ACTH do stay in solu­
t ion during the acidic precipi tat ion step in the assay, another way to 
isolate the products of t^-acetylat ion of these two peptides had to be 
devised. The enzymatic reaction was stopped by c h i l l i n g the assay mix­
ture in ice and adding DTNB to a f ina l concentration of 12.4 mM. In 
case of ACTH the reaction mixture was then fractionated at a flow rate 
of 125 ml/hr on Sephadex G-50 coarse (J6 χ 3.5 cm), equi l ibrated with 
0.1 M ammonia. The elut ion was monitored by taking a small al iquot of 
the f ract ions, followed by l i q u i d s c i n t i l l a t i o n counting with Pico-Fluor 
15 (Packard) on a Packard Tricarb Model 3380. The fractions containing 
acetylated ACTH were pooled and lyophil ized Complete p u r i f i c a t i o n could 
be obtained by rechromatography at a flow rate of 10.2 ml/hr on Sephadex 
G-75 (115 χ 1.5 cm), equil ibrated with 0 1 M ammonia. In case of ACTH-
(l-24)-tetracosapeptide the reaction mixture was fractionated immediately 
at a flow rate of 10 2 ml/hr on Sephadex G-50 superfine (115 χ 1.5 cm), 
equil ibrated with 0.1 M ammonia. 
Protein deternnnatjon. The protein content of an enzyme preparation was 
estimated according to the method of Peterson (18), in which in ter fer ing 
substances are removed by D0C-TCA precipi tat ion of the proteins pr ior 
to the addition of the Folin-Ciocalteu reagent. 
£o2yacryJ_amide_gel_e2e£tro£hores2s_ Analysis of protein fractions was 
performed by sodium dodecyl-sulphate-polyacrylamide gel electrophoresis 
according to Laemnmli (19) with the modification that slab gels instead 
of gel rods were used. 
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Pur i f icat ion procedures 
Lejis_extra£t_S^15. Lens extract S-15 was prepared as described by Gran-
ger ¿i aZ (6) . Buffers used were ei ther Tris-HCl pH 7.4 (sometimes 
containing 10 mM KCl) or Sflrensen's phosphate buffer (KH2P04-Na2HP04) 
pH 7.4. 
I soe lec t r i c fire capita tj^o η. The pH of 30-40 ml S-15 (prepared in 50 mM 
Tris-HCl pH 7.4, 10 mM KCl), cooled in i c e , was brought to 5.4 with 1 M 
HCl. The precipitate was collected by centri fugati on for 30 mm at 
21,800 g and 40C, resuspended in 5 ml of 0.01 M ammonia and dialyzed 
against 50 mM Tris-HCl pH 7.4, containing 10 mM KCl. The result ing 
opalescent solution was c l a r i f i e d by centrifugation for 10 mm at 
10,000 g and 4I>C. 
Estimation_of £el^tive_molecular_mas2 b y _ g ^ _ f l l i r i ' t l 0 £ T ^ e re lat ive 
molecular mass of the enzyme was estimated by gel f i l t r a t i o n at a flow 
rate of 17 ml/hr over Sephadex G-200 (100 χ 2.5 cm), equil ibrated with 
50 mM Tns-HCl pH 7.4, containing 10 mM KCl, and at 4 4 . The eluant was 
monitored at 280 nm. Three ml fractions were collected of which 0.2 ml 
was subjected to the assay. A cal ibrat ion curve was obtained by apply­
ing marker proteins on the same column. 
ЗкНг? çentr i fu£at ion^ Two ml of lens extract S-15 (prepared in 50 mM 
Tris-HCl pH 7.4) was layered on top of an isokinet ic 10.0-37.5 % (w/w) 
glycerol gradient, containing 50 mM Tris-HCl pH 7.4, and centrifugated 
for 45 hr at 27,000 rpm (ga v 74,000) in a Beekman SW-27 rotor at 40C. 
The gradient was pumped out through a flow cel l of a Gil ford 2400-2 
spectrophotometer, and monitored at 280 nm. Fractions of 2 ml were co l -
lected. 
Routinely fractions 8 unt i l 18 were combined (Fig. 3) and ei ther 
concentrated by saturated ammonium sulphate precipi tat ion or by dialysis 
against a concentrated solution of polyethylene glycol (M 17,000-
20,000, Serva) in water, unt i l the volume was 10 to 15 ml. Care was 
taken to avoid precipi tat ion of protein. After concentration the solu-
t ion was dialyzed against Stfrensen's phosphate buffer pH 7.4 in 25 % 
glycero1 or 50 mM Tris-HCl pH 7.4 in 25 % g lycerol . Al l concentration 
steps were carried out at 40C. 
Zonal .£erit£ifu£at.ion_ Zonal centri fugation was carried out in a B-XXIX 
rotor of an IEC-ultracentrifuge. The to ta l volume was 1400 ml. The 
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rotor was loaded with a convex 0-40 % (w/w) glycerol gradient in S0ren-
sen's phosphate buffer pH 7.4 This gradient is represented graphically 
in Fig. 4. The sample S-15 was applied in an inverted gradient. Centri-
fugation was performed at 35,000 rpm for 46 hr at 4°C. The gradient was 
removed from the rotor by pumping in a 50 % (w/w) glycerol solution at 
30 ml/min. The absorbance was measured automatically at 280 nm in the 
Gi l ford spectrophotometer equipped with an IEC 2-niii flow c e l l . Fractions 
of 50 ml were col lected. Routinely the gradient was pooled between 950 
and 1400 ml (Fig. 5). 
I 0 H exch^n£e_chromatog£a£h^. A column of DE-Sephadex A50 (Pharmacia, 
30 χ 1.5 cm) was equil ibrated at 24 ml/hr in 41 mM KH2P04, 26 mM 
Na-HPO., pH 7.0, containing 10 % g lycerol , 1 mM DTE, 20 mM KCl, and a 
sample of concentrated SH-74, dialyzed against the s t a r t buf fer , was 
applied. The column was eluted with the same buffer, at 40C, and elut ion 
was monitored at 230 nm. After the bulk of the ß-crystal l ins had been 
eluted, the column was developed with a l inear gradient from 20 to 500 
mM KCl in star t ing buffer (2 χ 250 ml). The fractionated eluate was 
concentrated with polyethylene glycol before determination of the en­
zymatic a c t i v i t y . 
A similar procedure was carried with DE-52 (Whatman), equi l ibrat ing 
and elut ing the column at 5.4 ml/hr with 3 25 nM KH-PO., 13.5 mM 
Na.HPO., pH 7.4, containing 10 % g lycerol , 1 mM DTE. The fractionated 
eluate was concentrated with polyethylene g lycol . 
The same procedure was also followed with CM-52 (Whatman). Start 
buffer was 6.5 mM KHyPO., 27 mM NaJIPO., pH 7.4, containing 10 % gly­
cerol , 1 mM DTE (flow rate 36 ml/hr). After the g-crystal l ins had been 
eluted, the column was developed with a l inear gradient from 0 to 250 
mM KCl in s t a r t buffer (2 χ 250 ml). The fractionated eluate was con­
centrated with polyethylene glycol . 
Chromatofoojsing^ The ion exchange gel PBE94 and polybuffer 74 were ob­
tained from Pharmacia. The gel was equil ibrated in 25 mM histidine-HCl 
pH 6.2, and packed in a column (30 χ 1.5 cm). The sample, 18 5 ml of 
concentrated ßH-74, was dialyzed against the star t ing buffer. The column 
was eluted at a flow rate of 17.2 ml/hr at 40C. Focusing was started by 
f i r s t running 5 ml polybuffer 74 (di luted 1 8 ) , whereafter the sample 
was applied, and the pH gradient developed with the polybuffer ( f ina l 
pH 4.0). The eluate was monitored at 280 nm and samples of 4.3 ml were 
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col lected. Prior to determiration of the enzymatic a c t i v i t y , the samp­
les were concentrated with polyethylene glycol and dialyzed against 
Stfrensen's phosphate buffer pH 7.4, containing 20 % g lycerol , 1 mM DTE. 
natbed^ Isofocusuijl · Preparative f latbed isofocusing was performed 
using a bed (20 χ 19 χ 1 cm) of Sephadex-IEF (Pharmacia), equil ibrated 
with 25 % g lycero l , 2 mM DTE, containing 10 ml carr ier ampholytes in the 
pH-range 5-8 and 2 ml in the range 6.5-9 (Pharmalytes; Pharmacia). The 
gradient was established overnight at 10 watt. About 10-15 ml of concen­
trated ßH-74 was dialyzed against 25 % g lycero l , 2 mM DTE at 40C and 
mixed with that part of the gel containing the pH-range 6.5-7.5. Iso-
focusing was performed for 5 hr at 10 watt , while the bed was cooled 
with icecold water. Then a paper replica (Whatman 1 №1) was made, f ixed 
with icecold 10 * TCA and stained with 5 % Coomassie B r i l l i a n t Blue R in 
H0Ac-Et0H-H20 (10 : 35 : 55 v/v). The replica was destained with the 
same solvent. Judged from the protein pattern on the repl ica, f i v e gel 
sl ices were cut out (cf. Fig. 7) , and the Sephadex-IEF was removed by 
centri fugati on (Christ, 5000 rpm, 40C). The gel material was washed 
with Sflrensen's phosphate buffer pH 7.4 in 25 1 g lycerol . The combined 
supernatants were dialyzed against the same buffer and the enzyme a c t i ­
v i t y was determined. 
Determination of k inet ic constants 
The apparent Michaelis constant f o r acetyl coenzyme A was determined 
in the standard assay with a substrate concentration of 0.31 mM. 
[aceítí£-3H]-acetyl coenzyme A was added in a concentration series of 
0.22-10.90 uM. The К was determined graphically from a Lineweaver-
m 
Burk p l o t . 
Determination of the substrate s p e c i f i c i t y 
The re lat ive acetylation of the ACTH-fragments was determined with 
the standard assay at a substrate concentration of 0.32 mM and with the 
coenzyme present at a concentration of 3.8 μΜ. As enzyme source concen­
trated gH-74 was used. Buffer was Stfrensen's phosphate buffer pH 7.4 in 
25 % g lycerol . 
To detect possible ε-ΝΗ- acetylat ion, the acetylated products of 
ACTH-(l-24)-tetracosapeptide and ACTH were isolated as described above, 
and lyophi l ized. Both were dissolved in 1 ml of 0.1 M aimonium bicar-
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bonate pH 8.9, and 1 μΐ of a trypsin solution (Worthington TRTPCK, 
10 mg/ml in 0.001 M HCl) was added. The samples were digested at 370C 
for 1 hr, then another 1 μΐ was added. After another hr the reaction 
mixture was lyophi l ized. The result ing peptides were separated by pep­
t ide mapping (15). The maps were cut in small pieces ( 4 x 1 cm), which 
were counted using a toluene-based s c i n t i l l a t o r 
RESULTS AND DISCUSSION 
The strategy of the p u r i f i c a t i o n is based on characteristics l i k e 
relat ive molecular mass and isoelectr ic point of the various c r y s t a l l i n s , 
which make up the bulk of the water-soluble lens proteins 
o, Mr 600,000-900,000 and pi 4.8-5.0, ßH, M 100,000-200,000 and pi 
5.7-6.5, 0L , Mr 40,000-90,000 and pi 6.6-6.9; γ , M r 20,000 and pi 7 . 1 -
8.1 (20, 21). 
I n i t i a l characterization and p u r i f i c a t i o n 
A 15,000 g lens supernatant (S-15), which s t i l l contains a l l the 
c r y s t a l l i n s , was prepared as described by Granger e i at. (6) . This 
crude lens extract is stable for several months at - 2 0 4 . Before at­
tempting to pur i fy the enzyme, we checked the behavior of the bovine 
N^acetyltransferase in the presence of very high KCl-concentrations, 
inspired by a publication of Kido eZ al. (10), in which they showed 
that wheat germ Na-acetyltransferase is activated by KCl-concentrations 
as high as 3 M. I t is clear that the bovine enzyme is inactivated by 
these high concentrations (Fig. 1). At 2.0 and 3.0 M KCl the uncataly-
zed N^acetylation of the substrate became actually higher than the 
enzymatic acetylat ion. 
2soelectri£ ¿rec^pvtatioji 
To eliminate some of the c rys ta l l i ns , the S-15 preparation was sub-
jected to isoelectr ic prec ip i ta t ion. A maximum percentage of the Na-
acetyltransferase was recovered in the f ract ion precipi tat ing at pH 5.4 
at 40C. Attempt to dissolve the pel let obtained by centri fugati on, re-
vealed a poor so lub i l i t y of th is f rac t ion. The pel let was eventually 
suspended in 0.01 M ammonia and dialyzed against Tns-buf fer pH 7.4. 
The opalescent solution obtained was c l a r i f i ed by centri fugation This 
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Fig. 1 Effect of KCl-concentration on the a c t i v i t y of the lens extract 
S-15. The enzyme was preincubated for 20 min at 40C with the reagent and 
the remaining a c t i v i t y measured. The determinations at a concentration 
of 2.0 and 3.0 M are rather inaccurate, because the uncatalyzed Na-
acetylation was actually higher than the enzymatic Na-acetylation. 
procedure leads to a 44 % recovery of the enzymatic a c t i v i t y with 28-
fo ld p u r i f i c a t i o n . 
The p a r t i a l l y pur i f ied enzyme obtained by isoelectr ic precip i tat ion 
(hereafter called IEP-5.4) looses i t s a c t i v i t y upon freezing or lyophi-
l i z a t i o n . A part ia l s t a b i l i z a t i o n can be obtained by adding glycerol 
to a f i n a l concentration of 25 %. The enzyme solution can then be kept 
at 4°С for 2 days without inact ivat ion, but af ter 4 days 20 % i n a c t i -
vation is observed. 
In order to f i n d s t a b i l i z i n g factors for the enzyme, IEP-5.4 was pre­
incubated with various reagents for 10 min at 40C, and the remaining 
a c t i v i t y was then measured (Table I I I ) . The enzyme seems sensitive to 
moderate amounts of KCl and NaCl, and to low concentrations of bivalent 
ions l ike Mn + , Mg + and Ca + . I t is completely inhibited by 1 mM Zn 
(no protein precip i tat ion was observed at this concentration). EDTA in 
low concentrations does not i n h i b i t the a c t i v i t y , indicating that no 
essential bivalent cation is associated with the enzyme. The ^ - a c e t y l -
transferase is very sensitive to t h i o l blocking agents, since a complete 
inact ivat ion is observed in the presence of 1 mM DTNB. The fact that the 
enzyme is moderately to extremely sensitive to almost a l l reagents which 
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have been used, is very serious, since it might imply that purification 
by ion exchange or affinity chromatography will be troublesome, since 
rather high concentrations of salts are normal in using these techniques. 
Reagent 
10 mM 
50 nfl 
50 mM 
1 mM 
10 mM 
10 mM 
1 mM 
1 mM 
1 mM 
1 mM 
10 mM 
1 mil 
10 mM 
50 mM 
1 mM 
1 mM 
1 mM 
10 mM 
KCl 
KCl 
NaCl 
Mgc i 2 
Mgci 2 
MgOAc2 
MnCl2 
ZnCl2 
ZnS04 
CaCl2 
CaCl2 
EOT A 
EDTA 
EDTA 
ATP 
DTNB 
0-mercaptoethanol 
ß-mercaptoethanol 
Two peaks of acetyl transferase ac t i v i t y were observed when IEP-5.4 
was fractionated by Sephadex G-200 chromatography (Fig 2) The f i r s t 
one emerges with the exclusion volume, the second one in the region of 
BH-crystal l in. Most l i ke l y these two peaks represent the same enzyme, 
which is found part ly in the void volume as a result of aggregation 
of the enzyme with i t s e l f or with other lens proteins, or as a resul t 
of coprecipitation (cf ^W^T^ centri fugat^£n). The apparent re lat ive 
molecular mass of the enzyme is about 170,000. 
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Relative ac t i v i t y 5» Table I I I . Effect of 
various reagents on the 
ac t i v i t y of the par t ia l -
94 ly pur i f ied acetyltrans-
ferase obtained by iso-
e lect r ic precip i tat ion 
61 (IEP-5 4) . The enzyme 
in 50 mM Tris-HCl pH 7.4 
was preincubated with 
60 the reagent for 10 mm 
at 40C and the remaining 
ac t i v i t y measured. 
100 
55 
30 
25 
65 
0 
0 
44 
23 
100 
74 
32 
100 
0 
100 
100 
F '9. 2 Sephadex G-200 
e l u t i on p r o f i l e of the 
f ract ion IEP-5.4, obtain­
ed by isoelectr ic preci­
p i t a t i o n of the lens ex­
t r a c t S-15. The column 
was equil ibrated with 
50 mil Tris-HCl pH 7.4, 
containing 10 mM KCl. 
Acetyl transferase a c t i ­
v i t y is expressed as the 
amount of 3H-acetate 
incorporated.min ^ .ml "'. 
elubonvolume (ml} 
Since lens N -acetyltransferase has an isoelectr ic point of approxi­
mately 5, i t w i l l coprecipitate with α-crystal 1 i n . On the other hand, 
as i t s apparent re lat ive molecular mass is about 170,000 i t w i l l co-
nigrate with BH-crystall in on gel f i l t r a t i o n (Fig. 2). Therefore a 
logical p u r i f i c a t i o n would be separation on the basis of re lat ive 
molecular mass, followed by separation on the basis of isoelectr ic 
point. The f i r s t step should remove α-, β.- and γ - , the second one 
Su-crystal l in. Isoelectr ic precip i tat ion as the f i r s t step is unfavorable, 
since i t gives a very unstable enzyme preparation. 
Pur i f icat ion of N^acetyltransferase based on i t s re lat ive molecular 
mass 
ΙΗΐΛΖ centri f ligation 
S-15 was layered on an isokinet ic glycerol gradient in Tr is-buffer 
and was centrifugated for 45 hr at 74,000 g in an SW-27 rotor. a-Crys-
t a l l i n is pelleted and the Na-acetyltransferase sediments together with 
8 H , although a small amount can be found at the bottom (Fig. 3) . Frac-
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Fig. 3 SW-27 centri fuga-
t ion p r o f i l e of the crude 
lens extract S-15 af ter 
spinning at 27,000 rpm for 
45 hr at 4<)C in an isokine­
t i c glycerol gradient 
(10.0 ->· 37.5 % in 50 mM Tr is-
HC1 pH 7.4). Fractions are 
2 ml (T = top, Ρ = p e l l e t ) . 
1 2 1 6 8 10 12 M 16 18 20 Ρ 
FRAGT ІОМ 
tions 8-18 contain about 80 % of the tota l a c t i v i t y . This confirms that 
most of the a c t i v i t y elut ing with the void volume of the Sephadex G-200 
column (Fig. 2) is indeed an aggregation artefact. The Tr is-buffer seems 
to provide the r ight conditions for part ia l separation of β. and γ from 
ßu, because replacement by Stfrensen's phosphate buffer resulted in a 
single peak for these three proteins. 
Although the d i lu t ion factor from S-15 to the β,,-fraction from the 
π 
SW-27 run (containing 80 t of the a c t i v i t y and hereafter called ßu-74) 
π 
is about 13, the activity can still be measured directly. However, the 
assay is not very accurate at this level (17). 
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£oncentraticm of_ßM274 
The Na-acetyUransferase obtained af ter the SW-27 centri fugati on was 
concentrated by means of fractionated ammonium sulphate prec ip i ta t ion. 
The enzymatic ac t i v i t y precipitated between 57 and 83 % saturation 
(Table IV) , and could readily be dissolved in a small amount of Tr is 
buffer. The recovery was reasonable (42 %) and the pur i f ica t ion about 
8- fo ld . Based on the protein recovery a 20-fold pur i f i ca t ion should 
have been expected, i f 100 % of the enzyme ac t i v i t y had been recovered. 
However, because pur i f icat ion and enzymic recovery are both about half 
of the expected value, there must have been a considerable loss of ac t i -
v i t y on ammonium sulphate prec ip i ta t ion. The recovered enzyme was sub-
jected again to fractionated ammonium sulphate prec ip i ta t ion. Almost a l l 
protein was recovered (Table IV) , but only 16 Ï of the ac t i v i t y . The fact 
that considerable loss of ac t i v i t y occurs upon repeated anmonium sulphate 
precip i tat ion is serious, since i t implies that fur ther concentration of 
the enzyme with this easy method should be avoided. 
We therefore employed a more gentle way to concentrate the enzyme: 
dialysis against a concentrated solution of polyethylene glycol (M 
17,000-20,000). Care has to be taken to dialyze only to a small volume, 
since complete dryness inactivates the enzyme. Although the method is 
gentle, i t is time-consuming. By this way of concentrating ßH-74 the 
recovery of the enzymic ac t i v i t y seems to be complete, while the pur i -
f i ca t ion is 5-fold (Table V). 
Çharacterist;j_« of_8^74 
The pa r t i a l l y pur i f ied enzyme SH-74 is stable upon storage at 40C and 
-200C for several weeks. After concentration with polyethylene glycol 
i t is equally stable. 
In search for further s tab i l iz ing factors for the enzyme, we prein-
cubated concentrated SM-74 with a th io l -b locking or s tab i l i z ing agent for 
10 min at 40C. I t appears that the enzyme is stable in the presence of 
DTE, and becomes destabilized by DTNB at concentrations as high as 1 mM 
(Table VI ) . Lower concentrations are harmless. Since the preparation 
consists predominantly of ß H -c rys ta l l in , which is composed mainly of sub-
units named ßBp (22) with two free thiolgroups (23), the concentration 
of thiolgroups in concentrated Βμ-74 is of the order of 5-20 uM, which 
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sample protein a c t i v i t y 
volume concentration 
ml πς.ηΐ cpm H-acetate. 
mm" .ml" 
specific 
a c t i v i t y 
cpm H-acetate. 
. -1 -1 
min .mg 
to ta l 
a c t i v i t y 
3 
cpm 
mm 
total protein enzyme puri f icat ion 
protein recovery recovery 
H-acetate. mg % % χ 
S-15 6.0 192 31150 162 186900 1152 100 100 
8H-74 80.0 3.7 296 26 
(NV2S04-
0- 56 5, 
57- 83 % 
84-100 % 
•preci 
Ρ· 
1.6 
10.0 
1.6 
46.8 
5.8 
3.6 
0 
7750 
0 
1340 77500 58 8.2 
(NH4)2S04-
0- 46 Χ 
47- 68 % 
69-100 % 
precip. 
2.3 
2.3 
2.3 
15.1 
8.7 
+0.3 
2500 
10500 
0 
166 
1210 
5750 
24150 
35 
20 
3 
13 
1.0 
17.5 
Table IV. P u r i f i c a t i o n o f N - a c e t y l t r a n s f e r a s e by SW-27 c e n t r i f u g a t i on and attempts t o c o n c e n t r a t e the 
-74 
f r a c t i o n ( c o n t a i n i n g the enzyme) by (NH.bSO. p r e c i p i t a t i o n . P r e c i p i t a t e s were c o l l e c t e d by c e n t r i f u g a t i o n " a n d 
s o l u b i l i z e d i n 50 mil Tr is-HCl pH 7 . 4 , c o n t a i n i n g 25 * g l y c e r o l . A l l f r a c t i o n s except S-15 were d i a l y z e d a g a i n s t 
the same b u f f e r before d e t e r m i n a t i o n o f the enzymatic a c t i v i t y . The second p r e c i p i t a t i o n was c a r r i e d o u t w i t h the 
f r a c t i o n 57-83 % o f the f i r s t p r e c i p i t a t i o n s t e p . 
sample protein act iv i ty 
vol urne concentrati on 
ml mg ml pmole acetate. 
mm .ml 
specific 
act iv i ty 
pmole acetate. 
mm" mg" . 
total 
act iv i ty 
pmole acetate. 
mm" 
total 
protein 
mg 
protein enzyme puri f icat ion 
recovery recovery 
% I χ 
S-1S 24.0 166 35 0.21 840 3984 100 100 1 
8H-74 after 15.0 SB.4 61 
PEG-concen­
t r a t i on 
1.05 915 876 22 110 
Table V. Concentration of S|r74, the enzyme preparation obtained by SW-27 centri fugati on of the lens 
extract S-15, by u l t r a f i l t r a t T o n against polyethylene g lycol . Before determination of the enzymatic 
a c t i v i t y , the sample was dialyzed against S0rensen's phosphate buffer pH 7.4, containing 25 % g lycerol . 
Reagent Relative a c t i v i t y % Table VI. Effect of t h i o l -
s t a b i l i z i n g or blocking agents 
,._ on the a c t i v i t y of concentra­
ted βμ-74 ( m Sflrensen's phos-
1 nil DTE 100 phateHbuffer pH 7.4). The en-
i „ M IYTUD η zyrae was preincubated for 10 
1 m D T N B 0
 mín at 4°C with the reagent 
1 μΜ DTNB 100 and the remaining a c t i v i t y 
1 nM DTNB 100 measured. 
may explain the apparent s t a b i l i t y of the enzyme at DTNB-concentrations 
of 1 μΜ or lower. However, upon further p u r i f i c a t i o n 1 mM DTE was often 
added for s t a b i l i z a t i o n against oxidants. 
l q n a l centri fucat i on 
Since the amount of S-15 which can be pur i f ied in one SW-27 run is 
only 12 ml , th is procedure was not suitable for preparative purposes. 
Large scale preparation could be accomplished with zonal centr i fugat ion. 
Since l^-acetyltransferase has an S-value corresponding to that of Вм, 
we devised a glycerol gradient, in which zone-sharpening occurs for e„ 
(Fig. 4). To prevent excessive droplet sedimentation, the sample was 
applied in an inverse gradient. In th is way about 70 ml S-15 can be 
pur i f ied in one run. However, the separation is not as good as in an 
SW-27 run. a-Crystal l in is pel leted, but β.- and γ are not completely 
separated from ßH (Fig 5). Nevertheless, the procedure is extremely 
useful for preparative work. 
I t thus has been possible to purify ^-acety l t ransferase from bovine 
lens considerably by ul tracentr i fugat ion (5-fold) a-Crystal lm is removed 
completely, β,- and γ - c r y s t a l l i n p a r t i a l l y . The enzyme is stable af ter 
this step and can be concentrated by u l t r a f i l t r a t i o n against polyethylene 
glycol. 
Pur i f icat ion of ^-acetyl transferase on basis of i t s isoelectr ic point 
10Д exchan£e_chromatogra£hy 
Since the isoelectr ic point of the acetylating enzyme is near 5, and 
that of ßH between 5.7 and 6.5, a weakly basic anion exchange resin should 
be the f i r s t choice for binding the enzyme. DE-Sephadex A50 was used 
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FÌQ. 4 Glycerol gradient ( ) used for pur i f ica t ion of N -acetyltrans-
ferase by zonal centr i fugation. The sample was loaded in an inverse gra-
dient ( — ) to prevent excessive droplet sedimentation. The part between 
480 and 660 ml of the glycerol gradient was removed and mixed thoroughly. 
About 75 ml was mixed in a l inear gradient with about 70 ml S-15 in 
Sftrensen's phosphate buffer pH 7.4 (di luted to 75 ml , and brought to a 
concentration of about 5 % g lycero l ) , which was pumped into the rotor , 
inverted with regard to the glycerol gradient. 
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Fig. 5 Pur i f icat ion of N -ace­
t y l transferase by zonal c e n t r i ­
fugation. A B-XXIX rotor loaded 
with the gradient shown in Fig. 4 
was spun at 35,000 rpm for 46 hr. 
Enzymatic a c t i v i t y was determined 
in the pooled eluate between 
600-800, 800-950, 950-1050, 1050-
1150, 1150-1250, 1250-1400 and 
1400-1500 ml. Act iv i ty is expres­
sed as percentage of the tota l 
a c t i v i t y (bars). 
6 0 0 ОО TOOO '200 
gradenwdume imi) 
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with a phosphate buffer and a sample of concentrated ßu-74 was applied. 
The 6-crysta l l in f ract ion did not bind to the column. However, upon 
development with a KCl-gradient no enzymic ac t i v i t y could be detected 
in the eluate. DE-52 was used next. Again the ß-crysta l l in f ract ion did 
not bind. In a small peak, following the bulk of the protein some en-
zymatic ac t i v i t y could be detected (Fig. 6 ) . However, recovery and 
s tab i l i t y were very poor. 
20 4) 
ELUTIOrMOLlft ( ft. ) 
Fig. 6 DE-52 elut ion p ro f i l e of a concentrated ßH-74 sample. No gradient 
was used. The crys ta l l ins did not bind to the colufln. Na-acetyltrans ferase 
ac t iv i ty could be detected in a small peak (+) following the c rys ta l l i ns . 
However, recovery and s t a b i l i t y of the enzyme were poor. 
As binding to an anion exchanger apparently adversely affects the sta-
b i l i t y of the enzyme, a weakly acidic cation exchange resin (CM-52) was 
t r i ed . The enzyme did not bind to the column, and about 86 % could be 
recovered. However, because the ß-crystal l in f ract ion did not bind ei ther, 
pur i f icat ion was not higher than 1.4-fold. Therefore a s ign i f icant pur i -
f icat ion could not be accomplished in th is way. 
£hro¡nato_focu¿™g 
Subsequently we t r ied chromatofocusing, the re la t ive ly novel column 
chromatographic method for separation of proteins according to the i r 
-131-
isoelectr ic point (24, 25). Although an excellent separation of the g-
c rys ta l l i n was obtained, no enzymic ac t i v i t y could be detected in the 
eluant. 
Flatbed focusi£g 
Preparative f latbed isofocusing (26) was performed in a bed of Sepha-
dex-IEF equi l ibrated with 25 % g lycero l , 2 mM DTE, with a re la t ive ly 
shallow pH-gradient (5-7) (Fig. 7) . This gradient was devised in order 
to give a somewhat steeper curve around pH 5, where the enzyme was 
expected to focus. About 10-15 ml of Зи-74 was applied as a broad band 
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Fig. 7 pH-gradient used for preparative f latbed isofocusing in Sephadex-
IEF, equi l ibrated with 25 % g l y c e r o l , 2 mM DTE (20 χ 19 χ 1 cm). After 
establishing the gradient, concentrated Ви-74, dialyzed against the 
focus ing-solvent, was applied in a broad zone by mixing with the gel 
f ract ion containing the pH-range 6.5-7.5 (shaded area). Focusing was per­
formed for 5 hr with thorough cooling of the bed. The enzymatic a c t i v i t y 
was determined for fractions I-V a f t e r removal of the gel material by 
centri fugati on. 
(pH 6.5-7.5) af ter establishing of the gradient. After isofocusing the 
bulk of the crysta l l ins was found between pH 5.5 and 7.0. Only a small 
amount of protein was present in f ract ion I (zone pH 4.5-5.5). I t was the 
only one in which enzymatic a c t i v i t y was present. However, the enzyme 
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was stable only for a few hours. Enzyme recovery seemed to be "175" % 
(Table V I I ) . This "high" y ie ld is caused by inaccurate measurement of 
the enzymatic ac t i v i t y . At such a high d i lu t ion of the enzyme the l im i ts 
of sens i t i v i t y of the assay are reached (17). The f latbed separation 
gives a pur i f ica t ion factor of about 150, which is actual ly lower because 
of the inaccuracy of the determination. The enzyme in f ract ion I was 
tested for purity by sodium dodecylsulphate-polyacrylamide gel e lectro-
phoresis (Fig. 8). There is no predominant band other than already 
known lens proteins. The main components s t i l l present are the subunits 
of the enzyme leucine amino peptidase (54,000), the subunits of a-crys-
t a l l i n , cxB (22,000), aA (20,000), and probably aA1 - 1 0 1 (11,000), which 
is normally found in the lens nucleus (27). Native leucine aminopeptidase, 
with re lat ive molecular mass 326,000 and isoelectr ic point 4.9 (28), 
and residual a -c rys ta l l in are apparently copurif ied during isofocusing. 
We assume, that the amount of Na-acetyltransferase present in bovine lens 
must be very small, since a maximum pur i f ica t ion of 760-fold (Tables V 
and VII) has been obtained, while no predominant unknown band is v is ib le 
on gel electrophoresis. Although the flatbed resul t could be repeated, 
in general the reproducibi l i ty was unsatisfactory. 
Fig. 8 SDS-gel electrophoresis 
of the protein present in zone I 
(pH 4.5-5.5) of the f latbed iso-
focusing (cf . Fig. 7). Lanes (a) 
and (h) contain reference proteins 
as indicated, lane (b) a - , (c) 
ßH-, (d) ßL-, (e) Y -c rys ta l l i n , 
( f ) lens Tr i ton X-100 insoluble 
proteins, (g) lens leucine amino-
peptidase, and ( i ) the proteins 
of zone I . 
Mr x10 -3 
66 
45 r· 
22 
20 
-
a b с d e f g h i 
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sample p r o t e i n a c t i v i t y s p e c i f i c t o t a l t o t a l p r o t e i n enzyme p u r i f i c a t i o n 
volume c o n c e n t r a t i o n a c t i v i t y a c t i v i t y p r o t e i n recovery recovery 
- 1 3 3 3 
ml mg. ml cpm Η-acetate, cpm Η-acetate, cpm Η-acetate, mg % % χ 
-1 , - l -1 -1 -1 
min .ml min .mg min 
дН-74 concen- 0.0 33.3 12500 375 100000 266 100 100 1 
t r a t e d 
zone pH 4.5-5.5 30.5 +0.1 5750 57500 175375 3 1 175 153 
o f f l a t b e d i s o -
focus ing 
Table V I I . Pur i f icat ion of Na-acetyltransferase by f latbed isofocusing of concentrated Su-74. Zone I (pH 4.5-
5.5) (cf Fig. 7) was centrifugated to remove Sephadex gel material and dialyzed against StfPensen's phosphate 
buffer pH 7.4, containing 25 % g l y c e r o l , 1 mM DTE before measurement of the enzymatic a c t i v i t y . 
One has to conclude that i t is not possible with the employed separa-
t ion techniques, which are based on charge differences of the proteins, 
to obtain reproducibly an Na-acetyltransferase preparation su f f i c ien t l y 
stable for k inet ic and substrate spec i f i c i t y measurements Although a 
maximum pur i f ica t ion of 760-fold was reached, the preparation s t i l l con-
sisted mainly of other proteins than the desired enzyme 
Determination of k inet ic constants 
Since the Na-acetyl transferase acetyl ates the NHL-temnnus of proteins 
or peptides, using acetyl coenzyme A as the acetyldonor, i t belongs to the 
group of acyltransferases (EC 2.3.1 - ) for which the kinetics of a bisub-
strate mechanism is to be expected I t seems probable that the enzyme-
catalyzed reactions in which an acylgroup is transferred from or to an 
acyl-CoA, proceed via pathways which involve the formation of acyl-enzyme 
intermediates (29-31). Although l i t t l e evidence is available concerning 
the nature of the covalent linkage between the enzymes and the acylgroups, 
the observations that many of these enzymes are inactivated by th io l group 
reagents led to the suggestion that acyl-enzymes may be thio-esters 
formed from the side-chain th io l groups of cysteinyl residues. For 
acetyl-CoA acetyl-CoA-acetyltransferase (EC 2 3.1 9) a double displace-
ment type of mechanism has been proposed (29) 
For the bovine lens Na-acetyltransferase (acetyl-CoA c rys ta l l i n 
N -acetyltransferase) the dependence on a free th io l group has been shown 
in the preceding sections Ue wanted to further investigate some mecha-
n is t i c aspects of the enzymic reaction. To th is end we routinely used the 
concentrated ßi."74 f rac t ion , because i t is stable and can be obtained 
reproducibly. The apparent Michaelis constant for acetyl coenzyme A was 
determined to be 4.6 + 0.3 μΜ, when the substrate des-Nai-Ac-[Nle'']a-f1SH-
(l-lO)-decapeptide (16) was present at 0.31 mM (Fig 9) At lower con­
centrations of the coenzyme there was considerable deviation from zero-
order k inet ics, since a sigmoidal curve was obtained for acetate incor­
poration versus time Moreover, the assay is not very accurate at these 
concentrations (17) The concentrations we normally use for determination 
of the enzyme a c t i v i t y are, as far as the coenzyme is concerned, near the 
apparent К value. However, the consumption of coenzyme did never r ise 
above 5 % during assays. Therefore we concluded that i t would not be 
feasible to carry out further kinet ic measurements, because this would 
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Fig. 9 Lineweaver-Burk plot for [aceii/i-эH]-acetyl coenzyme A. Des-N011-
Ac-[Nle^Ja-MSH-fl-lOJ-decapeptide was used as a substrate at a concentra­
t ion of 0.31 mM and concentrated ßH-74 as source of the enzyme The ap-
parent К for acetyl coenzyme A is 4 . 6 + 0 . 3 μΜ 
require unduly large amounts of the very expensive coenzyme Furthermore, 
on raising the concentration of coenzyme to the highest level used, 
10.9 μΜ, we found an increase in uncatalyzed N a -acetylation. 
Substrate s p e c i f i c i t y 
The substrate s p e c i f i c i t y of bovine lens Na-acetyltransferase was 
explored, especially with regard to the aminoterminal residue and the 
chain length. To t h i s end several peptides of d i f f e r e n t length corres­
ponding to the N-termi nal sequence of the adrenocorticotroph hormone 
(ACTH) were either obtained as a g i f t or synthesized (Tables I and I I ) 
The peptides were measured at a concentration of 0.32 mM with a concen­
trated 3μ-74 enzyme source. 
When serine at position 1 is replaced by the corresponding D-amino 
acid in the ACTH-(l-10)-decapeptide there is no [^"-acetylation detectable 
(Fig. 10), which is a confirmation of ear l ier results (6) The stereo-
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chemistry of the f i r s t amino acid is therefore decisive, which together 
with the fact that almost a l l proteins, which are Na-acetylated -ui v-ivo, 
have either serine, alanine or methionine at the N-termi nus (1 ) , shows 
the very specif ic and r i g i d demands for enzymatic l^ -acety la t ion. The 
replacement of methionine at posit ion 4 by norleucine in the decapeptide 
does not give a s ign i f icant dif ference, as already had been noted (17). 
rrOLE IhACETATE INCORPOÜATH) HIN 
M ENTVWe P R E P A M T I O N " - 1 
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то • 
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LENGTH OF ДСТН FRAGMENT ( RESIDUFS ) 
Fig. 10 Substrate s p e c i f i c i t y of bovine lens N^-acetyltransferase 
(Вм-74( concentrated by u l t r a f i l t r a t i o n against polyethylene glycol) 
with regard to the configuration of the aminoterminal residue and the 
chain length, as determined for peptides with the N-terminal sequence 
of ACTH. 
χ aminoterminal ACTH-fragments of d i f ferent lengths 
o [Nle-l-ACTH-il-lOJ-decapeptide 
• [D-Ser'J-ACTMl-lCO-decapeptide 
The length of the ACTH-fragment, necessary for N^acety lat ion, is mim-
mally 8 residues, as far as can be detected in our assay (17). The rate 
of Na-acetylation increases rougly l inear ly up to a length of at least 
39 residues, which was the largest substrate investigated. This is at 
variance with e a r l i e r measurements on bovine lens acetyl transferase, 
where i t was found that the (l-13)-peptide is comparable with the (1-24)-
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peptide (6). However, in those experiments measurements were done with 
crude lens extract S-15, which contains peptidases which incidental ly de­
graded the substrate. I t is also in contrast with the findings for Na-
acetyltransferase from rat p i t u i t a r y ( 8 ) , where the eff iciency of ACTH-
(l-lO)-decapeptide is comparable with that from ACTH-(l-24)-tetracosa-
peptide under saturating conditions. 
I t has been demonstrated that acetylation of the nascent chains of 
a - c r y s t a l l i n starts when the polypeptide is about 25 amino acids long, 
and is v i r t u a l l y completed when the chain has reached a length of about 
50 amino acids (32).while the peptide is s t i l l on the ribosome The 
acetylation thus starts when the growing chain emerges from the ribosome. 
Possibly the N^-acetyltransferase needs the support of the growing 
chain i t s e l f for e f f i c i e n t acety lat ion, as nbosomes are absent in our 
experiments (Fig. 10). However, one should keep in mind that the ACTH-
peptides are not the native substrate for the bovine lens Na-acetyl-
transferase 
Although i t has been shown that the enzyme does not acetyl ate the 
ε-ΝΗ.-group in ACTH-(l-13)-tridecapeptide amide ( 6 ) , we checked the 
occurence of ε-апппо acetylation in the two longer peptides. The acetyla-
ted substrates were digested with trypsin and the products separated 
by peptide mapping. Radioactive label was only found in the result ing 
( l-8)-octapeptide, thus confirming the absence of ε-acetylation on 
lysine residues. 
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APPENDIX 
SYNTHESIS OF ACTH-(l-3)-TRI- AND ACTH-(l-8)-0CTAPEPTIDE 
Granger it al. (1) studied the N^acetyltransferase from bovine lens 
and showed that i t acetyl ates synthetic aminotermnal ACTH-fragments 
solely at the N-terminus using acetyl coenzyme A. They also explored 
the substrate s p e c i f i c i t y with regard to chain length with the help of 
f i v e peptides having the N-tenmnal sequence of ACTH, and the crude 
lens extract (S-15) as the source of the enzyme ( 1 , 2) (Fig l a ) . Their 
assay did not allow for acetylation of endogenous substrates of the en­
zyme preparation, nor for the loss of substrate during work up in the 
assay Granger repeated the experiment on seven synthetic aminoterminal 
ACTH-fragments using the i s o l e c t r i c precipitate (IEP-5.4) as the source 
of the enzyme (2) (Fig. l b ) . In th is case values have been corrected for 
acetylation of endogenous substrates. I t is clear that the results are 
not consistent, especially for the shorter peptides, and i t was thought 
worthwhile to investigate the substrate s p e c i f i c i t y again with p u r i f i e d 
relative N a - acetylation (%) 
100 η 
Θ0 
6 0 -
40 
2 0 
τ
-
21 2 5 1 5 9 13 
l e n g t h of A C T H - f r a g m e n t ( res idues) 
Fig 1 Influence of the length of the substrate on the acetylat ion reac­
t ion using crude lens extract S-15 (a) and the isoelectr ic precipi tate 
(IEP-5 4) of S-15 (b) as the source of the enzyme 
- 1 4 1 -
ι cus N -acetyl transferase (see Chapter IV). Of the peptides used by 
Granger a i at. ( 1 , 2) there were s t i l l available the (1-2), (1-4), (1-5), 
(1-10), (1-13) and (l-24)-annnoterminal ACTH-fragments. Thus, for com­
pleteness i t appeared desirable to have available the peptides comprising 
the (1-3) and the (1-8) ACTH-sequence. Here the synthesis of both is 
described. 
With regard to the choice of the protecting groups and coupling method 
used, the reader is referred to Chapter I I . The numbering of the peptide 
derivatives corresponds to that of Chapter I I . The protected t r i peptide 
derivative Z-Ser(Bu )-Tyr(Du )-Ser(Bu )-0Bu 24 (Fig. 2) was prepared 
from the available dipeptide derivat ive Yl (p.89, Chapter I I ) and 
H-Ser(Bu )-0Bu 23 (3). After coupling the protecting groups were re­
moved with t r i f l u o r o a c e t i c acid and c a t a l y t i c hydrogenolysis. ACTH-(l-8)-
octapeptide was prepared by t r y p t i c digestion of ACTH-(l-10)-decapeptide 
(Fig. 3). The octapeptide was easily isolated from the digestion mixture 
using gel f i l t r a t i o n (Biogel P4). 
For results of the determination of the substrate s p e c i f i c i t y of Na-
acetyltransferase the reader is referred to Chapter IV. 
Fig. 2 
Synthesis of I 
H-Ser-Tyr-Ser-OH I H2 / P d 
г-$ег(Ви*)-Туг(Ви1)-«Н-НН2 12 + H-SerfBu'l-OBu' 23 
Ί 
N0 
Z-SerlBu'l-TyrtOu'l-SertBu'l-OBu' 24 
1 
Z-Ser-Tyr-Ser-OH 25 
H-Ser-Tyr-Ser-OH 26 
Fig. 3 
Synthesis of ACTH-(l-8)-octapeptide by t r y p t i c digestion. 
H-Ser-Tyr-Ser-Met-Glu-His-Phe-Arg-Trp-Gly-OH 27 
*
 Tl-8 * «-VlO-· 
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EXPERIMENTAL PROCEDURES 
For general procedures see Chapter II. 
5ел-Туп.-5ел U 
Z-SeMBuí)-Tí/A(Bu't)-SM.(BLi't)-OBu't 24. Condensation of 
Z-Ser(But)-Tyr(But)-NH-NH, 12 (p.92, Chapter I I ) and H-Ser(But)-OBut 
t t 
23, prepared by hydrogenolysis of Z-Ser(Bu )-0Bu 22 (3 ) , was performed 
as described for Z-Ser(But)-Tyr(But)-OMe U. (p.92, Chapter I I ) The 
product crysta l l ized from pet. ether. Since the material was impure, the 
crystals were dissolved in chloroform-methanol (90-10 v / v ) , and applied 
onto a column of Merck Kieselgel 60 (70-230 mesh ASTM, 30 χ 2.5 cm), 
equi l ibrated with the same solvent. On elut ion the fractions containing 
24 were col lected, and evaporated to dryness ΊΠ vacuo to y i e l d an o i l , 
which crysta l l i zed from pet. ether to give 1.98 g of white crystals. 
From the mother l iquor another 0.56 g were obtained. C-gHcgN-Oq (713.91), 
y i e l d 59 %; m.p. 129.0-130.0 "C. T.l c , one spot Rf 0.83 (A) u.v. +, 
TDM +. [a]23 +2.9 [c 1, DMF]. 
CHN analysis: С 65.7 (65.61), H 8.4 (3.33), Ν 6.0 (5.89). 
5ел-Ті/д-5ел 26. Removal of the teAt.-butyl functions from 
Z-Ser(Bu t)-Tyr(Bu t)-Ser(BiJ t)-0Bu t 24 (1.5 g, 2.1 mmol) was effected by 
dissolution in 75 ml of t r i f l u o r o a c e t i c acid-water (9.1 v/v), whereby 
the a i r in the vessel was replaced by pure nitrogen. After 30 mm the 
solvent was evaporated -ut vacuo, and the peptide was precipitated 
with ether. Subsequently the benzyloxycarbonyl group had to be removed, 
and therefore the peptide was dissolved in 60 ml of methanol-0.1 M 
acetic acid (1.1 v/v) and subjected to hydrogenolysis. The product 
precipitated during th is step and HCl had to be added to dissolve i t 
again p r i o r to removal of the catalyst by f i l t r a t i o n . The solution was 
concentrated -en vacuo, and applied onto a column of Merck-II (weak 
basic anion exchanger, acetate cycle, 15 χ 1.8 cm). On elut ion with 0.1 
M acetic acid the u l t r a v i o l e t absorbing fract ions were pooled and 
lyophil ized to give 0.50 g of white product. c i 5 H 2 i N 3 0 7 ( 3 5 5 · 3 5 ) ; y i e l d 
67 % (uncorrected for water content) T . l . c , one spot Rf 0.31 (C) 
u.v. +, TDM +, mn +, В +. [ α ] 2 3 +23.1 [с 1, 0.1 M HCl], [ α ] 2 3 + 4.5 
[с 0.15, МеОН-80 % acetic acid (175:925 v / v ) ] . 
Amino acid analysis. Ser 2.02 ( 2 ) , Туг 0.98 ( 1 ) . 
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Н-5гл-Ту>і.-5ел-Мг£-вЫ-НІ!,-Ріі£-Алд-0Н П 
ACTH-(l-10)-decapeptide 27 (74 mg, 57.0 μπιοί ) was dissolved in 7.4 ml of 
0.1 M NH 4HC0 3, pH 8.9. Then 74 μΐ of a trypsin solution in 0.001 M HCl 
(10 mg/ml) were added (enzyme-substrate ratio 1:100 w/w), and digestion 
was carried out for 1 hr at 370C. The solution was lyophilized, the 
residue dissolved in 0.5 ml of 0.1 M NH.HC0, and subjected to gel fil­
tration on Biogel P4 in two portions. The column (113 χ 1 cm), equili­
brated with the same solvent, was eluted at 3.0 ml/hr, and the eluant 
was monitored at 206 and 280 nm. Fractions containing octapeptide 26 
were pooled and lyophilized to give 40.7 mg of white solid material. 
C46 H65 N13 014 S ( 1 0 5 6· 1 8)· T.l.c, Rf 0.34 (C); sulfoxide Rf 0.23 (C) 
u.V. +, TDM +, nin +. [a] 2 3 -30.0 [c 1, 7.8 % acetic acid]. 
Amino acid analysis: Ser 1.94 (2), Glu 0.97 (1), Met 0.97 (1), Туг 1.04 
(1), Phe 0.99 (1), His 0.98 (1), Arg 1.02 (1). 
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CHAPTER V 
If-ACETYLATION OF THE BOVINE α-CRYSTALLIN A2 CHAIN IS NOT 
REQUIRED FOR PROTECTION AGAINST PROTEOLYSIS 
Huub P.C. Onessen, Frans С S Ramaekeis, Wilma Τ Μ Vree Eg­
berts, Huub J Dodemont, Wilfried Vi de Jong, Godefridus I. 
Tesser and Hans Bloemendal 
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SUMMARY 
N -acetyltransferase is assumed to be responsible for the 
N-terminal acetylation of a- and ß-crystallin subunits in the 
lens. ¡r-Crystallin subunits are not acetylated. The highest 
concentration of N -acetyltransferase is found in those re-
gions of the bovine lens, where crystallin synthesis takes 
place. The function of the N -acetylgroup may be protection 
against exopeptidases like leucine aminopeptidase, which is 
present in bovine lens in high concentiations. This possible 
protective role has been investigated in this paper. Syn-
thetic non-acetylated N-terminal tetrapeptides of nA - and 
ïll-chain are good substrates for leucine aminopeptidase. The 
acetylated peptides, however, are completely resistant. It 
appears that also the native ï-crystallin is resistant to de-
gradation by leucine aminopeptidase Newly synthesized 
aA_-crystallin, prepared by cell-free translation with pre-
vention of N-termmal acetylation, was exposed to leucine 
aminopeptidase. Only at extreme enzyme-substrate ratios the 
N-termmal methionine could be removed It is concluded, that 
N-terminal acetylation indeed protects crystallin chains 
against proteolytic breakdown, but is not essential for this 
purpose. It rather appears that the three-dimensional struc-
ture of the crystallins m itself can protect these proteins. 
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N-terminal acetylation is a widespread phenomenon in euka-
ryotes and to a lesser extent in prokaryotes and viruses (1). 
Virtually nothing is known about the underlying mechanism and 
functional implications. A general function for 
N -acetylation may be the protection of proteins against pro-
teolytic degradation by aminopeptidases (2). Experiments to 
sustain this hypothesis have not shown significant differ-
ences in the turnover rate of acetylated and non-acetylated 
forms of feline beta globin (3), and of proteins from mouse 
L-cells (4) . However, these cases have to be interpreted with 
great care, since the acetylated and non-acetylated proteins 
were not of the same type In Dictyostelium discoideum a minor 
non-acetylated form of cytoplasmic actin with a rapid turn-
over was found next to a major and moie stable acetylated form 
(5). However, this turnover is probably not caused by proteo-
lytic breakdown, but rather reflects a precursor-product 
processing. For the acetylated form of cytoplasmic actin from 
cultured Drosophila cells (6) and in vitro acetylated chole-
cystokimn (7) it has been shown that the acetylgroup protects 
against N-terminal degradation by kidney leucine aminopepti-
dase and tissue extracts, respectively However, until now no 
strong evidence has been presented for a protective role of 
N -acetylation in vivo 
Although a general function for N -acetylation has thus not 
been assessed with certainty, some specific effects for a 
small number of proteins have been obseived Contrary to nor-
mal non-acetylated hemoglobin, feline hemoglobin with 
N -acetylated S-chain amino termini is insensitive to the mod-
ifying influence on oxygen affinity of organic phosphates 
(8) . A similar effect has been noted for the human mutant hem-
oglobin Raleigh ( ß, Valine-'-Acetylalamne) (9), and the minor 
human fetal hemoglobin F. (10) N -acetylation of two of the 
products from the precursor protein pro-opiomelanocortm has 
a profound regulating effect on the biological activity of 
these polypeptides. the opioid activity of B-endorphin is 
completely suppressed (11, 12), while the melanotropic effect 
of a-MSH is increased (13). In the first case N -acetylation 
possibly is a reversible process. Both acetylated and 
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non~acetylated cy'-oplasmic actm from cultured Drosophila 
cells participate in the assembly of micrüfilaments (6), "he 
latter, however, '„'ith less efficiency .τ .nutant of Escheric­
hia coll, in which nbosomal protein S5 is not acetylated, ex­
hibits thermosensitivity (14) Non-асеtylaLed NADP-specific 
glutamate dehydrogeiase in a mutant of КеигоБро^а crassa is 
heatinstaole _i ccnti.ast to the acetylated fori (15) 
In bovine lens a relatively large amount of leucine amino-
peptidase is present (16), about 80 % of the wat^r-soluble 
calf lens proteins aie N -acetylated (17-19) However, the 
relative amoin-t differs among species (20) Therefore this 
- '~t-cm ^eems suitable for the investigation of = posE ole 
funct'on of Г -acetylation as protection against proteoly'is 
Herp we describe tne susceptibility of ci-crystallin λ. chain 
and ¡T-cr} 'staj.lin , two of che major lens proteins (20), v/ith 
respect to this enzyme It has already been suggested (2l) 
that the accessibility of the ammoterminal group and the rel-
ative susceptibility of the NH_-terminal peptide bond are 
major factors in resistance of lens proteins against hydroly-
sis . 
-148-
MATERIALS AND METHODS 
Materials 
Spermidine, tRNA, oxaloacetate, citrate synthase and RNase 
A were obtained from Sigma; proteinase К and creatine kinase 
from Boehnnger; L-leucineamide from Serva; micrococcal nu­
clease from P.L. Biochemicals Ine , Milwaukee, USA, oligo(dT) 
cellulose, T2 grade, from Collaborative Research Inc., Walt-
ham, USA; methylmercury hydroxide from Ventrón Division, 
Danvers, USA, [J5Sj-methionine (= 1000 Cl/mmol, = 14 mCi/ml) 
from Amersham; Pico-Fluor 15 from Packard. 
Des-Nal-Ac-ciA-( 1-4) - tetrapeptide (Met-Asp-I le-Ala) , 
aA2-(l-4)-tetrapeptide (Ac-Met-Asp-Ile-Ala), 
ÏII-(l-4)-tetrapeptide (Gly-Lys-Ile-Thr) and 
Nal-Ac-ÏII-(l-4)-tetrapeptide (Ac-Gly-Lys-Ile-Thr) were syn-
thesized by the classical approach ¡r-Crystallm was isolated 
as described earlier (20). 
Fractionation of the lens 
Eyes from 3 to 6 months old calves were obtained freshly 
from the slaughterhouse and kept on ice For the determination 
of N -acetyltransferase activity lenses were removed, and 
dissected into five fractions (Fig 1)-
I central region of the epithelial layer adhering to the cap-
sule of the lens. 
II germinative region and the region of cellular elongation 
adhering to the capsule at the equator 
III. elongated fiber cells in the superlicial cortical region 
(0 > 12 .0 mm) . 
IV. fiber cells in the deeper layers surrounding the nucleus 
(0 between 9.5 and 12 0 mm) 
V. deep cortex and nucleus (0 < 9 5 mm) 
To each of the fractions one volume of Sorensen's phosphate 
buffer pH 7.4 (Na-HPO. - ΚΗ,ΡΟ ) was added, and the mixtures 
were homogenized at 0°C The homogenates were centnfuged at 
15,000 χ g for 10 m m at 4''C The supernatant (S-15 fraction) 
was used for determination of the enzymatic activity 
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N -acetyltransíerase assay 
Details on the assay have been published elsewhere (22, 
23). One unit of activity equals 1 pmol 3H-acetate incorpo-
rated in the substrate per min under standard conditions. 
Isolation of calf lens ро1у(А )-RNA 
Calf lens polyribosomes were isolated as described previ­
ously (24) Polyribosomal RNA was deproteinized by treatment 
with proteinase К at 100 pg/ml for 2 hr at 37°C m 50 mM 
Ti is-HCl buffer, pP 7.5, containing 10 mM EDTA and 0. 5 % sodi­
um dodecylsulphate.The solution was adjusted to a final con­
centration of 0.5 M NaCl and applied to an oligo(dr) cellulose 
column for selection of poly(A )-RNA (25) . 
Isolation of calf lens aA^-mRNA 
Poly(A )-RNA (100 yg) was subjected to electrophoresis on a 
vertical 25 cm 1 5 % agarose slab gel in the presence of 10 mM 
methylmercury hydroxide (26). During electrophoresis the buf­
fer was constantly circulated between the buffer 
compartments. Following electrophoresis methylmercury hy­
droxide was removed by soaking the gel for 30 m m in 0.5 M 
NH.OAc at pH 8.3 The aA.-mRNA was localized by staining a 
small part of the preparative lane with ethidium bromide. The 
unstained gel slice was homogenized through a syringe in 2 ml 
high salt buffer containing 50 mM Tns-HCl, pH 7.5, 500 mM 
NaCl, 5 mM EDTA, 10 mM DTT, 0.2 % SDS in the presence of 25 ug 
Escherichia coli tRNA. The homogenate was extracted twice 
with an equal volume of phenol saturated with 10 mM Tns-HCl, 
pH 8.0, 1 mM EDTA, and subsequently extracted twice with an 
equal volume of chloroform-isoamylalcohol (24 · 1 v/v). After 
two successive ethanol precipitation steps the RNA pellet was 
dissolved in 5 ul of water. 
De novo synthesis of lens proteins 
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Rabbit reticulocytes were prepared as described by Pelham 
and Jackson (27) A 30,000 χ g supernatant of the lysed cells 
was used as a cell-free system The lysate was made mRNA de­
pendent by preincubation with 10 yg/ml micrococcal nuclease m 
the presence of 1 mM CaCl. for 15 m m at 20'C (27) After incu­
bation 2 mM ethyleneglycol- bis(2-aminoethylether ) Ν N'-
tetraacetic acid (EGTA) was added to chelate calcium ions 
Incubations were performed at 30°C for 1 5 hr The reaction 
mixtuie contained per ml 0 6 ml of reticulocyte cell-fiee ex­
tract, 1 umol ATP, 0 2 ymol GTP, 50 ug tRNA, 4 ymol DTT, 10 umol 
creatine phosphate, 100 ug cieatine kinase 0 2 pmol spermi­
dine, 100 ymol KOAc, 1 ymol Mg(OAc)„ and 0 1 ymol of 19 amino 
acids, 100 yl of [ 3 5S ]-methionine was added as the only labeled 
amino acid 
In order to obtain newly synthesized non-acetylated poly­
peptides internal acetylation capacity of the reticulocyte 
lysate was suppressed by adding 2 4 ymol oxaloacetate (neu­
tralized) and 72 units citiate syithase per ml (28) Polyribo­
somes, unfractionated poly(A )-RNA or purified otA--mRNA were 
added at a concentration of 0 5 mg/ml, 0 05 mg/ml and 0 01 
mg/ml, respectively 
Translation was performed in 20 yl batches, and was termi­
nated by adding 0 2 mg of RNase A pei ml and subsequent incu­
bation at 37°C for 20 m m 
Leucine aminopeptidase digestion of polypeptides 
Leucine aminopeptidase, isolated as described previously 
(30) (protein concentration 5 2 mg/ml), was activated in the 
presence of Mn 2 -ions (31) Activity was measured spetropho-
tometrically (31, 32) at loom temperature using 
L-leucineamide as a substrate One unit of activity equals 1 
ymol leucmamide hydrolyzed per m m under standard 
conditions 
The tetrapeptides and ï-ciystallin were dissolved to final 
concentrations of 6-12 mg/ml in 0 1 M ammonium bicarbonate, pH 
θ 9, and activated leucine aminopeptidase was added in a 1 to 
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5 % (w/w) enzyme-substrate ratio Digestion was performed at 
37°C. Alter different periods of time an aliquot was taken, 
a:id digestion was stopped by chilling in dry ice-acetone and 
lyophilization. 
Exposure of de novo synthesized chains to leucine amino-
peptidase was performed by adding 40-50 μΐ of the enzyme sol­
ution to 50-90 μΐ of the translation mixture Incubation was 
performed as described for the peptides. 
Analysis of digests 
Analysis of de novo synthesized polypeptides after incu­
bation with leucine ammopeptidase was perfoimed by 
two-dimensional gel electiophoresis according to O'Farrell 
(33) Radioactive spots were visualized by scintillation au­
toradiography (34) in combination with the drying procedure 
described by Berns and Bloemendal (35) Protein spots were cut 
from the gel, solubilized in a mixture of ammonia and hydrogen 
peroxide (1:19 v/v) at бО'С, and counted using Pico-Fluor 15 
as a scintillation agent. 
In case of ¡f-crystallin, the liberated amino acids were se-
parated from undigested chains by gel filtration on a Biogel 
P4 column (120 » 1 cm, running buffer 1 % ammonium bicarbonate, 
flow rate 2.2 ml/hr). Fractions of 1.1 ml were collected and 
lyophilized Relevant samples were analyzed by amino acid 
analysis on a Rank Hilger Chromaspek 
In the experiments with the N-terminal tetrapeptldes of 
пА-- and ÏII-crystallin the digest was analyzed by peptide 
mapping (36). Relevant spots were subjected to amino acid 
analysis. 
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RESULTS 
Distribution of N -acetyltransferase and leucine aminopepti-
dase in bovine lens 
In order to determine the vaiious stages in lens differen-
tiation where N -acetylation and proteolytic degradation of 
crystallins may occur, we compared the amount of 
N -acetyltransferase and leucine aminopeptidase in different 
layers of the calf lens Lenses weie dissected into five frac-
tions (Fig 1, Table I), following the morphological 
ANTERIOR SIDE 
POSTERIOR SIDE 
Fig. 1 Schematic drawing of the lens, showing the five regions 
used for determination of N -acetyltransferase activity Vol-
ume and protein content of the fractions are shown in Table I. 
Table I . 
Volume and protein content of lens 
fractions I to V (cf. Fig. 1). 
fract 
I 
II 
III 
IV 
V 
ion 
vo 
I* 
lume 
) 
1 
1 
49 
20 
29 
protein content 
I*) 
0.1 
0.2 
36.4 
20.7 
42.6 
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characterization of Kuwabara (37). Fractions I and II repre­
sent the epithelium and the zone of cellular elongation, frac­
tions III and IV the differentiated fibers of the cortex, 
while fraction V contains the deep cortex and the nucleus The 
fractions were homogenized and the water-insoluble material 
removed by centrifugation 
Since fractions I and II consisted of cells adhering to the 
collagenous capsule and were obtained simply by stripping the 
anterior part of the capsule of the lens, these fractions may 
be contaminated with fiber cells from fraction III (38). This 
can influence data considerably, since the former two frac­
tions comprise only small volumes In order to check for 
fiber cell impurities, the watei-insoluble part of each frac­
tion was subjected to gel electrophoresis (Fig 2). It 
is evident that the relative intensities of several protein 
bands in fractions I and II aie different from those m frac­
tion III. Therefore it is veiy likely that fractions I and II 
are reasonably pure. 
Fraction III contains half the volume of the lens (Table I), 
while fractions IV and V contain about 60 % of the total prote­
in amount. N -acetyltransferase activity in the supernatant 
of each fraction was determined as shown in Fig. ЗА. Frac­
tions I and II each contain only 1 % of the total enzyme activ­
ity, while fraction III contains 84 % In the deep cortex and 
the nucleus (fraction V) no significant activity could be de­
tected. 
Bovine lens contains a considerable amount of leucine ami-
nopeptidase (16). Van Kamp (17) has determined the activity 
of this enzyme in several zones of the lens. These data have 
been recalculated for fractions I to V and are shown in Fig. 
3B. No activity is present m the epithelium, while from the 
outer cortex towards the nucleus a gradual decrease is seen. 
The activity is highest in fraction III. 
N-terminal tetrapeptides of Til- and aA.-crystallin as subs­
trates for leucine aminopeptidase 
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I II III IV ν 
Fig. 2 Sodium dodecylsulphate gel electrophoresis patterns of 
the water-insoluble proteins from fractions I to V (cf. Fig. 
1)-
In the experiments described below (zinc-containing) leu­
cine aminopeptidase was used, which was isolated and purified 
from bovine lens as described by Cuijpers et al. (30). This 
preparation is essentially free from endopeptidases (39). 
Specific activity was increased by activation with manganese 
ions and was of the order of 500 to 1000 units per min per mg. 
First the sensitivity of the N-terminal sequences of a- and 
¡C-crystallin (both in the acetylated and non-acetylated form) 
to this activated enzyme was established. When using a 1 % en-
zyme-substrate ratio (w/w) it was obvious that the 
non-acetylated aA_-(l-4)- and ÏII-(1-4)-tetrapeptides are 
good substrates for lenticular leucine aminopeptidase (Table 
II). However, the acetylated aA_-(1-4)-tetrapeptide, which 
bears the N -acetylgroup normally found on αΑ,-chain in vivo. 
is completely resistant. Similarly, the 
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Fig. 3 Distribution of the activity and specific activity of 
Na-acetyltransferase (A) and leucine aminopeptidase (Б) in 
bovine lens, as determined (A) and calculated from reference 
17 (B), respectively, for fractions I to V. Activity is ex­
pressed as percentage of the total activity. 
№ -Ac-ÏII-(1-4)-tetrapeptide is also resistant to leucine 
aminopeptidase. 
In the case of des-N11 -Ac-oA- ( 1-4) -tetrapeptide the 
N-terminal methionine is lost within 1 min (Fig. 4-5). Aspar-
tic acid in position 2 is removed within the next 10 min. The 
remaining Ile-Ala dipeptide is further degraded (data not 
shown). When the non-acetylated ¡ΓΙ I-crystallin tetrapeptide 
is exposed to leucine aminopeptidase degradation is less rap­
id. The N-terminal glycine is lost within several hours, 
while the next three ammo acids are liberated within seconds, 
as concluded from the fact that no di- or tnpeptides are ob­
served (Fig. 6-7). 
Exposure of ¡f-crystallin to leucine aminopeptidase 
In order to test the stability of native ¡T-crystdllm 
chains with respect to leucine aminopeptidase, we subjected 
complete ï-crystallin, which had been dialyzed extensively to 
remove small compounds, to this enzyme. The enzyme-substrate 
ratio used (units/nmole) was approximately 60 times higher 
than the ratio used for the (1-4)-tetrapeptides. Only a few 
percent of the N-teiminal amino acids of ï-crystallin II (40), 
III and IV chain (41) were liberated within 21 h (data not 
shown). The experiment was repeated using an 
enzyme-substrate ratio 118 times higher than the one used for 
the tetrapeptides. Hov/ever, even after 24 hr of incubation no 
amino acids at all had been liberated. These two incubations 
differed only m the fact that in the first case ï-crystallin 
has been used, that had been stored for several months at 
-2O0C, while in the second case fresh protein was used. The re-
sults are summarized in Table III. 
-156-
A Na-ACETYLTRANSFERASE 
Activity % 
8 0 
6 0 -
Λ 0 -
20 
II III 
Fraction 
Specific activity 
E3 U.mg-'xIO7 
_EL 
IV 
- 8 
В LEUCINE AMINOPEPTIDASE 
Activity % 
6 0 
/.0 
2 0 
II 
Specific activity 
Ξ U. mg"1 »IO"2 
6 
m ιν 
Fraction 
dl L 0 
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Legends to the figures of the next pages in order of appear­
ance . 
Fig. 4 Electrophoresis pattern of the products of a 
time-course incubation of dAj-tl-·!)- (A) and 
des-N -Ac-aA-(l-4)-tetrapeptide (B) with leucine aminopep-
tidase. Peptides and amino acids have been visualized with 
fluorescamme, which obviously does not reveal the blocked, 
intact aA7-(1-4)-tetrapeptide. Peptides are indicated with 
the one-letter code. Spots marked with arrows represent impu­
rities . 
Fig. 6 Electrophoresis pattern of the products of a 
time-course incubation of λΙΙ-(1-4)- (A) and 
N° -Ac-ïII-(l-4)-tetrapeptide (B) with leucine aminopepti-
dase. Peptides and amino acids have been visualized with 
fluorescamme The one-letter code has been used for iden-
tification. Spots indicated with arrows represent impurities 
or intermediates below the detection level of the amino acid 
analyzer. 
Fig. 5 Time-course degradation of Met-Asp-lie-Ala by leucine 
aminopeptidase. The peptides are indicated with the 
one-letter code. 
Fig. 7 Time-course degradation of Gly-Lys-Ile-Thr by leucine 
aminopeptidase. Peptides are indicated with the one-letter 
code. 
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αΑ2-(1-4)- αθ5-Ν
α1
-Αε-αΑ2- γΙΙ-(1-4)-
tetrapeptide (l-4)-tetrapeptide tetrapeptide 
Nal-Ac-YlI-(l-4)-
tetrapeptide 
substrate concentration 
(mg/ml) 
6.8 6.8 6.4 6.4 
enzyme-substrate ratio 
(w/w) 
1:100 1:100 1:100 1:100 
enzyme-substrate ratio 
(units/nmol) 
0.0063 0.0058 0.0043 0.0043 
result stable during 
at least 6 hr 
loss of Met1 
within 1 min; 
loss of Asp2 
within 10 min; 
further degra­
dation 
loss of Gly1 
within 2-6 hr, 
followed by 
instantaneous, 
complete degra­
dation 
stable during 
at least 24 hr 
Table II. 
Conditions and results for the exposure of a- and Y-crystal1in-(l-4)-tetrapeptides, both in acetylated and 
non-acetylated form, to leucine aminopeptidase at 370C. 
Synthesis of non-acetylated aA chains in a reticulocyte 
cell-free system 
To inhibit N -acetylation of newly synthesized proteins in 
a reticulocyte cell-free system we used the method described 
by Palmiter (28). By adding oxaloacetate and citiate synthase 
just before the addition of polysomes or mRNA the endogenous 
pool of acetylcoenzyme A is metabolized in the citric acid cy­
cle. As expected, translation of lens polyribosomes with 
prevention of N -acetylation did result in only 40 % inhibi­
tion in the case of aA_ chain, as judged from two-dimensional 
gels. However, when poly(A ) RNA was used, inhibition was of 
the order of 60-90 %. Addition of the inhibitor caused in fact 
a slight impairment of the translational capacity of the sys­
tem . 
Translation of total lens poly(A )-RNA results in the syn­
thesis of many polypeptides in the relative molecular mass re­
gion between 20,000 and 32,000. When these products are 
analyzed by two-dimensional gel electrophoresis crowding and 
overlapping occurs, especially after prevention of 
N -acetylation. We therefore subjected total poly(A )-RNA to 
electrophoresis in a denaturatmg slab gel, and selected 
aA_-mRNA (about 1250 bases). Translation of this mRNA gives a 
surveyable picture on a two-dimensional gel (Fig. 8) 
Stained gel patterns of o-crystallin normally show four su-
bunits, i.e. aB_, oB. , aA. and пА. , where ctA. (pi 5.4/5.60) is 
the deamidated form of aA (pi 5 7/5.92) (20) (Fig. 9B). 
Translation of nA^-mRNA without prevention of acetylation di­
rects the synthesis of aA_ as the main product (Fig. 9A). In 
addition a small amount of supposedly deamidated product, 
which does not comigrate with aA. can be seen (Fig. 9A,B) . Un­
der inhibiting conditions, the main product is a more basic 
polypeptide (pi 5.9/6.1) besides a minor amount of the acety-
lated aA^-chain (Fig. 9C) . The main product of this 
translation is assumed to be des-N -Ac-aA for the following 
reasons: first, in vivo aA? is known to be N -acetylated (18); 
second the procedure as described by Palmiter(28) produces 
non-acetylated polypeptides, which are then accessible for 
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b a s i c 
-•JEF 
a c i d i c 
S D S 
α A3 
Fig. 8 Two-dimensional gel electrophoretic analysis of newly 
synthesized protein under the direction of purified αΑ-,-mRNA 
(autoradiograph) . 
Fig. 9 Relevant parts of two-dimensional gel electrophoretic 
patterns of: (A) translation ofaA^-mRNA, autoradiograph; (B) 
o-crystallin marker, stained pattern of gel A; (C) translation 
products of aAj-mRNA with prevention of I^-acetylation, auto­
radiograph; (D) a-crystallin marker, stained pattern of gel C. 
; »-lEF 
basic acidic 
SDS 
В 
des -N a l -Ac -áA 
- D 
*я» 
аВз аВ-, аАг аА 
-164-
sequence methods starting from the N-terminus (29, 42), 
third, the pi of the synthesized αΑ-chain shifts to a more bas­
ic value than that of the native aA.-chain, as expected for 
the formation of a free N-terminus At any rate, since essen­
tially pure αΑ,-mRNA has been used (Fig 8), the more basic 
product, synthesized by this mRNA with prevention of acetyla-
tion, must be an aA polypeptide (Fig 9C) From these results 
it is obvious that the relative amounts of acetylated and 
non-acetylated oA-chains can be estimated by determination of 
the amount of radioactivity in protein spots on the gels 
since no significant overlap between the two spots is seen 
Exposure of newly synthesized aA- and des-N -Ac-aA to leucine 
ammopeptidase 
-i 
When des-N -Ac-aA is exposed to leucine ammopeptidase the 
following degradation steps can be expected Initially, the 
N-terminal ,5S-labeled methionine may be removed resulting 
in a 50 % decrease in radioactivn y of the polypeptide since 
the only other labeled methionine is present at position 138 
(43) No shift in position on two-dimensional gels would re­
sult after this step Further degradation would then remove 
aspartic acid in position 2, resulting in a change of isoelec­
tric point of the shortened polypeptide On the gel this 
would give rise to a shift to the basic side 
First we made sure that oxaloacetate present in the trans­
lation mixture for prevention of acetylation does not inhib­
it activated leucine ammopeptidase The reticulocyte lysate 
we used had a protein concentration of 105 mg/ml For calcu­
lation of the enzyme-substrate ratios we used the globins of 
the reticulocyte lysate as a basis assuming a mean relative 
molecular mass of 15,700 A mixtuie of acetylated and 
non-acetylated aA (ratio 0 84) was exposed to leucine amino-
peptidase at an enzyme-substrate ratio of 0 057 units/nmol, 
or about 10 times higher than that used for the 
tetrapeptides After 1 hr no shift on two-dimensional gels was 
seen, nor was there a decrease in the ratio between the two 
oA-chains (Table III, Fig 10A) When the enzyme-substrate 
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ratio was increased to 0.851 units/nmol (about 200 times high-
er than for the tetrapeptides), again no shift on the gel was 
seen However, a rapid decrease in the ratio des-N -Ac-oA/oA_ 
was observed within 1 hr (Table III, Fig 10B), indicating the 
loss of the N-terminal methionine. 
Fig. 10 Incubation of a mixture of des-N -Ac-aA and aA, with 
leucine aminopeptidase at (A) 0.057 units/nmol and (B) 0.851 
units/nmol . The dashed line indicates the value expected for 
a complete loss of N-terminal methionine in des-N -Ac-aA 
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γ - c r y s t a l l i n oA^-chain des-Nai-Ac-aA-chain 
substrate concentration 
(mg/ml ) 
enzyme-substrate 
(w/v) 
enzyme-substrate 
(units/nmol) 
result 
ra t io 
ra t io 
A 
В 
A 
В 
A 
В 
A 
В 
11.0 
11.5 
1.0.100 
5.0:100 
0.238 
0.472 
loss of only a 
few percent of 
the N-terminal 
amino acids in 
21 hr 
stable during 
at least 26 hr 
A 
В 
A 
В 
A 
В 
A 
В 
31.5 
40.0 
0.3:100 
7.9:100 
0.057 
0.851 
stable di 
at least 
stable di 
at least 
1 
j r i 
24 
ng 
hr 
ng 
• hr 
A 
В 
A 
В 
A 
В 
A 
В 
31.5 
40.0 
0.3.100 
7.9:100 
0.057 
0.851 
stable during 
at least 1 hr 
loss of Met1 
within 1 hr 
Table III 
Conditions and results for the incubation of γ-crystallin, aA ? and des-N
ai
-Ac-aA with leucine 
aminopeptidase at 370C In all cases low (A) and high (B) enzyme-substrate ratios have been used 
CONCLUSIONS 
From the distribution pattern of N -acetyltransferase in 
bovine lens (Fig. ЗА) it is clear that the enzyme is present 
only in those regions where crystallin synthesis takes place 
(44). This is in accordance with the fact that N -acetylation 
of the ii-crystallin A- chain takes place as soon as the nascent 
chain emerges from the nbosome (45). On the other hand, the 
cortex of bovine lens per se contains 250 to 380 yg of leucine 
aminopeptidase, which is approximately 0 03 % of the wet 
weight of the lens (16). This enzyme is found in all layers of 
the cortex and the nucleus (Fig. 3B) with the highest activity 
in those areas where synthetic activity is assumed to be ter­
minated (17) Since the nucleus of the lens contains intact 
crystallins which are almost as old as the organism itself 
(20), these proteins would have to be piotected against pro­
teolytic attack by this enzyme during the lifetime. 
N -acetylation of the a- and ß-crystallins might give this 
protection A question that emerges immediately, however, is 
why ï-crystallin is not acetylated at the N-terminus. Does the 
three-dimensional structure of this protein by itself protect 
it from N-terminal degradation7 These questions have been ad-
dressed in this paper. 
When the synthetic N-terminal ÏII- and nA_-tetrapeptides 
are exposed to leucine aminopeptidase, the non-acetylated 
forms are completely broken down within a short time (Table 
II). Thus both the N-terminal sequences of aA. and ÏII are good 
substrates for this exopeptidase On the contrary the acety-
lated tetrapeptides are completely stable as indeed can be 
expected from the substrate specificity of leucine aminopep-
tidase (46) . 
However, when native ï-crystallm, which is not 
N-terminally blocked, was exposed to leucine aminopeptidase, 
the protein remains completely intact, even at concentrations 
of the exopeptidase 60 times higher than those used for the 
tetrapeptides (Table III). It is therefore very likely that 
the three-dimensional structure of ï-crystallm makes this 
protein completely resistant to leucine aminopeptidase. This 
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is conceivable, since the N-terminal sequence of ï-crystallin 
Il-cham is firmly embedded in the molecule (47) The fact 
that ï-crystallm, stored for several months at -20°C, showed 
some sensitivity to proteolytic degradation by leucine amino-
peptidase may be explained by a partial loss of structural in-
tegrity. 
The method described by Palmiter (28) for the prevention of 
N-terminal acetylation in a reticulocyte lysate, allowed us 
to produce aA-chains without the blocking group at the 
N-termmus. In this way it was possible to establish the sen-
sitivity of the N-terminal region of this protein with regard 
to proteolytic degradation. This could not be done otherwise, 
since it is not possible to remove the N -acetylgroup from na-
tive aA-chains without damaging the polypeptides. From our 
digestion experiments it has become evident that also this 
non-acetylated form of aA is resistant against proteolytic de-
gradation by leucine aminopeptidase. Only at extreme 
enzyme-substrate ratios the N-terminal methionine is 
removed In the interpretation of these experiments one has to 
keep in mind that aA synthesized under the direction of 
aA_-mRNA in a reticulocyte lysate remains in the monomenc 
form (48), this m contrast to the situation in vivo, where oiA_ 
is found together with аВ^ in complexes with an average rela­
tive molecular mass of 800,000 (20). It therefore is very 
likely that in vivo aggregation makes the aA-chains even more 
resistant to proteolytic breakdown. 
In all the experiments described here, lenticular leucine 
aminopeptidase has been activated with manganese ions In 
vivo this enzyme occurs in a less active form (46), while also 
glutathione, an inhibitor of the enzyme (49), is present in 
considerable amounts in the lens (50) Therefore, it is not 
very clear to what extent leucine aminopeptidase exhibits its 
proteolytic action in vivo. 
We have shown here that ¡f- and non-acetylated aA-crystallin 
are resistant to proteolytic degradation by leucine aminopep-
tidase in vitro, although their N-terminal sequences are good 
substrates for this enzyme. We tentatively conlude that the 
three-dimensional structure of both proteins in itself is a 
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stabilizing feature, and suggest that the N -acetylgroup of 
ah- gives protection without being essential. Therefore, the 
experiments described in this paper do not prove unequivocal-
ly that the function of N -acetylation is protection against 
proteolysis of native protein. Moreover, it should be real-
ized that our vigorous in vitro treatment of crystallins with 
leucine aminopeptidase is not identical to the continuous in 
vivo exposure to moderate levels of the enzyme in a less ac-
tive form. 
The only place where aA is not protected by its 
thiee-dimensional structure may be during its synthesis, when 
the nascent chain emerges from the nbosome. The 
N -acetylgroup, which is coupled to the chain at exactly this 
moment (45), may then function as protection for the not yet 
folded, protruding polypeptide. Ï-Ciystallm, which has a 
slightly more resistant N-terinmal sequence would not require 
this extra protection. 
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CHAPTER VI 
THE BOVINE ß-CRYSTALLIN Bp CHAIN IS N-TERMINALLY ACETYLATED 
Huub P.C. Driessen, Hans Bloemendal and Wilfried W. de Jong 
SUMMARY 
The elucidation of the primary structure of the blocked N-terminal 
tryptic peptide of ßBp, the major subunit of lens ß-crystallin, is 
described. The N-terminal alanine residue was shown, by mass spectro-
metry, to be N-a-acetylated. 
This chapter has been published as part of a report on the primary 
structure of ßBp: 
Driessen, H.P.C., Herbrink, P., Bloemendal, H. and De Jong, W.W. (1981) 
Eur. J. Biochem. 121, 83-91. 
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The water-soluble eye lens proteins, the c r y s t a l l i n s , have proven to 
be suitable tools for the study of protein biosynthesis, d i f f e r e n t i a t i o n , 
aging and nolecular evolution (1) For these purposes a knowledge of the 
primary structure of the crystal!1ns is required, and these ha/e indeed 
already been established for the bovine a - c r y s t a l l i n A and В chains (2, 3) 
and the bovine γ - c r y s t a l l i n I I chain (4) In the early seventies Herbrink 
(5) started the elucidation of the bovine ß-crysta l l in Bp chain, the 
major polypeptide of the remaining class of marmialian c rys ta l l ins . We 
now have determined the complete amino acid sequence (6) 
Hoenders et at established in 1967 (7, 8) that the N-terminus of 
both a -c rys ta l l in subumts is Na-acetylated In 1968 Mok and Haley 
confirmed t h i s , and found that bovine fS-crystall in subumts are №-асе-
tylated ( 9 ) , although they could not establish unequivocally that th is 
holds true for a l l subumts Since about 80 % of the water-soluble lens 
proteins belongs either to a- or g-crysta l l in (10), i t appears that the 
bulk of the lens proteins is l^-acetylated. In the course of the sequence 
studies on SBp (5) i t became clear that i t s N-terminus is indeed blocked. 
This blocking group was expected to be an Na-acetylgroup Here the e l u c i ­
dation of the sequence of the N-terminal t r y p t i c peptide Tl-17 (5, 6) 
and the determination of the blocking group is described 
MATERIALS AND METHODS 
Isolation and fragmentation of the tryptic peptide Tl-17 
The isolation of the N-terminal tryptic peptide Tl-17 from the bovine 
lens 0-crystallin Bp chain is described elsewhere (6) Digestion with 
pepsin (Sigma) was carried out in 0 01 M HCl at a peptide concentration 
of 1 pmol/ml, using 0 5 mg of enzyme/umol, during 5 hr at 370C Digestion 
with elastase (Whatman) was carried out in 0 1 M ammonium bicarbonate, 
brought to pH 8.9 with 1 M antnoma, at 370C for 90 m m Substrate concen­
tration waslymol/ml, the enzyme-substrate ratio was 0 5 mg/ymol. Digests 
were either lyophilized or directly applied onto a gel filtration column 
for peptide separation 
Purification of peptides 
Peptide maps of enzymic digests were obtained by high-voltage paper-
el ectrophoresi s at pH б 5, followed in the second dimension by descending 
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chromatography (2). Analytical maps, using up to 0.2 uraol of digest, were 
stained with mnhydnn. N-terminally blocked peptides were detected with 
4,4l-tetramethyldiaminediphenylraethane (Fluka, TDM) (11) For preparative 
purposes 0.5-1.0 umol of digest was applied, and peptides were localized 
by staining with fluorescamin (12), a small part of the electrophoresis 
strip was stained with TDM to detect the blocked peptides Peptides were 
eluted with 10 % acetic acid 
The peptic digest of the tryptic peptide Tl-17 was also fractionated 
on a Biogel P4 column (120 χ 1.2 cm) in 0 1 И ammonium bicarbonate at a 
flow rate of 5.0 ml/hr 
Amino acid analysis and sequence determination 
Peptide samples (5-10 nmol) were hydrolyzed in 0 5 ml 6 M HCl, con­
taining 0 05 % phenol (w/v), for 22 hr at 1100C -en vacuo. Amino acid 
analysis was performed on a Rank Hilger Chromaspek Analyzer. 
Sequence analyses were carried out using the dansyl-Edman procedure 
(13). Dansyl amino acids were identified by thin-layer chromatography 
on polyamide sheets ( 5 x 5 cm) (14). 
The sequence of the blocked N-terminal tripeptide was determined by 
mass spectrometry (electron impact and chemcal ionization) by Dr H.R. 
Morris and Mr. M. Judkins. (Imperial College of Science and Technology, 
London). For electron impact studies a sample (120 nmol) of the peptide 
was dissolved in 100 μΐ of water and denvatized by adding [3H6]acetic 
anhydride in methanol, after drying, the peptide was permethylated with 
CH,I. Details of the derivatization and mass-spectronetnc technique can 
be found elsewhere (15, 16). Chemcal ionization studies were performed 
on another 120-nmol sample, according to Morris tt at (17). 
Amide groups were assigned from electrophoretic mobilities of peptides 
at pH 6.5 (18) 
Peptide nomenclature 
Peptides resulting from enzymatic digestion of (3Bp are preceded by Τ 
(trypsin) and С (chymotrypsin), followed by the appropriate numbers in 
the chain Peptides resulting from subdigestion of Tl-17 with elastase 
or pepsin are indicated as T-E and T-P, respectively 
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RESULTS AND DISCUSSION 
The sequence of the blocked N-terrainal tryptic peptide Tl-17 (6) 
(table I) was solved by subdigestions with elastase and pepsin The 
Table I. Amino acid composition of the tryptic peptide Tl-17 
and of the chymotryptic peptides of the aminotenninal cyanogen-
bromide fragment of 0Bp (6) necessary for deduction of the se­
quence of Tl-17 
Residues 
number 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Leu 
His 
Lys 
Charge 
Ninhydrin 
reaction 
Τ 
1-
17 
1.9 
1.2 
1.2 
2 8 
3 1 
1.2 
1 8 
1.2 
1.0 
1.7 
+1 
+ 
1-
7 
1.1 
1.0 
1 0 
2.0 
1 0 
0.9 
-1 
-
С 
8-
14 
1.0 
2.2 
1.0 
1.0 
0.9 
0.9 
+1 
-г 
15-
17 
0.9 
1 1 
1.0 
+1 
+ 
elastase peptides could well be separated by peptide mapping (Fig 1), 
and the peptic digestion very specificially produced two smaller peptides 
which were effectively separated by gel filtration (Fig 2). Amino acid 
compositions (Table II) and Edman degradations revealed most of the se­
quence of Tl-17 (Fig 3) The sequence of the N-terminal tripeptide 
T-Pl-3 was solved by nass spectrometry The electron impact spectrum 
obtained fron the pprmethylated peptide showed clear signals at m/e 100 
ana 128, indicating a naturally blocked N-terminal acetylalamne At 
higher mass the signal at m/e 243 showed the presence of Ac-Ala-Ser, and 
a signal at n/e 354 could be "iterpreted as a sensible loss from ibe 
molecular ion of Ac-Ala-Ser-Asp A chemical ionization spectrum con­
firmed the presence of a C-terminal Ser-Asp sequence at m/e 291 The 
finding of residue Asp-3 is at variance with the results of the charge 
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pH 6.5 
Fig. 1 Peptide map of an elastase subdigestion of Tl-17. Amino acid 
analyses are given in Table II. 
1.0-
0.8-
0.6-
0.4-
0.2-
0 -
A 2 0 6 
_J/ s , > 
f_2_80 
T-P 4-17 
T-P 1-3 
Λ 
Λ UI 0.02 
О 
Fig. 2 Fractionation 
of a pepsin subdigestion 
of Tl-17 by gel filtration 
on Biogel P-4. The first 
peak contained the enzyme, 
the second T-P4-17 besides 
some undigested Tl-17. 
Amino acid analyses are 
given in Table II. 
ι 1 1 г 
30 50 70 90 110 ml 
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5 10 15 
Ac-A1a-Ser-Asn-His-Glu-Thr-Gln-Ala-Gly-Lys-Pro-Gln-Pro-Leu-Asn-Pro-Lys 
•+ Τ ». 
-T-E » — T-E ».«*_τ-Ε-
T-E »-— T-E • 
-*—T-E—*--« T-E-
•T-P • - * T-P 
Kig. 3 Amino acid sequence of the N-terminal t r y p t i c peptide Tl-17 of 
BBp. Amino acid analyses of elastase and pepsin subdigestions (T-E, T-P) 
are given in Table I I , those of Tl-17 and the chymotryptic peptides (C) 
obtained from the N-terminal cyanogenbromide fragment in Table I . Se­
quences were determined by dansyl-Edman degradation (—7) or by mass 
spectrometry ( = ) . 
Table I I . Amino acid compositions of elastase and peptic peptides of Tl-17 
Residues 
number 
Asp 
Thr 
Ser 
Glu 
Pro 
Gly 
Ala 
Leu 
His 
Lys 
Yield [%) 
Charge 
Ninhydrin 
reaction 
1-
6 
1.1 
0.9 
0.9 
1.1 
1.1 
1.0 
29 
-1 
-
1-
8 
1.1 
1.0 
0.9 
2.0 
2.0 
1.0 
11 
-1 
-
7-
9 
1.0 
0.9 
1.2 
6 
0 
+ 
T-E 
7-
14 
1.8 
2.0 
1.0 
1.0 
1.0 
1.3 
7 
+1 
+ 
9-
11 
0.9 
1.7 
1.1 
1.1 
1.2 
12 
+1 
+ 
10-
14 
0.9 
2.0 
1.0 
1.2 
7 
+1 
+ 
15-
17 
1.0 
0.8 
1.2 
51 
+1 
+ 
T-
1-
3 
1.0 
0.9 
1.1 
60 
-2 
-
•P 
4-
17 
0.7 
0.9 
3.1 
2.7 
1.0 
0.8 
0.9 
0.9 
2.0 
48 
+2 
+ 
-182-
determination of peptide T-El-6, which indicates the presence of Asn-3 
(Table III). Quantitative deamidation of Asn-3 during gel filtration 
of T-Pl-3 in amnonium bicarbonate or during storage must be responsible 
for this discrepancy. 
For the final completion of the sequence of Tl-17 some chymotryptic 
peptides obtained from the N-terminal cyanogenbromide fragment of ßBp 
were also used (Table I) (6). Within peptide Tl-17 the overlaps between 
residues 6-7 and 14-15 are based on the compositions and partial sequence 
determinations of Tl-17, Cl-7, C8-14, C15-17, and the elastase and pepsin 
peptides obtained by subdigestion of Tl-17, which leaves no other possible 
alignment than the one shown in Fig. 3. The assignment of amide groups 
is documented in Table III. 
Table III. Amide assignment. Assignment is based on the charge of 
small peptides at pH 6.5, as deduced from electrophoretic mobilities 
(18). 
Residue Peptide Charge Remar« 
Asn-3 T-El-6 -1 because Glu-5 is acidic (however, 
found as Asp in T-Pl-3 after storage 
for several months) 
Glu-5 T-P4-17 +2 because Gln-7, Gln-12 and Asn-15 are 
amides 
Gln-7 T-E7-9 0 
Gln-12 T-E10-14 +1 
Asn-15 T-E15-17 +1 
The primary structure of the N-terminally blocked tryptic peptide of 
BBp has thus been elucidated, and the blocking group has been shown to 
be an №l-acetylgroup. This establishes that in bovine lens the three 
major polypeptides, oA-, oB ? and eBp are l^-acetylated. 
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SAMENVATTING 
N-terminale acetylermg van eiwitten is een wijdverbreid 
fenomeen in eukaryoten en in mindere mate in prokaryoten en 
virussen. Er is vrijwel niets bekend over het verant-
woordelijke mechanisme en mogelijke functionele implicaties. 
Aangezien 80 % van de wateroplosbare lenseiwitten N-terminaal 
geacetyleerd is, is het interessant deze belde aspecten m het 
relatief eenvoudig toegankelijke lens systeem te bestuderen. 
Een enzymatische N-terminaal acetylerende activiteit is reeds 
enige jaren geleden in de kalfslens aangetoond. 
In de periode 1958-1981 is de gedeeltelijke of volledige 
sequentie van 361 eiwitten beschreven die N-terminaal 
geacetyleerd zijn. Met behulp van deze sequenties zijn de 
structurele en andere voorwaaiden voor M -acetylermg onder-
zocht (Hoofdstuk I) Het blijkt dat N -acetylermg een ver-
schijnsel is dat praktisch uitsluitend bij eukaryoten 
voorkomt en daarbinnen voor een belangrijk deel bij struktu-
rele eiwitten. N - acetylermg is een post-mitiatie proces, 
waarvoor de aanwezigheid van het enzym N -acetyltransferase 
en de cofactor acetylcoenzym A vereist is Enzymatische ver-
wijdering van de acetylgroep blijkt niet voor te komen. 
N -acetyltransferases blijken een nauwe 
substraatspecificiteit te hebben die vrijwel identiek ±s voor 
enzymen uit verschillende weefsels en soorten. De aminozuren 
die hoofdzakelijk aanwezig zijn op de N-terminus van 
geacetyleerde eiwitten zijn alanine, serine en methionine. 
De aanwezigheid van deze residuen is zeer belangrijk. Het 
N-terminaal gebied dat hierop volgt is ook een zeer belang-
rijke factor Voor eiwitten die beginnen met 
acetylmethionine ligt de informatie nodig voor acetylermg 
besloten binnen de eeiste d u e le^iduen De tweede positie is 
altijd sterk hydrofiel, vaak zuur Vooi geacetyleerde ei-
witten die met alanine of serine beginnen is de lengte van dit 
gebied respectievelijk 4 en 5 posities. In beide gevallen mag 
de totale plaatselijke hydrofobiciteit van dat gebied niet 
-187-
extreem zi]n. Twee- en driedimensionale stuktuurkenmerken 
schijnen geen beslissende rol te spelen bij N -acetylering. 
Teneinde het kalfslens N -acetyltransferase verder te ka-
rakteriseren en te zuiveren was het noodzakelijk een verbe-
terde enzymbepaling te ontwikkelen. Allereerst werd een 
stabiel substraat voor enzymatische acetylering 
gesynthetiseerd (Hoofdstuk II) Daartoe werd een analogon van 
het o-MSH-(1-10)-decapeptide met norleucine i.p.v methionine 
op plaats 4 bereid. Dit [ Nie1" ¡decapeptide is een even goed 
substraat voor enzymatische acetylering als het originele 
decapeptide, dat methionine bevat Daarna werd een snelle en 
specifieke test voor N -acetyltransferase activiteit ontwik-
keld (Hoofdstuk III) Hierbij wordt gebruik gemaakt van zure 
precipitatie voor verwijdeling van de producten, die resul-
teren uit acetylering van endogene substraten in het 
enzympreparaat Isolatie van het N-teiminaal geacetyleerde 
synthetisch substraat geschiedt m.b ν reverse-phase HPLC. 
De kracht van deze methode ligt in zijn snelle, niet te be­
werkelijke en redelijk nauwkeurige bepaling van activiteit 
tijdens isolatie en zuivering. 
De isolatie en karakterisatie van het kalfslens 
N -acetyltransferase wordt beschreven m Hoofdstuk IV Het 
enzym heeft een schijnbaar moleculair gewicht van 170.000 en 
een isoelectnsch punt van ongeveer 5. Een stabiel preparaat 
kan in goede opbrengst verkregen worden door 
ultracentnfugatie van een 15 000 g supernatant van 
gehomogeniseerde lens in een isokinetische glycerol gradient 
(zuivering ca. 5-voudig) . Pogingen om het enzym verder te 
zuiveren op grond van zijn isoelectnsch punt strandden van­
wege de extreme instabiliteit na een dergelijke stap. 
Niettemin resulteerde isoelectn sehe focusenng in een hori­
zontaal bed van Sephadex-IEF in een vier- tot 
achthonderdvoudige zuivering van het enzym De methode bleek 
echter moeilijk reproduceerbaar De schijnbare Michaelis 
constante van acetyl coenzym A, de acetyldonor, is 4,6 ± 0,3 μΜ 
in aanwezigheid van 0,31 mM substraat. Door gebruik te maken 
Van een aantal N-termmale ACTH-fragmenten, deels verkregen 
als gift, deels zelf gesynthetiseerd, werd vastgesteld dat de 
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minimale lengte nodig voor acetylenng, althans zoals bepaald 
met de bovengenoemde enzymbepaling, acht aminozuren is. 
Daarna neemt de snelheid van de acetylenng ruwweg lineair toe 
tot tenminste 39 residuen Tevens kon bevestigd worden dat 
het enzym een N-terminaal aminozuur met de L-configuratie no­
dig heeft. 
In Hoofdstuk V is gekeken naar de functie van de N-terminale 
acetylgroep bij de ooglenseiwitten, de crystallines. Een mo­
gelijke functie zou kunnen zijn het geven van bescherming te­
gen exopeptidasen. Een van de polyptides van α-crystalline, 
de aA--keten, die in vivo N-terminaal geacetyleerd is, kon be­
reid worden door celvrije translatie, waarbij de N-termmale 
acetylenng verhinderd werd door oxaalazijnzuur en 
citraatsynthase hieraan toe te voegen. Deze niet 
geacetyleerde ketens werden blootgesteld aan leucine 
aminopeptidase, een proteolytisch enzym, dat in relatief 
grote hoeveelheden in de kalfsiens aanwezig is. Slechts bij 
extreme enzym-substraat verhoudingen bleek het mogelijk de 
N-terminale methionine te -erwijderen Echter, het 
ongeacetyleerde N-terminaal tetrapeptide van de aA_-keten 
blijkt volledig gehydtolyseerd te worden in slechts enkele 
minuten. Het geacetyleerde tetrapeptide is volledig stabiel 
t.o.v. dit enzym ï-Crystalline, dat in vivo niet 
geacetyleerd is, is stabiel t o.v. leucine aminopeptidase. 
Het N-terminale tetrapeptide hiervan echter wordt binnen 
enige uren wel volledig verteerd Wij concluderen dat de 
N-terminale acetylgroep bescheiming geeft tegen de werking 
van exopeptidasen zonder essentieel te zijn voor deze func-
tie. De driedimensionale structuur van de crystallines op 
zich geeft al stabilisatie. Het enzym N -acetyltransferase 
blijkt zijn hoogste specifieke activiteit te hebben in die ge-
bieden van de lens, waar de eiwitsynthese plaats vindt en de 
a-ketens nog op het nbosoom geacetyleerd worden. Mogelijk is 
de acetylenng in die fase nog wel essentieel voor be-
scherming. 
In Hoofdstuk VI wordt de opheldering van de primaire struc-
tuur van het geblokkeerde N-terminale tryptische peptide van 
BBp, de belangrijkste keten van lens ß-crystalline, be-
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schreven. М.Ь. . massaspectrometrie werd aangetoond dat de 
N-terminale alanine N -geacetyleerd is. 
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SUMMARY 
Ν-terminal acetylation of proteins is a wide-spread phenom­
enon in eukaryotes and to a lesser extent in prokaryotes and 
viruses. Virtually nothing is known concerning the responsi­
ble mechanism and possible functional implications. Since 80 
% of the water-soluble lens proteins is N-terminally acety-
lated, it is interesting to study both these aspects in the 
relatively simply accessible lens system. An enzymatic 
N-terminally acetylating activity has been demonstrated in 
calf lens already several years ago 
In the period 1958-1981 the partial or complete sequence of 
361 proteins has been described which are N -acetylated. With 
the aid of these sequences the structural and other require­
ments for N -acetylation have been examined (Chapter I) It 
appears that N -acetylation is л phenomenon which is almost 
exclusively restricted to eukaryotes, and for a large part to 
structural proteins. N -acetylation is a post-imtiational 
process, requiring the presence of the enzyme 
N -acetyltransferase and the cofactor acetylcoenzyme A. En­
zymatic deacetylation does not appear to occur. 
N -acetyltransferases appear to have a narrow substrate spe­
cificity which is almost identical for enzymes from different 
tissues and species. The amino acids which are predominantly 
present at the N-terminus of acetylated proteins are alanine, 
serine and methionine. The presence of these residues is a 
very important prerequisite for N -acetylation The 
N-terminal region following these amino acids is also a major 
factor. For proteins starting with acetylmethionine the in­
formation necessary for acetylation is enclosed within the 
first three residues. The second position is always strongly 
hydrophilic, very often acidic. For acetylated proteins 
starting with alanine or serine the N -acetylation is deter­
mined by the first 4 and 5 residues, respectively. In both 
cases the overall hydrophobicity of this region must not be 
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extreme. Two- and three-dimensional structural character­
istics do not seem to play a decisive role in N -acetylation. 
In order to characterize and purify the 
Na-acetyltransferase from calf lens, it was necesssary to de­
velop a better assay. First a stable substrate for enzymatic 
acetylation was synthesized (Chapter II). To this end an ana­
log of o-MSH-(1-10J-decapeptide, having a norleucine instead 
of methionine at position 4, was prepared This [ Nie" ]decapep-
tide is as good a substrate for enzymatic acetylation as the 
original decapeptide which contains methionine. Thereafter a 
rapid and specific assay for N -acetyltransferase was devel­
oped (Chapter III) Use is made of acidic precipitation for 
removal of the products resulting from acetylation of endoge­
nous substrates from the enzyme preparation. Isolation of the 
N-termmally acetylated synthetic substrate is done by means 
of reversed phase HPLC The virtue of this assay can be found 
in its rapid, not too tedious and reasonably accurate determi­
nation of activity during isolation and purification. 
The isolation and characterization of bovine lens 
N -acetyltransferase is described in Chapter IV. The enzyme 
has an apparent relative molecular mass of 170,000 and an 
isoelectric point of about 5. A stable preparation can be ob­
tained in good yield by ultracentrifugation of a 15,000 g lens 
supernatant in an isokinetic glycerol gradient (purification 
about 5-fold). Attempts to further purify the enzyme on basis 
of its isoelectric point became unfeasible, because of the ex­
treme instability following such separation steps. 
Nevertheless, isoelectric focusing in a flatbed of Sepha-
dex-IEF yielded the enzyme in 400 to 800-fold purity. However, 
the procedure was difficult to reproduce. The apparent Mi­
chaelis constant for acetylcoenzyme A, the acetyldonor, is 
4.6 ± 0.3 μΜ in the presence of 0.31 mM substrate. By using se­
veral aminoterminal ACTH-fragments, partly obtained as a 
gift, partly synthesized, we could establish that the minimal 
length needed for enzymatic N -acetylation is at least 8 amino 
acids The rate of acetylation then increases roughly line­
arly with length up to at least 39 residues We confirmed that 
the enzyme needs an N-terminus with the L-configuration. 
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In Chapter V the function of the N-terminal acetylgroup of 
the lens proteins, the crystallins, has been investigated f 
possible function might be to provide protection against exo-
peptidases. One of the subunits of a-crystallin, the 
aA.-chain, which is N -acetylated in vivo, could be prepared 
by cell-free translation with prevention of M-terminal acety-
lation by adding oxaloacetate and citrate synthase. These 
non-acetylated chains were exposed to leucine aminopeptidase, 
a proteolytic enzyme, which is present in relatively large 
amount in bovine lens Only at extieme enzyme-substrate ra-
tios it was possible to remove the N-terminal methionine. 
However, the non-acetylated N-terminal tetrapeptide of 
ŒA_-chain appears to be hydrolyzed completely in only a few 
minutes. The acetylated tetrapeptide is comp',etely resist-
ant. T-Crystallm, which is non-acetylated in vivo, is stable 
with respect to leucine aminopeptidase Its N-termmal tetra-
peptide, however, is digested completely within a few hours. 
We conclude that the N-terminal acetylgroup gives protection 
against the action of exopeptidases without being essential 
for this function The three-diirensional structure of the 
crystallins in itself provides stabilization The enzyme 
N -acetyltransferase appears to havp its highest specific ac-
tivity in those areas of the lens where protein synthesis 
takes place and where aA_ is acetylated as a nascent chain on 
the ribosome. Possibly acetylation is essential for pro-
tection at that stage. 
In Chapter VI the elucidation of the primary structure of 
the blocked N-terminal tryptic peptide of BBp, the major sub-
unit of lens &-crystallin, is described The N-terminal ala-
nine residue was shown, by mass spectrometry, to be 
N -acetylated 
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ENZYMES 
Ν
α
-Acetyl transferase 
Carboxypeptidase A 
a-Chymotrypsin 
Citrate synthase 
Creatine kinase 
Elastase 
Lpucine aminopeptidase 
π
1
 rococcal nuclease 
Pepsin 
Proteinase К 
Ribonuclease A 
Trypsin 
EC 
EC 
EC 
EC 
EC 
EC 
EC 
EC 
EC 
EC 
EC 
EC 
2.З.1.-
3.4.17.1 
3.4.21 1 
4.1.3.7 
2.7.3.2 
3.4.21.11 
3.4.11.' 
3.1.31.1 
3.4.23.1 
3.4.21.14 
3.1.27.5 
3.4.21.4 
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ABBREVIATIONS 
A : absorbance 
Ac : acetyl 
ACTH : a d r e n o c o r t i c o t r o p i c hormone 
amino ac ids : for a short n o t a t i t i o n the one-letter 
code is used 
ATP : adenosine-5'-triphosphate 
В : Barton, staining agent 
BOC : ίβΛί.-butyloxycarbonyl 
B0C-0-B0C : di-ie/t-t.-butyldicarbonate 
n-BuOH : n-butanol 
Bu1" : tesit.-butyl 
В
н
-74 : Na-acetyltransferase preparation (con­
taining B M ) , obtained by centrifugation 
of S-15 at 74,000 χ g 
CHjCO-O-NPht : acetoxyphtalimide 
CHN : elemental analysis (carbon, hydrogen, 
nitrogen) 
CM : carboxymethyl 
DE : diethylaminoethyl 
DOC : sodium deoxycholate 
DTE : 1,4-dithioerythritol 
DTNB : 5,5'-dithiobis-2-nitrobenzoic acid 
DTT : 1,4-dithiothreitol 
EDTA : ethylenediaminetetraacetate 
EtOH : ethanol 
GTP : guanosine-S'-triphosphate 
H-ONSu : N-hydroxysuccinimide 
HPLC : high-performance liquid chromatography 
H.PO« : c.tido-phosphoric acid 
IEP-5.4 : Na-acetyltransferase preparation, ob­
tained by isoelectric precipitation of 
S-15 at pH 5.4 at 4i'C 
LAP : leucine aminopeptidase 
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LSC 
M
r 
MeOH 
a-MSH 
mRNA 
NH 2-NH 2 
m n 
Nie 
N0 + 
OBu* 
ONp 
PEG 
Pi 
Rf 
RNA 
S-15 
S^rensen's phosphate buffer 
TCA 
TDM 
TFA 
TLC 
Tris 
TRTPCK 
: liquid scintillation counting 
. relative molecular mass 
: methanol 
: α-melanocyte stimulating hormone 
messenger RNA 
: hydrazine 
• mnhydrin, staining agent 
: norleucine 
: nitrosomum ion 
: teAt.-butyloxy 
: pota-mtrophenyloxy 
: polyethylene glycol 
• isoelectr K point 
: re lat ive mobi l i ty 
: ribonucleic acid 
: crude lens extract , obtained by c e n t r i -
fugat'on of lens homogenate at 15,000 χ g 
кн 2Р0 4 Na 2HP0 4 
trichloroacetic acid 
4,4'-tetramethy1 di aminediphenylmethane, 
staining agent 
: trifluoroacetic acid 
: thin-layer chromatography 
: tris(hydroxymethylJaminomethane 
: trypsin treated with L-(l-tosylamido-
2-phenyl)ethyl chloromethyl ketone 
: benzyloxycarbonyl 
-197-

CURRICULUM VITAE 
Huub >и.еме.п. шала gebogen te. HoiAt (L^mbu/ig) op 27 maafit Ï953. Саия^ 
7965 volgde. k<j гги.ааеЛЬалл. oitdeAni-tji ααη heÂ. Jhomcu, a. Кетрлл Cotíege. te. 
AAnhem, тал ¿η 1971 heX дутшиит ß-cUptoma bthaaZd тела. 
In ¿гріетЬіЛ van datzelfde, JCWA begon kcj геп c.hejJu.eitu.cU.z cum de 
Katholceke. инихелиХелХ Nijmegen, ихшл -un 1974 heX ЫпаЫааХлгкатгп SZ 
aígelzgd WM.d. Pe doctonaatbtucUi omvaXte twee. hoofdvakken. Ali eeAite 
we/id ол.даплдске. chemce gedaan ¿.η de іоелкдіоер naXiuiutjo^en o.l.v. dn.. 
H.C.J. UttenheA.¡m en p>io(¡. dn.. R.J.F Utvand. H-ten wend деиіелкх. aan 
а--им.посллЬопгиил a^geteA-den a¿i рпгсимопл ооп zmvetoveAbimgde 
dLoxop.LpeAaz-<.neJi. AZí tuieede hoo&vab. мела biochemie gedaan -си de шелк-
ghoep рплшиле ¿¿лиеАшл o.l.v. dn. W.W. de Jong en pnof¡. du. H. bloemen-
dal. Ні.ел wend de рплмиле ¿tnucXuun van het оодІе ьелшЛ 6Βρ opgeZoit. 
ΜΑ шЛЬіеААспд van de hoofdvakken wenden aoUegei geZopen ¿.η de 
theon&tcbche. chemce., theoneXUiche NMR, ¿уилсііе. tnjm&pontmethoden, 
ian/nacolog-te en kZcn^iche chemce. Oe еглліе gnaadi l&ibevoegdheAÁ wend 
слНледеп, е епаіл de C-beuoegctfie-td voon de omgang met >Ladí04¿otopen. 
Vaannaait wend vzeZ aandacht beitzed aan compatznwetenichappen. In maant 
197S wend heX docXonaaltUploma venknegen. 
In ap>uZ van datzeZ^de ¡aan wend hcj aangezocht doon de afadeZingen 
bcochemce ipno^. dn. H. bloemendal en dn. W.W. de Jong) en окдапллсіхе 
cftemte [dn. G.I. Teiien) van de Katholieke UniveuitesX Nijmegen om ali 
wetenichappetíjk medejw&nkfi щ cUemt van de Nedenlandie ОпдапллаХхе 
voon IwLven WeXeYibchappeZA-jk Ondenzoek {Sttciitcng SOU) ondenzoek te doen 
aan de ojntnotznmtnale асеХуІелл-пд van e-uuctten. Vit plocfachnj-it voimt 
ксел ап heX ел&іад. Tevem venzongde KLJ medí heX chemLeondenuu-ji voon 
eeAAtejaau itudenten er een FORTRAN-силлил voon tweedejaau. 
Vanai 1 apliZ 19&3 zaZ kcj wenkzaam ZÍJ η аіл ¿ellow van de lunopean 
Hol&cuZan Biology Oigamzation (EMBÖ) op de a&deltng kiataZZogiaiie 
van het Scnkbeck College, ИммелиХелХ van ionden [hoo&d pno¿. ал. T.L. 
BlundeU). 
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STELLINGEN 
I 
Teneinde fouten bij het toekennen van aminozuren aan codons te vermijden (2 DÜ 
m het geval van de vier Drosophiia heat shock eiwitten die beschreven zijn door 
Ingoha en Craig) verdient het aanbeveling deze omzetting te doen m b ν een 
gecontroleerd computer programma 
Ingoha, Τ D and Cra ig, E A (1982) Proc Nat. Acad. Sci. USA 79, 2360-2364 
II 
Door sommige "wetenschappers" werden onlangs enige eigenschappen van 
mer-rhodanese van de soorten Guiñees biggetje {Lepus camculus) en albino rat 
(Mus muscufus) beschreven Het moet m deze kr ingen nog bekend worden dat 
de muis (Mus musculus) met hetzelfde is als de rat (Rattus norvegicus), noch 
het Guiñees biggetje (Cavia porceHus) identiek met de haas (Lepus europaeus) 
of het konijn (Oryctoiagus cumculus) 
Anosike, E O and Jack, A S (1982) Enzyme 27, 33-39 
III 
In de biotechnologie dient men er rekening mee te houden dat een in vivo 
N-terminaal geacetyleerd eiwit na produkt ie als deel van een chimeer eiwit in 
Escherichia coli alsnog geacetyleerd moet worden 
Wetzel, R , Heyneker, H L , Goeddel, D V , Jhuram, Ρ , Shapiro, J , Crea, 
R , Low, Τ L К , McClure, J E , Thurman, G В and Goldstein, A L. (1980) 
Biochemistry 19, 6096-6104 
IV 
Het is met geoorloofd slechts op grond van de primaire s t r u c t u u r van een 
protease van prokaryotische oorsprong en de overeenkomst met enkele 
aminozuren m de active site van de pancreatische senneproteases te stel len, 
dat de C-termmus zich ver van de potentiële active site van het betrokken eiwit 
bevindt 
Drapeau, G R (1978) Can J Biochem. 56, 534-544 
Drapeau, G R (1978) J. Б/о/. Chem. 253, 5899-5901 
V 
Het toepassen van genclonering (Baralle et al.) maakt de klacht van Gale et a/. 
over het wegvallen van hun onderzoeksobject overbodig Het betref t hier het 
ethisch problematische menselijk embryonaal hemoglobine, dat door een nieuwe 
techniek voor het beëindigen van zwangerschap in het eerste tr imester nog maar 
in geringe mate ter beschikking komt 
Baralle, F E , Shoulders, С С and Proudfoot, N J (1980) Cell 21, 621-626 
Gale, R E , Clegg, J В and Huehns, E R (1979) Nature 280, 162-164 
VI 
De moleculair-evolutionaire klok, ofwel de hypothese van een prakt isch con­
stante ammozuursubstitutiesnelheid over langere t i j d , is een sterk omstreden 
punt in de evolutiebiologie Het toepassen van di t concept in de 
paleoantropologie is dan ook geen beslissend argument ten gunste van de op­
vatt ing dat de voorouders van de mens en de mensapen pas 5 miljoen jaar ge­
leden uit elkaar gegaan zijn ten opzichte van de klassieke opvatt ingen die 
divergentieti jden tot rond 20 miljoen jaar voorstaan 
Goodman, M. (1981) J. Mol. Evo!. 17, 114-120. 
Kimura, M (1981) J. Mol. Evol. 17, 110-113. 
Sanch. V M. and Wilson, А С (1967) Science 158, 1200-1203. 
Strien, W van (1982) De Volkskrant, il dec., ρ 25 
V I I 
Behalve als toevoeging blijken ook van nature m ons voedsel stoffen voor te 
komen die potentieel bedreigend zijn. In basale voedingsmiddelen als melk en 
brood komen namelijk exorfmes (stoffen die opiaatachtige werking vertonen) 
voor of kunnen eruit ontstaan, waarvan (althans voor die uit gluten) een rol 
verondersteld wordt in de etiología van enige ziekten, waaronder schizofrenie. 
Brantl, V . , Teschemacher, H , Bläsig, J . , Menschen, A and Lottspeich, F. 
(1981) Life Sci. 28, 1903-1909. 
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